WO2024203572A1 - Copolymer and contact lens treatment solution - Google Patents
Copolymer and contact lens treatment solution Download PDFInfo
- Publication number
- WO2024203572A1 WO2024203572A1 PCT/JP2024/010658 JP2024010658W WO2024203572A1 WO 2024203572 A1 WO2024203572 A1 WO 2024203572A1 JP 2024010658 W JP2024010658 W JP 2024010658W WO 2024203572 A1 WO2024203572 A1 WO 2024203572A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- copolymer
- formula
- contact lens
- carbon atoms
- group
- Prior art date
Links
- 229920001577 copolymer Polymers 0.000 title claims abstract description 88
- 238000011282 treatment Methods 0.000 title claims description 55
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 23
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 20
- 125000005702 oxyalkylene group Chemical group 0.000 claims abstract description 18
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 33
- 125000002947 alkylene group Chemical group 0.000 claims description 9
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 6
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 claims description 5
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- 239000000470 constituent Substances 0.000 abstract description 5
- 239000000243 solution Substances 0.000 description 90
- 239000000178 monomer Substances 0.000 description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 41
- 238000006243 chemical reaction Methods 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 36
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 32
- 238000011156 evaluation Methods 0.000 description 26
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 25
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 23
- 230000000052 comparative effect Effects 0.000 description 20
- -1 ethyl 2-(trimethylammonio)ethyl phosphate Chemical compound 0.000 description 19
- 238000005227 gel permeation chromatography Methods 0.000 description 19
- 238000000034 method Methods 0.000 description 19
- 229920000642 polymer Polymers 0.000 description 19
- 238000006116 polymerization reaction Methods 0.000 description 19
- 238000012360 testing method Methods 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 15
- 239000003054 catalyst Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 229910052757 nitrogen Inorganic materials 0.000 description 13
- 239000002504 physiological saline solution Substances 0.000 description 13
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- 238000000502 dialysis Methods 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 238000004821 distillation Methods 0.000 description 10
- WRTVTCFELAEIEQ-YVLHZVERSA-N o-(1,3-benzothiazol-2-yl) (2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoethanethioate Chemical compound N=1C2=CC=CC=C2SC=1OC(=S)\C(=N/OC)C1=CSC(N)=N1 WRTVTCFELAEIEQ-YVLHZVERSA-N 0.000 description 9
- 230000003204 osmotic effect Effects 0.000 description 9
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 8
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000011521 glass Substances 0.000 description 8
- 125000006353 oxyethylene group Chemical group 0.000 description 8
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 7
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 6
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 6
- 229910001873 dinitrogen Inorganic materials 0.000 description 6
- 230000002688 persistence Effects 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- YHHSONZFOIEMCP-UHFFFAOYSA-N 2-(trimethylazaniumyl)ethyl hydrogen phosphate Chemical group C[N+](C)(C)CCOP(O)([O-])=O YHHSONZFOIEMCP-UHFFFAOYSA-N 0.000 description 5
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000007870 radical polymerization initiator Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 230000002459 sustained effect Effects 0.000 description 4
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000882 contact lens solution Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229920001515 polyalkylene glycol Polymers 0.000 description 3
- 230000000379 polymerizing effect Effects 0.000 description 3
- 238000010526 radical polymerization reaction Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- UZKWTJUDCOPSNM-UHFFFAOYSA-N 1-ethenoxybutane Chemical compound CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- RJKPEKIHHFNMGS-UHFFFAOYSA-N 2,4-ditert-butyl-3-methylphenol Chemical compound CC1=C(C(C)(C)C)C=CC(O)=C1C(C)(C)C RJKPEKIHHFNMGS-UHFFFAOYSA-N 0.000 description 2
- TZTMSSSFELKJNL-UHFFFAOYSA-N 2-acetamidoethyl 2-methylprop-2-enoate Chemical compound CC(=O)NCCOC(=O)C(C)=C TZTMSSSFELKJNL-UHFFFAOYSA-N 0.000 description 2
- MKTOIPPVFPJEQO-UHFFFAOYSA-N 4-(3-carboxypropanoylperoxy)-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OOC(=O)CCC(O)=O MKTOIPPVFPJEQO-UHFFFAOYSA-N 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229920003081 Povidone K 30 Polymers 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 102100032889 Sortilin Human genes 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 2
- 230000000274 adsorptive effect Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Chemical class 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 150000004292 cyclic ethers Chemical class 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000004210 ether based solvent Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000012812 general test Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000001451 organic peroxides Chemical class 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Chemical class 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 108010014657 sortilin Proteins 0.000 description 2
- 239000003381 stabilizer Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229920001567 vinyl ester resin Polymers 0.000 description 2
- 229960000834 vinyl ether Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- FVQMJJQUGGVLEP-UHFFFAOYSA-N (2-methylpropan-2-yl)oxy 2-ethylhexaneperoxoate Chemical compound CCCCC(CC)C(=O)OOOC(C)(C)C FVQMJJQUGGVLEP-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CYIGRWUIQAVBFG-UHFFFAOYSA-N 1,2-bis(2-ethenoxyethoxy)ethane Chemical compound C=COCCOCCOCCOC=C CYIGRWUIQAVBFG-UHFFFAOYSA-N 0.000 description 1
- AYMDJPGTQFHDSA-UHFFFAOYSA-N 1-(2-ethenoxyethoxy)-2-ethoxyethane Chemical compound CCOCCOCCOC=C AYMDJPGTQFHDSA-UHFFFAOYSA-N 0.000 description 1
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 description 1
- OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 description 1
- OVGRCEFMXPHEBL-UHFFFAOYSA-N 1-ethenoxypropane Chemical compound CCCOC=C OVGRCEFMXPHEBL-UHFFFAOYSA-N 0.000 description 1
- JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- LPQTVHUEAIDBBY-UHFFFAOYSA-N 2,3-ditert-butyl-6-methoxyphenol Chemical compound COC1=CC=C(C(C)(C)C)C(C(C)(C)C)=C1O LPQTVHUEAIDBBY-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 description 1
- HPQIRFXIDGVWBA-UHFFFAOYSA-N 2-[13,17,18,21-tetrahydroxy-7-(hydroxymethyl)-2,10,14-trioxo-5-(3,4,5-trihydroxybenzoyl)oxy-3,6,9,15-tetraoxatetracyclo[10.7.1.14,8.016,20]henicosa-1(19),16(20),17-trien-11-yl]acetic acid Chemical compound OC1C2OC(=O)C(C3=4)=CC(O)=C(O)C=4OC(=O)C(O)C3C(CC(O)=O)C(=O)OC1C(CO)OC2OC(=O)C1=CC(O)=C(O)C(O)=C1 HPQIRFXIDGVWBA-UHFFFAOYSA-N 0.000 description 1
- SBYMUDUGTIKLCR-UHFFFAOYSA-N 2-chloroethenylbenzene Chemical compound ClC=CC1=CC=CC=C1 SBYMUDUGTIKLCR-UHFFFAOYSA-N 0.000 description 1
- VUIWJRYTWUGOOF-UHFFFAOYSA-N 2-ethenoxyethanol Chemical compound OCCOC=C VUIWJRYTWUGOOF-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- AGBXYHCHUYARJY-UHFFFAOYSA-N 2-phenylethenesulfonic acid Chemical compound OS(=O)(=O)C=CC1=CC=CC=C1 AGBXYHCHUYARJY-UHFFFAOYSA-N 0.000 description 1
- VFXXTYGQYWRHJP-UHFFFAOYSA-N 4,4'-azobis(4-cyanopentanoic acid) Chemical compound OC(=O)CCC(C)(C#N)N=NC(C)(CCC(O)=O)C#N VFXXTYGQYWRHJP-UHFFFAOYSA-N 0.000 description 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical class ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- VWWQXMAJTJZDQX-UHFFFAOYSA-N Flavine adenine dinucleotide Natural products C1=NC2=C(N)N=CN=C2N1C(C(O)C1O)OC1COP(O)(=O)OP(O)(=O)OCC(O)C(O)C(O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 1
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- PVCJKHHOXFKFRP-UHFFFAOYSA-N N-acetylethanolamine Chemical compound CC(=O)NCCO PVCJKHHOXFKFRP-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical group [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229920005603 alternating copolymer Polymers 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003373 anti-fouling effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000002585 base Chemical class 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- PZXSLFQJOZPCJG-UHFFFAOYSA-N bis[2-(5-methyl-4,5-dihydro-1h-imidazol-2-yl)propan-2-yl]diazene;dihydrochloride Chemical compound Cl.Cl.N1C(C)CN=C1C(C)(C)N=NC(C)(C)C1=NCC(C)N1 PZXSLFQJOZPCJG-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 238000012662 bulk polymerization Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- DGLRDKLJZLEJCY-UHFFFAOYSA-L disodium hydrogenphosphate dodecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O DGLRDKLJZLEJCY-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 239000003759 ester based solvent Substances 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940113094 isopropylparaben Drugs 0.000 description 1
- 239000005453 ketone based solvent Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- QYZFTMMPKCOTAN-UHFFFAOYSA-N n-[2-(2-hydroxyethylamino)ethyl]-2-[[1-[2-(2-hydroxyethylamino)ethylamino]-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCNCCO QYZFTMMPKCOTAN-UHFFFAOYSA-N 0.000 description 1
- PNLUGRYDUHRLOF-UHFFFAOYSA-N n-ethenyl-n-methylacetamide Chemical compound C=CN(C)C(C)=O PNLUGRYDUHRLOF-UHFFFAOYSA-N 0.000 description 1
- RQAKESSLMFZVMC-UHFFFAOYSA-N n-ethenylacetamide Chemical compound CC(=O)NC=C RQAKESSLMFZVMC-UHFFFAOYSA-N 0.000 description 1
- ZQXSMRAEXCEDJD-UHFFFAOYSA-N n-ethenylformamide Chemical compound C=CNC=O ZQXSMRAEXCEDJD-UHFFFAOYSA-N 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229940093158 polyhexanide Drugs 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- BWJUFXUULUEGMA-UHFFFAOYSA-N propan-2-yl propan-2-yloxycarbonyloxy carbonate Chemical compound CC(C)OC(=O)OOC(=O)OC(C)C BWJUFXUULUEGMA-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- GQTHJBOWLPZUOI-FJXQXJEOSA-M sodium D-pantothenate Chemical compound [Na+].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O GQTHJBOWLPZUOI-FJXQXJEOSA-M 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 229940068459 sodium pantothenate Drugs 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000012756 surface treatment agent Substances 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- OPQYOFWUFGEMRZ-UHFFFAOYSA-N tert-butyl 2,2-dimethylpropaneperoxoate Chemical compound CC(C)(C)OOC(=O)C(C)(C)C OPQYOFWUFGEMRZ-UHFFFAOYSA-N 0.000 description 1
- NMOALOSNPWTWRH-UHFFFAOYSA-N tert-butyl 7,7-dimethyloctaneperoxoate Chemical compound CC(C)(C)CCCCCC(=O)OOC(C)(C)C NMOALOSNPWTWRH-UHFFFAOYSA-N 0.000 description 1
- WKEWCYHGACEYTR-UHFFFAOYSA-N tert-butyl decaneperoxoate Chemical compound CCCCCCCCCC(=O)OOC(C)(C)C WKEWCYHGACEYTR-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K3/00—Materials not provided for elsewhere
Definitions
- the present invention relates to a copolymer and a treatment solution for contact lenses.
- Surface treatment agents have been widely proposed that can impart surface hydrophilicity, biocompatibility, antithrombogenicity, etc. due to phosphorylcholine groups by treating the surfaces of various materials with phosphorylcholine group-containing copolymers.
- Applications include hydrophilization treatment to hydrophobic substrates, antifouling treatment of industrial filter surfaces, and surface treatment to suppress the adsorption of proteins and cells to medical polymer materials. In particular, they have been used in soft contact lenses in recent years.
- the comfort of wearing soft contact lenses is closely related to the hydrophilicity and lubricity of the lens surface, and maintaining these properties for a long period of time leads to sustained comfort when worn all day.
- Patent Document 1 discloses a technique in which soft contact lenses are subjected to plasma treatment and hydrophilized with zwitterionic groups.
- Patent Document 2 discloses a technique in which a soft contact lens containing reactive groups is chemically reacted with and bonded to a hydrophilic polymer having reactive groups, thereby hydrophilizing the surface of the soft contact lens. These techniques involve treating the soft contact lens itself to impart hydrophilicity to the surface, and because the treatment process is complicated, they require highly controlled manufacturing equipment tailored to the treatment technology, which can be economically disadvantageous.
- Patent Documents 3, 4, and 5 which incorporate polyethylene glycol or a cellulose-based polymer into a treatment solution for soft contact lenses to impart and enhance hydrophilicity to the surface of soft contact lenses and improve wearing comfort.
- phosphorylcholine group-containing polymers have a structure similar to phospholipids derived from biological membranes, and are known to have excellent properties such as being very hydrophilic and having high moisturizing properties.
- Patent Document 6 discloses a technology that improves the wearing comfort by adding a copolymer of a phosphorylcholine group-containing monomer and butyl methacrylate to a treatment solution for soft contact lenses.
- the present invention aims to provide a copolymer that can easily impart hydrophilicity and lubricity to the surface of a soft contact lens and maintain these properties for a long period of time, and a contact lens treatment solution using the copolymer.
- the present invention comprises the following [1] to [4].
- R 1 and R 2 each independently represent a hydrogen atom or a methyl group.
- X represents O or NR 3 , where R 3 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.
- R 4 O represents an oxyalkylene group having 2 to 4 carbon atoms, R 4 O contains at least two kinds of oxyalkylene groups having different carbon numbers, and the addition form thereof may be either block or random, and p represents the average number of moles of oxyalkylene groups added, which is a number from 4 to 100.
- [2] The copolymer according to [1], wherein the copolymer has a constitutional unit represented by the following formula (C) or (D), and the sum of the molar ratios nC and nD of the constitutional units represented by the following formula ( C ) or (D) relative to the entire copolymer is more than 0 mol% and 50 mol% or less.
- R 5 is H or a methylene group
- R 6 is an alkyl group having 1 to 5 carbon atoms, or when R 5 is a methylene group, an alkylene group having 1 to 5 carbon atoms, the end of which is bonded to R 5 to form a cyclic structure.
- R 7 is a hydrogen atom or a methyl group
- Y is O or NR 10
- R 10 is H or an alkyl group having 1 to 4 carbon atoms
- E 1 is a structure represented by formula (E)
- E 1 is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, or a structure represented by formula (E).
- R 8 is H or an alkyl group having 1 to 4 carbon atoms
- R 9 is a hydrogen atom or an alkyl group having 1 to 18 carbon atoms.
- the copolymer of the present invention can impart excellent hydrophilicity and lubricity to the surface of soft contact lenses, and these properties are sustainable. Therefore, the copolymer of the present invention is suitable as a treatment solution for soft contact lenses.
- FIG. 1 is a drawing for explaining wb and wf in a chromatogram (vertical axis: refractive index intensity, horizontal axis: retention time).
- (meth)acrylate means “acrylate or methacrylate,” and the same applies to other similar terms.
- an alkyl group may be either linear or branched.
- all day refers to the period from when contact lenses are first worn to when they are finished being worn in one day, and is assumed to be 8 to 16 hours of continuous wear.
- Long periods refers to the time contact lenses are worn throughout the day.
- compositions containing the copolymer of the present invention include compositions that are applied directly to the eye, and compositions used to treat devices worn on the eye, such as contact lenses, and can be specified as follows. Specific examples include contact lens treatment solutions. Further, specific product forms of the contact lens treatment solution of the present invention include contact lens packing solutions (contact lens shipping solutions), contact lens storage solutions, contact lens cleaning solutions, contact lens cleaning and storage solutions, contact lens disinfectants, contact lens wearing agents, etc.
- shipping solution for soft contact lenses refers to a solution that is sealed in a packaging container such as a blister package together with soft contact lenses when the soft contact lenses are distributed. Since soft contact lenses are generally used in a state where they are swollen with an aqueous solution, the lenses are sealed in a packaging container in a state where they are swollen with an aqueous solution when shipped from the factory so that they can be used immediately.
- the copolymer (P) of the present invention contains constitutional units represented by the following formulas (A) and (B), the molar ratio nA of the constitutional units represented by the following formula (A) to the whole copolymer (P) is 10 to 80 mol %, the molar ratio nB of the constitutional units represented by the following formula (B) to the whole copolymer (P) is 20 to 90 mol %, and the weight average molecular weight is 10,000 to 2,000,000.
- R 1 and R 2 each independently represent a hydrogen atom or a methyl group.
- X in formula (A) is O or NR 3 , where R 3 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.
- R 4 O in formula (B) represents an oxyalkylene group having 2 to 4 carbon atoms, R 4 O contains at least two kinds of oxyalkylene groups having different carbon numbers, and the addition form thereof may be either block or random, and p represents the average number of moles of oxyalkylene groups added and is a number from 4 to 100.
- the copolymer (P) used in the present invention has a constitutional unit represented by general formula (A).
- the constitutional unit is obtained by polymerizing a monomer having a phosphorylcholine structure represented by the following general formula (a) (hereinafter, also referred to as a "PC monomer").
- PC monomer a monomer having a phosphorylcholine structure represented by the following general formula (a)
- hydrophilicity can be imparted to the soft contact lens.
- R 1 represents a hydrogen atom or a methyl group
- X represents O or NR 3
- R 3 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.
- the PC monomer is preferably 2-((meth)acryloyloxy)ethyl 2-(trimethylammonio)ethyl phosphate, and more preferably 2-(methacryloyloxy)ethyl 2-(trimethylammonio)ethyl phosphate (hereinafter also referred to as "2-methacryloyloxyethyl phosphorylcholine”) represented by the following formula (a').
- the content of the structural unit represented by formula (A) in the copolymer (P) (molar ratio n A ) is 10-80 mol%, preferably 15-75 mol%, more preferably 25-65 mol%, and even more preferably 30-55%. If the molar ratio n A is less than 10 mol%, the effect of improving the hydrophilicity of the soft contact lens surface cannot be expected, and if the molar ratio n A is more than 80 mol%, the content of the structural unit represented by formula (B) is reduced, the adsorption force of the copolymer (P) to the soft contact lens surface is reduced, and the durability of the good wearing feeling is insufficient.
- the effect of improving the hydrophilicity and lubricity of the soft contact lens surface can be further enhanced by adjusting the ratio of the structural unit represented by formula (A) and the structural unit represented by formula (B).
- the copolymer (P) used in the present invention has a constitutional unit represented by the following formula (B).
- the constitutional unit is obtained by polymerizing a monomer represented by the following general formula (b), that is, a monomer having a polyalkylene glycol structure (hereinafter also referred to as "PAG monomer").
- PAG monomer a monomer having a polyalkylene glycol structure
- the copolymer (P) may also contain multiple structural units represented by the following (B) having different values of p.
- R2 represents a hydrogen atom or a methyl group
- R4O represents an oxyalkylene group having 2 to 4 carbon atoms
- R4O includes at least two types of oxyalkylene groups having different numbers of carbon atoms.
- Formula (b) is, for example, a polyalkylene glycol mono(meth)acrylate containing at least two of oxyalkylene groups selected from oxyethylene groups (-CH 2 CH 2 O-), oxypropylene groups (-CH(CH 3 )CH 2 O-, -CH 2 CH(CH 3 )O-), and oxybutylene groups (-CH(CH 2 CH 3 )CH 2 O-, -CH 2 CH(CH 2 CH 3 )O-, -CH(CH 3 )CH(CH 3 )O-), in which the addition form of R 4 O may be either block or random, and p represents the average number of moles of oxyalkylene groups added, p being a number from 4 to 100.
- oxyalkylene groups selected from oxyethylene groups (-CH 2 CH 2 O-), oxypropylene groups (-CH(CH 3 )CH 2 O-, -CH 2 CH(CH 3 )O-), and oxybutylene groups (-CH(CH 2 CH 3
- the oxyalkylene groups in formulae (B) and (b) preferably have a form consisting of an oxyethylene group and an oxypropylene group, an oxyethylene group and an oxybutylene group, an oxypropylene group and an oxybutylene group, or an oxypropylene group, an oxyethylene group and an oxybutylene group, and more preferably have a form consisting of an oxyethylene group and an oxypropylene group.
- the molar ratio of oxyethylene groups to the number of moles of all oxyalkylene groups added is 0-90%, preferably 40-90%, and more preferably 60-80%.
- the molar ratio of oxypropylene groups added is 0-70%, more preferably 10-50%, and the molar ratio of oxybutylene groups added is 0-70%, more preferably 0-30%.
- the molar ratio of oxyethylene groups added is more than 90%, the ratios of oxypropylene groups and oxybutylene groups are relatively reduced, and the adsorptive force to the contact lens surface is reduced.
- the oxypropylene groups and oxybutylene groups exceed 70%, the cohesive force between the copolymers (P) becomes excessive, and the transparency of the resulting contact lens treatment solution and the contact lens after treatment is deteriorated.
- the monomer represented by formula (b) is a monomer having a ratio wb/wf of wb to wf calculated from a chromatogram (vertical axis: refractive index intensity, horizontal axis: retention time) obtained by gel permeation chromatography ( GPC) measurement using a differential refractometer , which satisfies the following formula (1): 1.10 ⁇ w b /w f ⁇ 2.50 (1) (In formula (1), when the retention time at the maximum peak height (h) in the peak of the chromatogram is th and two retention times at 1/10 (h 1/10 ) of the maximum peak height are tf and tb (where tf ⁇ tb ), wf represents the difference between th and tf ( th - tf ), and wb represents the difference between tb and th ( tb - th )) is preferably satisfied (see FIG. 1).
- the wb / wf of the monomer (b) is smaller than 1.10, the molecular weight distribution of the monomer (b) may be biased toward the high molecular weight side, the concentration of the polymerizable functional group may be reduced, and the polymerizability of the monomer (b) may be reduced.
- the wb / wf is preferably 1.20 or more, and more preferably 1.30 or more.
- the adsorptivity of the copolymer (P) to the surface of a soft contact lens may decrease.
- wb / wf is 2.00 or less, more preferably 1.80 or less.
- the chromatogram for calculating w b /w f (vertical axis: refractive index intensity, horizontal axis: retention time) was obtained by using an EcoSEC GPC calculation program, with a gel permeation chromatography (GPC) system equipped with an HLC-8320GPC (registered trademark), a guard column equipped with a SHODEXKF-G, and three SHODEXKF804L columns in series, a column temperature of 40° C., tetrahydrofuran as a developing solvent flowing at a flow rate of 1 mL/min, and 0.1 mL of a 0.1 wt % tetrahydrofuran solution of polyalkylene glycol mono(meth)acrylate injected.
- GPC gel permeation chromatography
- the content (molar ratio n B ) of the structural unit represented by formula (B) in copolymer (P) is 20 to 90 mol %, preferably 25 to 85 mol %, more preferably 35 to 75 mol %, and even more preferably 45 to 70 mol %.
- copolymer (P) used in the present invention has a monomer represented by formula (B) as a structural unit, the adsorptive power of copolymer (P) to the surface of a soft contact lens can be improved, and the durability of the wearing comfort can be improved.
- the content of the structural unit represented by formula (B) is preferably greater than the content of the structural unit represented by formula (A) (molar ratio nA ). This further enhances the effect of improving the hydrophilicity and lubricity of the soft contact lens surface.
- the ratio of the molar ratio nA to the molar ratio nB ( nB / nA ) is preferably 0.5 to 7.0, and more preferably 1.0 to 3.0.
- p is 4 to 100, preferably 5 to 70, and more preferably 7 to 40. If p is less than 4, the adhesive force of the copolymer (P) to the surface of a soft contact lens decreases, and if it is greater than 100, the cohesive force between the copolymers (P) becomes strong, and the transparency of the resulting contact lens treatment solution and the contact lens after treatment deteriorates.
- the above formula (b) can be produced by adding ethylene oxide, propylene oxide, or butylene oxide (preferably propylene oxide or ethylene oxide) to a starting material (e.g., 2-hydroxypropyl methacrylate) in the presence of a composite metal cyanide complex catalyst (hereinafter sometimes referred to as "DMC catalyst").
- a composite metal cyanide complex catalyst hereinafter sometimes referred to as "DMC catalyst”
- the starting material and the DMC catalyst are added to a reaction vessel, and at least two of ethylene oxide, propylene oxide, and butylene oxide (hereinafter collectively referred to as "alkylene oxides having 2 to 4 carbon atoms") are added continuously or intermittently under stirring in an inert gas atmosphere to carry out addition polymerization.
- the alkylene oxides having 2 to 4 carbon atoms may be added under pressure or at atmospheric pressure.
- the reaction temperature for adding an alkylene oxide having 2 to 4 carbon atoms to the starting material is preferably 50°C to 120°C, and more preferably 70°C to 90°C. If the reaction temperature is lower than 50°C, the reaction rate is very slow, and if it is higher than 120°C, problems such as polymerization of the polymerizable groups in the starting material and discoloration occur.
- a known DMC catalyst can be used in the present invention, for example, the DMC catalyst described in JP-A-2022-130139.
- a particularly preferred DMC catalyst is Zn(II) 3 [Co(III)(CN) 6 ] 2 (H 2 O) 4 (tert-butyl alcohol) 2 .
- the amount of the DMC catalyst used is not particularly limited, but is preferably 0.0001 to 0.1 parts by mass, and more preferably 0.001 to 0.05 parts by mass, per 100 parts by mass of the monomer represented by formula (b).
- the DMC catalyst may be added to the reaction system all at once at the beginning, or may be added in portions one by one. After the polymerization reaction is completed, the DMC catalyst is removed.
- the catalyst can be removed by known methods such as filtration, centrifugation, or treatment with a synthetic adsorbent.
- hydroquinone (HQ), hydroquinone monomethyl ether (MQ), 2,6-di-tert-butylhydroxytoluene (BHT), di-tert-butylhydroxyanisole (BHA), ⁇ -tocopherol, ⁇ -tocopherol, ⁇ -tocopherol, etc. may be added to the reaction system as a polymerization inhibitor.
- the polymerization inhibitor is preferably MQ and/or BHT, more preferably BHT.
- the amount of polymerization inhibitor added is preferably 0.001 to 0.3 parts by mass per 100 parts by mass of the total of the starting material (e.g., 2-hydroxypropyl methacrylate) and the alkylene oxide having 2 to 4 carbon atoms. If the amount added is less than 0.001 part by mass, the function of the polymerization inhibitor becomes insufficient, and gelation may occur during the addition of the alkylene oxide having 2 to 4 carbon atoms. If the amount added is more than 0.3 parts by mass, the purity of the resulting compound of formula (1b') may be low.
- the copolymer (P) used in the present invention may contain a structural unit represented by the following formula (C) or (D).
- the structural unit is obtained by polymerizing a monomer represented by the following general formula (c) or (d), respectively.
- R 5 is H or a methylene group
- R 6 is an alkyl group having 1 to 5 carbon atoms, or when R 5 is a methylene group, R 6 is an alkylene group having 1 to 5 carbon atoms that is bonded to R 5 to form a cyclic structure.
- R 7 is a hydrogen atom or a methyl group
- Y is O or NR 10
- R 10 is H or an alkyl group having 1 to 4 carbon atoms
- E 1 is a structure represented by formula (E)
- E 1 is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, or a structure represented by formula (E).
- R 8 is H or an alkyl group having 1 to 4 carbon atoms
- R 9 is a hydrogen atom or an alkyl group having 1 to 18 carbon atoms.
- Examples of the monomer represented by formula (c) include N-vinylpyrrolidone, N-vinylcaprolactam, N-vinylformamide, N-vinylacetamide, and N-methyl-N-vinylacetamide.
- Examples of the monomer represented by formula (d) include N-methyl(meth)acrylamide, N-ethyl(meth)acrylamide, N-propyl(meth)acrylamide, N-isopropyl(meth)acrylamide, N-butyl(meth)acrylamide, N-tert-butyl(meth)acrylamide, N,N-dimethyl(meth)acrylamide, N,N-diethyl(meth)acrylamide, 2-(acetylamino)ethyl(meth)acrylate, 2-(stearamido)ethyl(meth)acrylate, and 2-palmitamidoethyl(meth)acrylate.
- copolymer (P) contains structural units represented by formula (C) and formula (D), the total content of the structural unit represented by formula (C) (molar ratio n C ) and the content of the structural unit represented by formula (D) (molar ratio n D ) in copolymer (P) is preferably more than 0 mol and not more than 50 mol%, and more preferably 10 to 50 mol%.
- the monomer in which E 1 in the formula (d) is the formula (E) is, for example, as described in JP 2017-160380 A, which can be synthesized by an esterification reaction between an alcohol having an amide structure at its terminal and (meth)acrylic acid or (meth)acrylic acid chloride.
- Copolymer (P) may contain polymerizable monomers other than the PC monomer, PAG monomer, and the structural units represented by (c) or (d) within a range that does not impair the effects of the present invention.
- the blending ratio of these monomers may be appropriately selected within a range that does not affect the effects of the present invention, but it is preferable that the copolymer (P) is composed only of the PC monomer and PAG monomer.
- the other monomers may be, for example, polymerizable monomers selected from linear or branched alkyl (meth)acrylates, cyclic alkyl (meth)acrylates, aromatic group-containing (meth)acrylates, styrene-based monomers, vinyl ether monomers, vinyl ester monomers, hydroxyl group-containing (meth)acrylates, carboxyl group-containing monomers, and sulfonyl group-containing monomers.
- polymerizable monomers selected from linear or branched alkyl (meth)acrylates, cyclic alkyl (meth)acrylates, aromatic group-containing (meth)acrylates, styrene-based monomers, vinyl ether monomers, vinyl ester monomers, hydroxyl group-containing (meth)acrylates, carboxyl group-containing monomers, and sulfonyl group-containing monomers.
- linear or branched alkyl (meth)acrylate examples include methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, butyl (meth)acrylate, ethylhexyl (meth)acrylate, lauryl (meth)acrylate, stearyl (meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, and triethylene glycol di(meth)acrylate.
- cyclic alkyl (meth)acrylates examples include cyclohexyl (meth)acrylate.
- aromatic group-containing (meth)acrylates include benzyl (meth)acrylate and phenoxyethyl (meth)acrylate.
- styrene monomer examples include styrene, methylstyrene, and chlorostyrene.
- vinyl ether monomer include methyl vinyl ether, propyl vinyl ether, butyl vinyl ether, triethylene glycol divinyl ether, and ethylene glycol monovinyl ether.
- vinyl ester monomers include vinyl acetate and vinyl propionate.
- hydrophilic hydroxyl group-containing (meth)acrylates examples include hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, hydroxybutyl (meth)acrylate, and glycerol (meth)acrylate.
- carboxyl group-containing monomer and the sulfonyl group-containing monomer include (meth)acrylic acid, styrenesulfonic acid, and (meth)acryloyloxyphosphonic acid.
- the weight average molecular weight of the copolymer (P) is 10,000 to 2,000,000, preferably 20,000 or more, more preferably 30,000 or more, even more preferably 40,000 or more, and preferably 1,000,000 or less, more preferably 500,000 or less, and even more preferably 300,000 or less.
- weight-average molecular weight is less than 10,000, the adhesive force to the soft contact lens surface will decrease, and the effect of the copolymer (P) on the soft contact lens surface may not be sustained. If the weight-average molecular weight is more than 2,000,000, the viscosity may increase, making handling difficult.
- the weight average molecular weight of the copolymer (P) is the value measured by gel permeation chromatography (GPC).
- the copolymer (P) can be prepared by copolymerizing the above-mentioned monomers. It is usually a random copolymer, but may be an alternating copolymer or a block copolymer in which the monomers are regularly arranged, or may have a graft structure in part.
- a mixture of the monomers can be subjected to radical polymerization in the presence of a radical polymerization initiator under an inert gas atmosphere such as nitrogen, carbon dioxide, argon, or helium to obtain a copolymer (P).
- a radical polymerization initiator under an inert gas atmosphere such as nitrogen, carbon dioxide, argon, or helium to obtain a copolymer (P).
- the radical polymerization method can be carried out by known methods such as bulk polymerization, suspension polymerization, emulsion polymerization, and solution polymerization. Of the radical polymerization methods, solution polymerization is preferred from the viewpoint of purification, etc.
- the copolymer (P) can be purified by general purification methods such as reprecipitation, dialysis, and ultrafiltration.
- radical polymerization initiator examples include an azo-based radical polymerization initiator, an organic peroxide, and a persulfate.
- examples of the azo radical polymerization initiator include 2,2'-azobis(2-methylpropionamidine) dihydrochloride (V-50), 2,2'-azobis(2-diaminopropyl) dihydrochloride, 2,2'-azobis(2-(5-methyl-2-imidazolin-2-yl)propane) dihydrochloride, 4,4'-azobis(4-cyanovaleric acid), 2,2'-azobisisobutyronitrile dihydrate, 2,2'-azobis(2,4-dimethylvaleronitrile), and 2,2'-azobisisobutyronitrile (AIBN).
- V-50 2,2'-azobis(2-methylpropionamidine) dihydrochloride
- 2,2'-azobis(2-diaminopropyl) dihydrochloride 2,2'-azobis(2-(5
- organic peroxides examples include t-butyl peroxyneodecanate (Perbutyl (registered trademark) ND), benzoyl peroxide, diisopropyl peroxydicarbonate, t-butyl peroxy-2-ethylhexanoate, t-butyl peroxypivalate, t-butyl peroxyisobutyrate, lauroyl peroxide, t-butyl peroxydecanoate, and succinic acid peroxide (succinyl peroxide).
- persulfate oxides include ammonium persulfate, potassium persulfate, and sodium persulfate.
- radical polymerization initiators can be used alone or in combination of two or more.
- the amount of the polymerization initiator used is usually 0.001 to 10 parts by mass, preferably 0.02 to 5.0 parts by mass, and more preferably 0.03 to 3.0 parts by mass, based on 100 parts by mass of the total of the monomers.
- the polymerization reaction of the copolymer (P) can be carried out in the presence of a solvent.
- the solvent is not particularly limited as long as it dissolves each monomer composition and is not reactive itself, and examples of the solvent include water, alcohol solvents, ketone solvents, ester solvents, linear or cyclic ether solvents, and nitrogen-containing solvents.
- the alcohol solvent include methanol, ethanol, n-propanol, and isopropanol.
- the ketone solvent include acetone, methyl ethyl ketone, and diethyl ketone.
- An example of the ester solvent is ethyl acetate.
- linear or cyclic ether solvents examples include ethyl cellosolve and tetrahydrofuran.
- nitrogen-containing solvents include acetonitrile, nitromethane, and N-methylpyrrolidone.
- a mixed solvent of water and an alcohol is preferred.
- the soft contact lens treatment solution of the present invention has a concentration of copolymer (P) of 0.001 w/v % or more, preferably 0.01 w/v % or more, more preferably 0.05 w/v % or more, and 5.0 w/v % or less, preferably 2.0 w/v % or less, more preferably 1.0 w/v % or less.
- the concentration of the copolymer (P) is less than 0.001 w/v%, the amount of the copolymer (P) added is so small that sufficient hydrophilicity and lubricity and their durability cannot be obtained, whereas if the concentration exceeds 5.0 w/v%, the sterile filtration performed during production may become difficult.
- w/v % refers to the mass of a certain component in 100 mL of solution, expressed in grams (g).
- the treatment solution of the present invention contains 1.0 w/v % copolymer (P)” means that 100 mL of solution contains 1.0 g of copolymer (P).
- the solvent used in the treatment solution of the present invention may be water, ethanol, n-propanol, isopropanol, glycerol, alcohol such as propylene glycol, or a mixture of these. Water or a mixture of water and alcohol is preferred, and water is more preferred.
- the water used in the contact lens treatment solution of the present invention can be water that is normally used in the manufacture of pharmaceuticals and medical devices. Specifically, ion-exchanged water, purified water, sterilized purified water, distilled water, and water for injection can be used.
- the contact lens treatment solution of the present invention may contain other ingredients, such as vitamins, amino acids, sugars, thickening agents, cooling agents, inorganic salts, salts of organic acids, acids, bases, antioxidants, stabilizers, preservatives, etc., as necessary.
- vitamins include sodium flavin adenine dinucleotide, cyanocobalamin, retinol acetate, retinol palmitate, pyridoxine hydrochloride, panthenol, sodium pantothenate, calcium pantothenate, and the like.
- the amino acids include aspartic acid or a salt thereof, and aminoethylsulfonic acid.
- sugars include glucose, mannitol, sorbitol, xylitol, and trehalose.
- thickening agents include hydroxypropylmethylcellulose and hydroxyethylcellulose.
- cooling agent include menthol and camphor.
- inorganic salts include sodium chloride, potassium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, anhydrous sodium dihydrogen phosphate, potassium dihydrogen phosphate, and dipotassium hydrogen phosphate.
- the salts of organic acids include sodium citrate and the like. Examples of the acid include phosphoric acid, citric acid, sulfuric acid, acetic acid, hydrochloric acid, and boric acid.
- Examples of the base include potassium hydroxide, sodium hydroxide, borax, trishydroxymethylaminomethane, monoethanolamine, and the like.
- Examples of the antioxidant include tocopherol acetate and dibutylhydroxytoluene.
- examples of stabilizers include sodium edetate, glycine, and taurine.
- Examples of preservatives include benzalkonium chloride, chlorhexidine gluconate, potassium sorbate, methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, polyhexanide hydrochloride, and sulfamexazole.
- the pH of the contact lens treatment solution of the present invention is preferably 3.0 to 8.0, more preferably 3.5 to 7.8, even more preferably 4.0 to 7.6, and still more preferably 4.5 to 7.5.
- the pH of the contact lens treatment solution refers to a value measured in accordance with the 18th Edition of the Japanese Pharmacopoeia, General Test Method 2.54 pH Measurement Method.
- the osmotic pressure of the contact lens treatment solution of the present invention is preferably 200 to 400 mOsm, more preferably 225 to 375 mOsm, even more preferably 230 to 350 mOsm, and even more preferably 240 to 340 mOsm.
- the osmotic pressure ratio is preferably 0.7 to 1.4, more preferably 0.7 to 1.3, and even more preferably 0.8 to 1.2.
- the osmotic pressure of the contact lens treatment solution refers to a value measured in accordance with the 18th Edition of the Japanese Pharmacopoeia, General Test Method 2.47 Osmotic Pressure Measurement Method (Osmolarity Measurement Method), and the osmotic pressure ratio refers to a value obtained by dividing the obtained osmotic pressure value by the osmotic pressure value (286 mOsm) of 0.9 mass % physiological saline solution.
- the soft contact lens treatment solution of the present invention can be produced by a general method for producing a contact lens solution. For example, it can be produced by mixing and stirring the polymer (P), a solvent and other components as necessary.
- the obtained soft contact lens treatment solution may be subjected to a procedure such as sterilization filtration as necessary.
- the reaction mixture was filtered to remove the precipitate, and the filtrate was washed with water, a saturated aqueous solution of sodium bicarbonate, and a saturated aqueous solution of sodium chloride in that order, and then dried with sodium sulfate.
- the mixture was concentrated under reduced pressure with a rotary evaporator to obtain an oily product.
- the mixture was further purified by silica gel chromatography using hexane and ethyl acetate as eluents, and the example compound 2-(acetylamino)ethyl methacrylate was obtained.
- the structure was confirmed by 1 H NMR.
- 2-(acetylamino)ethyl methacrylate (MAEM) was synthesized according to the procedure described in JP-A-2017-160380.
- MPC 2-methacryloyloxyethyl phosphorylcholine (product of NOF Corporation)
- MAEM 2-(acetylamino)ethyl methacrylate (synthesized in Synthesis Example 1-3)
- NVP N-vinylpyrrolidone (product of Fujifilm Wako Pure Chemical Industries, Ltd.) Table 1 summarizes the corresponding formulas of the compounds used.
- PB-ND Perbutyl (registered trademark) ND
- Lens A One Day Fine UV Plus, a soft contact lens (a product of Seed Co., Ltd.)
- Lens B AQUAFORCE UV, a soft contact lens (a product of Aimi Co., Ltd.)
- a physiological saline solution was prepared with reference to the literature (ISO 18369-3:2017, Ophthalmic Optics-Contact Lenses Part 3: Measurement Methods.). 8.3 g of sodium chloride, 5.993 g of sodium hydrogen phosphate dodecahydrate, and 0.528 g of sodium dihydrogen phosphate dihydrate were weighed out, dissolved in water to make 1000 mL, and filtered to make physiological saline solution.
- Example 2-1> The solution of copolymer 1 was dissolved in a predetermined amount of physiological saline to prepare a 5 wt % polymer solution as shown in Table 2 below. Furthermore, 2 g of the polymer solution was mixed with 98 g of physiological saline to prepare a contact lens treatment solution as shown in Table 2 below. Test contact lenses treated with this contact lens treatment solution were evaluated for hydrophilicity, lubricity and durability. The evaluation results are shown in Table 2 below.
- Examples 2-2 to 2-9 The hydrophilicity, lubricity and durability of test contact lenses treated with contact lens treatment solutions prepared according to the same procedure as in Example 1 were evaluated, except that the polymers shown in Tables 2 and 3 were used. The evaluation results are shown in Tables 2 and 3.
- the surface hydrophilicity of the soft contact lenses was evaluated according to the following procedure: Surface hydrophilicity evaluation assuming the start of wearing the soft contact lenses (1) 10 mL of physiological saline was added to a 15 mL conical tube, and five test contact lenses removed from the blister pack were immersed in the solution, and the lenses were shaken at room temperature for 6 hours at a rotation speed of 50 rpm using a roller mixer. (2) The test contact lenses were taken out and each was placed in a 10 mL glass vial containing 5 mL of the prepared soft contact lens treatment solution. (3) The container was sterilized at 121°C for 20 minutes. (4) The test contact lens was removed from the glass vial, and the time (BUT) until the water film on the lens surface disappeared was measured with a stopwatch and evaluated according to the following criteria.
- test contact lens taken out of the glass vial was immersed in the saline solution, followed by shaking at 80 rpm at 37° C. for 4 hours using a shaker.
- the test contact lenses were removed from the 12-well plate, and the time (BUT) until the water film on the lens surface disappeared was measured with a stopwatch and evaluated according to the following criteria.
- the evaluation assuming the end of wearing takes into account the actual tear volume and blink rate throughout the day, and estimates the condition of the contact lenses after wearing them all day (12 hours of continuous wear).
- the evaluation criteria are as follows: 4 points: 20 seconds or more 3 points: 15 seconds or more 2 points: 10 seconds or more but less than 15 seconds 1 point: 5 seconds or more but less than 10 seconds 0 point: Less than 5 seconds
- the lubricity evaluation of the contact lenses was carried out according to the following procedure: Lubricity evaluation assuming the start of wearing soft contact lenses (1) 10 mL of physiological saline was added to a 15 mL conical tube, and five test contact lenses removed from a blister pack were immersed in the solution, and the solution was shaken at room temperature for 6 hours at a rotation speed of 50 rpm using a roller mixer. (2) The test contact lenses were taken out and each was placed in a 10 mL glass vial containing 5 mL of the prepared soft contact lens treatment solution. (3) The container was sterilized at 121°C for 20 minutes.
- test contact lens was removed from the glass vial, and the friction coefficient in physiological saline was measured using a nanotribometer NTR3 (probe material: polypropylene, load: 2 mN, movement distance: 1.00 mm, speed: 0.1 mm/s), and the results were evaluated according to the following criteria.
- Lubricity evaluation assuming the end of wearing soft contact lenses (1) 10 mL of physiological saline was added to a 15 mL conical tube, and five test contact lenses removed from their blister packs were immersed in the solution, followed by shaking at room temperature for 6 hours at a rotation speed of 50 rpm using a roller mixer. (2) The test contact lenses were taken out and each was placed in a 10 mL glass vial containing 5 mL of the prepared soft contact lens treatment solution. (3) The container was sterilized at 121°C for 20 minutes. (4) 2 mL of physiological saline was added to one well of a 12-well plate, and one test contact lens taken out of the glass vial was immersed in the saline solution, followed by shaking at 80 rpm at 37° C.
- test contact lenses were removed from the 12-well plate, and the friction coefficient was measured using a nanotribometer NTR3 (probe material: polypropylene, load: 2 mN, movement distance: 1.00 mm, speed: 0.1 mm/s) and evaluated according to the following criteria.
- the evaluation assuming the end of wearing takes into account the actual tear volume and blink rate throughout the day, and estimates the condition of the contact lenses after wearing them all day (12 hours of continuous wear).
- the evaluation criteria are as follows: 4 points: less than 0.30 3 points: 0.30 or more, less than 0.5 2 points: 0.50 or more, less than 1.0 1 point: 1.0 or more, less than 1.5 0 point: 1.5 or more
- ⁇ Sustainability evaluation> the durability was evaluated based on the evaluation results of hydrophilicity and lubricity and was evaluated according to the following criteria.
- the scores for the assumed time at the start and end of wearing were reduced by 2 points in either evaluation.
- the scores for the assumed time at the start and end of wearing were reduced by 2 points in both evaluations, or the scores for the assumed time at the start and end of wearing were reduced by 3 points or more in either evaluation.
- the contact lens treatment solutions of Examples 2-2, 2-4, 2-5, and 2-9 were able to impart excellent hydrophilicity and excellent lubricity to the surface of soft contact lenses at the start and end of wear, and the persistence of these properties was also very good. That is, the contact lens treatment solutions of Examples 2-2, 2-4, 2-5, and 2-9 were able to impart an excellent wearing sensation to soft contact lenses for a long period of time due to their excellent hydrophilicity and lubricity and the persistence of these properties.
- the contact lens treatment solutions of Examples 2-7 and 2-8 were able to impart good hydrophilicity and good lubricity to the surface of soft contact lenses at the start and end of wear, and the persistence of these properties was also very good.
- the contact lens treatment solutions of Examples 2-7 and 2-8 were able to impart good wearing comfort to soft contact lenses for long periods of time due to their good hydrophilicity and good lubricity and the persistence of these properties.
- the contact lens treatment solutions of Examples 2-1, 2-3, and 2-6 were able to impart good hydrophilicity and good lubricity to the surface of soft contact lenses at the start and end of wear, and the persistence of these properties was also good. That is, the contact lens treatment solutions of Examples 2-1, 2-3, and 2-6 were able to impart good wearing comfort to soft contact lenses for long periods of time due to their good hydrophilicity and lubricity and the persistence of these properties.
- the contact lens treatment solution of Comparative Example 1-1 had good hydrophilicity at the start of use compared to the other Examples, but was significantly inferior in durability.
- the contact lens treatment solution of Comparative Example 1-2 had good hydrophilicity as expected at the start of wearing, but did not have sufficient lubricity and was not comfortable to wear.
- the contact lens treatment solution of Comparative Example 1-3 had good hydrophilicity as expected at the start of use, but did not have sufficient lubricity, and the durability and wearing comfort were also insufficient.
- the contact lens treatment solution of Comparative Example 1-4 had good hydrophilicity as expected at the start of wearing, but did not have sufficient lubricity and was extremely poor in durability.
- the contact lens treatment solution of Comparative Example 1-5 provided a good wearing sensation as expected at the beginning of use, but was significantly inferior in durability.
- the soft contact lens treatment solution of the present invention By using the soft contact lens treatment solution of the present invention on soft contact lenses, it is possible to impart excellent wearing comfort to the soft contact lenses all day (for a long period of time).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Provided is a copolymer that can easily impart hydrophilic properties and lubricity properties to the surface of soft contact lenses, and superior long-lastingness to said properties. The copolymer has constituent units represented by formulas (A) and (B). A molar ratio nA of the constituent unit represented by formula (A) in relation to the entirety of the copolymer (P) is 10-80 mol%, a molar ratio nB of the constituent unit represented by formula (B) in relation to the entirety of the copolymer (P) is 20-90 mol%, and the weight-average molecular weight of the copolymer is 10,000-2,000,000. [In formula (A) and formula (B), R1 and R2 individually represent a hydrogen atom or a methyl group. X in formula (A) is O or NR3, R3 being a hydrogen atom or an alkyl group having a carbon number of 1-4. R4O in formula (B) represents an oxyalkylene group having a carbon number of 2-4, R4O including at least two types of oxyalkylene groups with different carbon numbers, an additional form of these may be block or random, and p represents the average number of moles of the oxyalkylene groups added and is a number from 4-100.]
Description
本発明は、共重合体及びコンタクトレンズ用処理液に関する。
The present invention relates to a copolymer and a treatment solution for contact lenses.
従来、ホスホリルコリン基含有共重合体を各種材料表面に処理することにより、ホスホリルコリン基に起因する表面親水性、生体適合性、抗血栓性等を付与しうる表面処理剤が広く提案されている。その用途としては、疎水性基材を親水化するための親水化処理、工業用フィルター表面の防汚処理、医療用高分子材料に対する蛋白質や細胞の吸着抑制のための表面処理等が挙げられる。特に近年では、ソフトコンタクトレンズに用いられている。
Surface treatment agents have been widely proposed that can impart surface hydrophilicity, biocompatibility, antithrombogenicity, etc. due to phosphorylcholine groups by treating the surfaces of various materials with phosphorylcholine group-containing copolymers. Applications include hydrophilization treatment to hydrophobic substrates, antifouling treatment of industrial filter surfaces, and surface treatment to suppress the adsorption of proteins and cells to medical polymer materials. In particular, they have been used in soft contact lenses in recent years.
ソフトコンタクトレンズの装用感には、レンズ表面の親水性や潤滑性が大きく関わっており、これらを長時間良好なまま維持することが、終日快適に装着する装用感の持続につながる。
The comfort of wearing soft contact lenses is closely related to the hydrophilicity and lubricity of the lens surface, and maintaining these properties for a long period of time leads to sustained comfort when worn all day.
このようにレンズの装着感を持続させるための技術として、例えば、特許文献1及び2に記載の技術が知られている。特許文献1には、ソフトコンタクトレンズにプラズマ処理を施し、双性イオン基で親水化処理を行う技術が開示されている。また、特許文献2には、反応性基を含有させたソフトコンタクトレンズと反応性基を有する親水性ポリマーとを化学的に反応させて結合し、ソフトコンタクトレンズ表面を親水化する技術が開示されている。これらはソフトコンタクトレンズ自体に処理を施して表面に親水性を付与するものであり、処理工程が複雑であることから、高度に管理され、処理技術に合わせた製造設備が必要となり経済的に不利となる面があった。
Technologies for maintaining the fit of the lenses include those described in Patent Documents 1 and 2, for example. Patent Document 1 discloses a technique in which soft contact lenses are subjected to plasma treatment and hydrophilized with zwitterionic groups. Patent Document 2 discloses a technique in which a soft contact lens containing reactive groups is chemically reacted with and bonded to a hydrophilic polymer having reactive groups, thereby hydrophilizing the surface of the soft contact lens. These techniques involve treating the soft contact lens itself to impart hydrophilicity to the surface, and because the treatment process is complicated, they require highly controlled manufacturing equipment tailored to the treatment technology, which can be economically disadvantageous.
このような問題を解決する技術として、例えば、特許文献3、4、及び5にはソフトコンタクトレンズ用処理液へポリエチレングリコールやセルロース系高分子を配合することでソフトコンタクトレンズ表面に親水性を付与、増強し、装用感を改善する技術が知られている。
Technologies for solving such problems are known, for example, from Patent Documents 3, 4, and 5, which incorporate polyethylene glycol or a cellulose-based polymer into a treatment solution for soft contact lenses to impart and enhance hydrophilicity to the surface of soft contact lenses and improve wearing comfort.
また、ホスホリルコリン基含有重合体は、生体膜に由来するリン脂質類似構造を有しており、非常に親水性が高く、保湿性が高い等の優れた性質を有することが知られている。例えば、特許文献6には、ホスホリルコリン基含有単量体とブチルメタクリレー卜との共重合体をソフトコンタクトレンズ用処理液に添加することで、装用感を改善した技術が開示されている。
Furthermore, phosphorylcholine group-containing polymers have a structure similar to phospholipids derived from biological membranes, and are known to have excellent properties such as being very hydrophilic and having high moisturizing properties. For example, Patent Document 6 discloses a technology that improves the wearing comfort by adding a copolymer of a phosphorylcholine group-containing monomer and butyl methacrylate to a treatment solution for soft contact lenses.
しかしながら、特許文献3、4、5及び6に記載のソフトコンタクトレンズ用処理液を用いたコンタクトレンズは、装用初期における装用感に優れるものの、共重合体及び配合成分のコンタクトレンズ表面への吸着が十分でなく、良好な装用感の持続は一時的なものだった。
However, although contact lenses using the soft contact lens treatment solutions described in Patent Documents 3, 4, 5, and 6 provide excellent comfort when worn at the beginning of use, the copolymer and blended ingredients are not sufficiently adsorbed to the contact lens surface, and the good comfort is only sustained temporarily.
本発明は、上記課題に鑑み、簡便にソフトコンタクトレンズ表面へ親水性及び潤滑性を付与でき、かつそれらを長時間持続できる共重合体及びこれを用いたコンタクトレンズ用処理液を提供することを目的とする。
In view of the above problems, the present invention aims to provide a copolymer that can easily impart hydrophilicity and lubricity to the surface of a soft contact lens and maintain these properties for a long period of time, and a contact lens treatment solution using the copolymer.
本発明者らは、鋭意検討した結果、少なくとも特定の2種類の単量体を共重合させることで得られる新規の共重合体が上記目的を達成できることを見出し、本発明を完成するに至った。
After extensive research, the inventors discovered that the above-mentioned objectives could be achieved by copolymerizing at least two specific types of monomers, leading to the completion of the present invention.
すなわち、本発明は以下の[1]~[4]よりなる。
[1].下記式(A)及び(B)で表される構成単位を有し、共重合体全体に対する下記式(A)で表される構成単位のモル比率nAが10~80モル%であり、共重合体全体に対する下記式(B)で表される構成単位のモル比率nBが20~90モル%であり、重量平均分子量が10,000~2,000,000である共重合体。
[前記式(A)及び式(B)中、R1及びR2はそれぞれ独立に水素原子又はメチル基を示す。式(A)中のXはO又はNR3、ここでR3は水素原子又は炭素数1~4のアルキル基である。式(B)中のR4Oは炭素数2~4のオキシアルキレン基を示し、R4Oは炭素数が異なる少なくとも2種のオキシアルキレン基を含み、それらの付加形態はブロックまたはランダムのいずれでもよく、およびpはオキシアルキレン基の平均付加モル数を示し、4~100の数である。]
[2].前記共重合体が、下記式(C)または(D)で表される構成単位を有し、共重合体全体に対する下記式(C)または(D)で表される構成単位のモル比率nCおよびnDの合計が0モル%より多く50モル%以下である、[1]に記載の共重合体。
[前記式(C)中、R5はHまたはメチレン基であり、R6は炭素数1~5のアルキル基、またはR5がメチレン基である場合は末端がR5に結合し環状構造を形成している炭素数1~5のアルキレン基である。式(D)中、R7は水素原子またはメチル基であり、YはOまたはNR10、ここで、R10はHまたは炭素数1~4のアルキル基であり、YがOの場合は、E1は式(E)で表される構造であり、YがNR10の場合は、E1は水素原子または炭素数1~4のアルキル基または式(E)で表される構造である。式(E)中、R8はHまたは炭素数1~4のアルキル基、R9は水素原子または炭素数1~18のアルキル基である。]
[3].前記構成単位(A)が2-(メタクリロイルオキシ)エチル2-(トリメチルアンモニオ)エチルホスフェートに由来する構成単位である、[1]または[2]に記載の共重合体。
[4].[1]から[3]のいずれか一項に記載の共重合体(P)を0.001w/v%以上、5.0w/v%以下含有する、コンタクトレンズ用処理液。 That is, the present invention comprises the following [1] to [4].
[1] A copolymer having constitutional units represented by the following formulas (A) and (B), in which the molar ratio nA of the constitutional units represented by the following formula (A) to the entire copolymer is 10 to 80 mol %, the molar ratio nB of the constitutional units represented by the following formula (B) to the entire copolymer is 20 to 90 mol %, and the weight average molecular weight is 10,000 to 2,000,000.
[In the formulas (A) and (B), R 1 and R 2 each independently represent a hydrogen atom or a methyl group. In formula (A), X represents O or NR 3 , where R 3 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms. In formula (B), R 4 O represents an oxyalkylene group having 2 to 4 carbon atoms, R 4 O contains at least two kinds of oxyalkylene groups having different carbon numbers, and the addition form thereof may be either block or random, and p represents the average number of moles of oxyalkylene groups added, which is a number from 4 to 100.]
[2] The copolymer according to [1], wherein the copolymer has a constitutional unit represented by the following formula (C) or (D), and the sum of the molar ratios nC and nD of the constitutional units represented by the following formula ( C ) or (D) relative to the entire copolymer is more than 0 mol% and 50 mol% or less.
[In the formula (C), R 5 is H or a methylene group, R 6 is an alkyl group having 1 to 5 carbon atoms, or when R 5 is a methylene group, an alkylene group having 1 to 5 carbon atoms, the end of which is bonded to R 5 to form a cyclic structure. In the formula (D), R 7 is a hydrogen atom or a methyl group, Y is O or NR 10 , where R 10 is H or an alkyl group having 1 to 4 carbon atoms, when Y is O, E 1 is a structure represented by formula (E), and when Y is NR 10 , E 1 is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, or a structure represented by formula (E). In the formula (E), R 8 is H or an alkyl group having 1 to 4 carbon atoms, and R 9 is a hydrogen atom or an alkyl group having 1 to 18 carbon atoms.]
[3] The copolymer according to [1] or [2], wherein the structural unit (A) is a structural unit derived from 2-(methacryloyloxy)ethyl 2-(trimethylammonio)ethyl phosphate.
[4] A contact lens treatment solution containing 0.001 w/v % or more and 5.0 w/v % or less of the copolymer (P) according to any one of [1] to [3].
[1].下記式(A)及び(B)で表される構成単位を有し、共重合体全体に対する下記式(A)で表される構成単位のモル比率nAが10~80モル%であり、共重合体全体に対する下記式(B)で表される構成単位のモル比率nBが20~90モル%であり、重量平均分子量が10,000~2,000,000である共重合体。
[2].前記共重合体が、下記式(C)または(D)で表される構成単位を有し、共重合体全体に対する下記式(C)または(D)で表される構成単位のモル比率nCおよびnDの合計が0モル%より多く50モル%以下である、[1]に記載の共重合体。
[3].前記構成単位(A)が2-(メタクリロイルオキシ)エチル2-(トリメチルアンモニオ)エチルホスフェートに由来する構成単位である、[1]または[2]に記載の共重合体。
[4].[1]から[3]のいずれか一項に記載の共重合体(P)を0.001w/v%以上、5.0w/v%以下含有する、コンタクトレンズ用処理液。 That is, the present invention comprises the following [1] to [4].
[1] A copolymer having constitutional units represented by the following formulas (A) and (B), in which the molar ratio nA of the constitutional units represented by the following formula (A) to the entire copolymer is 10 to 80 mol %, the molar ratio nB of the constitutional units represented by the following formula (B) to the entire copolymer is 20 to 90 mol %, and the weight average molecular weight is 10,000 to 2,000,000.
[2] The copolymer according to [1], wherein the copolymer has a constitutional unit represented by the following formula (C) or (D), and the sum of the molar ratios nC and nD of the constitutional units represented by the following formula ( C ) or (D) relative to the entire copolymer is more than 0 mol% and 50 mol% or less.
[3] The copolymer according to [1] or [2], wherein the structural unit (A) is a structural unit derived from 2-(methacryloyloxy)ethyl 2-(trimethylammonio)ethyl phosphate.
[4] A contact lens treatment solution containing 0.001 w/v % or more and 5.0 w/v % or less of the copolymer (P) according to any one of [1] to [3].
本発明の共重合体は、優れた親水性及び潤滑性とそれらの持続性をソフトコンタクトレンズ表面に付与できる。そのため、本発明の共重合体は、ソフトコンタクトレンズ用処理液として好適である。
The copolymer of the present invention can impart excellent hydrophilicity and lubricity to the surface of soft contact lenses, and these properties are sustainable. Therefore, the copolymer of the present invention is suitable as a treatment solution for soft contact lenses.
以下、本発明を詳しく説明する。
The present invention is explained in detail below.
本明細書において、「(メタ)アクリレート」とは、「アクリレート又はメタクリレート」を意味し、他の類似用語についても同様である。また、本明細書において、アルキル基とは、直鎖でも分岐していてもよい。
In this specification, "(meth)acrylate" means "acrylate or methacrylate," and the same applies to other similar terms. In this specification, an alkyl group may be either linear or branched.
本明細書において、「終日」とは、一日においてコンタクトレンズ装着開始時からコンタクトレンズ装用終了までの期間であり、連続装着8~16時間を想定している。また、「長時間」とはコンタクトレンズを装着する終日の時間を指す。
In this specification, "all day" refers to the period from when contact lenses are first worn to when they are finished being worn in one day, and is assumed to be 8 to 16 hours of continuous wear. "Long periods" refers to the time contact lenses are worn throughout the day.
また、本明細書において、好ましい数値範囲(例えば、濃度や重量平均分子量の範囲)を段階的に記載した場合、各下限値及び上限値は、それぞれ独立して組み合わせることができる。例えば、「好ましくは10以上、より好ましくは20以上、そして、好ましくは100以下、より好ましくは90以下」という記載において、「好ましい下限値:10」と「より好ましい上限値:90」とを組合せて、「10以上90以下」とすることができる。また、例えば、「好ましくは10~100、より好ましくは20~90」という記載においても、同様に「10~90」とすることができる。
In addition, when preferred numerical ranges (e.g., ranges of concentration or weight average molecular weight) are described in stages in this specification, the lower and upper limits can be combined independently. For example, in the description "preferably 10 or more, more preferably 20 or more, and preferably 100 or less, more preferably 90 or less," the "preferred lower limit: 10" and the "more preferred upper limit: 90" can be combined to read "10 or more and 90 or less." Also, in the description "preferably 10 to 100, more preferably 20 to 90," the range can be similarly set to "10 to 90."
本発明の共重合体を含む組成物の製品形態としては、眼に直接付与する組成物、およびコンタクトレンズ等の眼に装着する機器を処理するために用いる組成物が含まれ、次のようなものを明示することができる。具体的には、コンタクトレンズ用処理液などが挙げられる。さらに本発明のコンタクトレンズ用処理液の具体的な製品形態としては、コンタクトレンズ用パッキング液(コンタクトレンズ出荷液)、コンタクトレンズ用保存液、コンタクトレンズ用洗浄液、コンタクトレンズ用洗浄保存液、コンタクトレンズ消毒剤、コンタクトレンズ装着薬等が挙げられる。
Product forms of the composition containing the copolymer of the present invention include compositions that are applied directly to the eye, and compositions used to treat devices worn on the eye, such as contact lenses, and can be specified as follows. Specific examples include contact lens treatment solutions. Further, specific product forms of the contact lens treatment solution of the present invention include contact lens packing solutions (contact lens shipping solutions), contact lens storage solutions, contact lens cleaning solutions, contact lens cleaning and storage solutions, contact lens disinfectants, contact lens wearing agents, etc.
本明細書において、ソフトコンタクトレンズ用出荷液とは、ソフトコンタクトレンズを流通する際にソフトコンタクトレンズと共にブリスターパッケージ等の包装容器に封入される溶液のことである。一般にソフトコンタクトレンズは水溶液で膨潤した状態で使用するため、レンズは工場出荷時に水溶液で膨潤した状態で、すぐに使用できるように包装容器へ封入されている。
In this specification, shipping solution for soft contact lenses refers to a solution that is sealed in a packaging container such as a blister package together with soft contact lenses when the soft contact lenses are distributed. Since soft contact lenses are generally used in a state where they are swollen with an aqueous solution, the lenses are sealed in a packaging container in a state where they are swollen with an aqueous solution when shipped from the factory so that they can be used immediately.
<共重合体(P)>
本発明の共重合体(P)は、下記式(A)及び(B)で表される構成単位を含み、共重合体(P)全体に対する下記式(A)で表される構成単位のモル比率nAが10~80モル%であり、共重合体(P)全体に対する下記式(B)で表される構成単位のモル比率nBが20~90モル%であり、重量平均分子量が10,000~2,000,000である。 <Copolymer (P)>
The copolymer (P) of the present invention contains constitutional units represented by the following formulas (A) and (B), the molar ratio nA of the constitutional units represented by the following formula (A) to the whole copolymer (P) is 10 to 80 mol %, the molar ratio nB of the constitutional units represented by the following formula (B) to the whole copolymer (P) is 20 to 90 mol %, and the weight average molecular weight is 10,000 to 2,000,000.
本発明の共重合体(P)は、下記式(A)及び(B)で表される構成単位を含み、共重合体(P)全体に対する下記式(A)で表される構成単位のモル比率nAが10~80モル%であり、共重合体(P)全体に対する下記式(B)で表される構成単位のモル比率nBが20~90モル%であり、重量平均分子量が10,000~2,000,000である。 <Copolymer (P)>
The copolymer (P) of the present invention contains constitutional units represented by the following formulas (A) and (B), the molar ratio nA of the constitutional units represented by the following formula (A) to the whole copolymer (P) is 10 to 80 mol %, the molar ratio nB of the constitutional units represented by the following formula (B) to the whole copolymer (P) is 20 to 90 mol %, and the weight average molecular weight is 10,000 to 2,000,000.
前記式(A)及び式(B)中、R1及びR2はそれぞれ独立に水素原子又はメチル基を示す。式(A)中のXはO又はNR3、ここでR3は水素原子又は炭素数1~4のアルキル基である。式(B)中のR4Oは炭素数2~4のオキシアルキレン基を示し、R4Oは炭素数が異なる少なくとも2種のオキシアルキレン基を含み、それらの付加形態はブロックまたはランダムのいずれでもよく、およびpは、オキシアルキレン基の平均付加モル数を示し、4~100の数である。
In the formulas (A) and (B), R 1 and R 2 each independently represent a hydrogen atom or a methyl group. X in formula (A) is O or NR 3 , where R 3 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms. R 4 O in formula (B) represents an oxyalkylene group having 2 to 4 carbon atoms, R 4 O contains at least two kinds of oxyalkylene groups having different carbon numbers, and the addition form thereof may be either block or random, and p represents the average number of moles of oxyalkylene groups added and is a number from 4 to 100.
[式(A)で表される構成単位]
本発明で用いられる共重合体(P)は、一般式(A)で表される構成単位を有する。該構成単位は、下記一般式(a)で表されるホスホリルコリン構造を有する単量体(以下、「PC単量体」ともいう。)を重合して得られる。共重合体(P)がPC単量体に由来する構成単位を含むことにより、ソフトコンタクトレンズに親水性を付与することができる。 [Structural unit represented by formula (A)]
The copolymer (P) used in the present invention has a constitutional unit represented by general formula (A). The constitutional unit is obtained by polymerizing a monomer having a phosphorylcholine structure represented by the following general formula (a) (hereinafter, also referred to as a "PC monomer"). By including a constitutional unit derived from a PC monomer in the copolymer (P), hydrophilicity can be imparted to the soft contact lens.
本発明で用いられる共重合体(P)は、一般式(A)で表される構成単位を有する。該構成単位は、下記一般式(a)で表されるホスホリルコリン構造を有する単量体(以下、「PC単量体」ともいう。)を重合して得られる。共重合体(P)がPC単量体に由来する構成単位を含むことにより、ソフトコンタクトレンズに親水性を付与することができる。 [Structural unit represented by formula (A)]
The copolymer (P) used in the present invention has a constitutional unit represented by general formula (A). The constitutional unit is obtained by polymerizing a monomer having a phosphorylcholine structure represented by the following general formula (a) (hereinafter, also referred to as a "PC monomer"). By including a constitutional unit derived from a PC monomer in the copolymer (P), hydrophilicity can be imparted to the soft contact lens.
前記式(A)及び式(a)中、R1は水素原子又はメチル基を示し、XはO又はNR3、ここでR3は水素原子又は炭素数1~4のアルキル基を示す。
In the formulae (A) and (a), R 1 represents a hydrogen atom or a methyl group, and X represents O or NR 3 , where R 3 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms.
PC単量体は、好ましくは2-((メタ)アクリロイルオキシ)エチル2-(トリメチルアンモニオ)エチルホスフェートであり、より好ましくは下記式(a′)で表される2-(メタクリロイルオキシ)エチル2-(トリメチルアンモニオ)エチルホスフェート(以下、「2-メタクリロイルオキシエチルホスホリルコリン」ともいう。)である。
The PC monomer is preferably 2-((meth)acryloyloxy)ethyl 2-(trimethylammonio)ethyl phosphate, and more preferably 2-(methacryloyloxy)ethyl 2-(trimethylammonio)ethyl phosphate (hereinafter also referred to as "2-methacryloyloxyethyl phosphorylcholine") represented by the following formula (a').
共重合体(P)中の式(A)で表される構成単位の含有量(モル比率nA)は、10~80モル%であり、好ましくは15~75モル%であり、より好ましくは25~65モル%であり、さらに好ましくは30~55%である。モル比率nAが10モル%未満であると、ソフトコンタクトレンズ表面への親水性を向上させる効果が期待できず、モル比率nAが80モル%より多いと、式(B)で表される構成単位の含有量が少なくなり、共重合体(P)のソフトコンタクトレンズ表面への吸着力が低下し、かつ良好な装用感の持続性が不十分となる。また、モル比率nAが80モル%以下であると、式(A)で表される構成単位と式(B)で表される構成単位との比率を調整して、ソフトコンタクトレンズ表面の親水性および潤滑性を向上させる効果をより高めることができる。
The content of the structural unit represented by formula (A) in the copolymer (P) (molar ratio n A ) is 10-80 mol%, preferably 15-75 mol%, more preferably 25-65 mol%, and even more preferably 30-55%. If the molar ratio n A is less than 10 mol%, the effect of improving the hydrophilicity of the soft contact lens surface cannot be expected, and if the molar ratio n A is more than 80 mol%, the content of the structural unit represented by formula (B) is reduced, the adsorption force of the copolymer (P) to the soft contact lens surface is reduced, and the durability of the good wearing feeling is insufficient. In addition, if the molar ratio n A is 80 mol% or less, the effect of improving the hydrophilicity and lubricity of the soft contact lens surface can be further enhanced by adjusting the ratio of the structural unit represented by formula (A) and the structural unit represented by formula (B).
[式(B)で表される構成単位]
本発明で用いられる共重合体(P)は、下記式(B)で表される構成単位を有する。該構成単位は、下記一般式(b)で表される単量体、すなわち、ポリアルキレングリコール構造を有する単量体(以下、「PAG単量体」ともいう。)を重合して得られる。共重合体(P)がPAG単量体に由来する構成単位を含むことにより、得られるソフトコンタクトレンズを装着した場合に良好な装用感が持続されるようになる。また、式(A)で表される構成単位と式(B)で表される構成単位とを有することで、ソフトコンタクトレンズ表面の親水性および潤滑性を向上させる効果もより高まる。 [Constituent unit represented by formula (B)]
The copolymer (P) used in the present invention has a constitutional unit represented by the following formula (B). The constitutional unit is obtained by polymerizing a monomer represented by the following general formula (b), that is, a monomer having a polyalkylene glycol structure (hereinafter also referred to as "PAG monomer"). By containing a constitutional unit derived from a PAG monomer in the copolymer (P), a good wearing feeling can be sustained when the obtained soft contact lens is worn. In addition, by having a constitutional unit represented by formula (A) and a constitutional unit represented by formula (B), the effect of improving the hydrophilicity and lubricity of the soft contact lens surface is further enhanced.
本発明で用いられる共重合体(P)は、下記式(B)で表される構成単位を有する。該構成単位は、下記一般式(b)で表される単量体、すなわち、ポリアルキレングリコール構造を有する単量体(以下、「PAG単量体」ともいう。)を重合して得られる。共重合体(P)がPAG単量体に由来する構成単位を含むことにより、得られるソフトコンタクトレンズを装着した場合に良好な装用感が持続されるようになる。また、式(A)で表される構成単位と式(B)で表される構成単位とを有することで、ソフトコンタクトレンズ表面の親水性および潤滑性を向上させる効果もより高まる。 [Constituent unit represented by formula (B)]
The copolymer (P) used in the present invention has a constitutional unit represented by the following formula (B). The constitutional unit is obtained by polymerizing a monomer represented by the following general formula (b), that is, a monomer having a polyalkylene glycol structure (hereinafter also referred to as "PAG monomer"). By containing a constitutional unit derived from a PAG monomer in the copolymer (P), a good wearing feeling can be sustained when the obtained soft contact lens is worn. In addition, by having a constitutional unit represented by formula (A) and a constitutional unit represented by formula (B), the effect of improving the hydrophilicity and lubricity of the soft contact lens surface is further enhanced.
また、共重合体(P)は、異なるpの値を有する複数の下記(B)で表される構造単位を含んでもよい。
The copolymer (P) may also contain multiple structural units represented by the following (B) having different values of p.
前記式(B)及び(b)中、R2は水素原子又はメチル基を示す。R4Oは炭素数2~4のオキシアルキレン基を示し、R4Oは炭素数が異なる少なくとも2種のオキシアルキレン基を含む。式(b)は、例えば、オキシアルキレン基としてオキシエチレン基(-CH2CH2O-)、オキシプロピレン基(-CH(CH3)CH2O-、-CH2CH(CH3)O-)、オキシブチレン基(-CH(CH2CH3)CH2O-、-CH2CH(CH2CH3)O-、-CH(CH3)CH(CH3)O-)のうち少なくとも2種を含むポリアルキレングリコールモノ(メタ)アクリレートであり、R4Oの付加形態はブロックまたはランダムのいずれでもよく、pは、オキシアルキレン基の平均付加モル数を示し、p=4~100の数である。
In the formulae (B) and (b), R2 represents a hydrogen atom or a methyl group, and R4O represents an oxyalkylene group having 2 to 4 carbon atoms, and R4O includes at least two types of oxyalkylene groups having different numbers of carbon atoms. Formula (b) is, for example, a polyalkylene glycol mono(meth)acrylate containing at least two of oxyalkylene groups selected from oxyethylene groups (-CH 2 CH 2 O-), oxypropylene groups (-CH(CH 3 )CH 2 O-, -CH 2 CH(CH 3 )O-), and oxybutylene groups (-CH(CH 2 CH 3 )CH 2 O-, -CH 2 CH(CH 2 CH 3 )O-, -CH(CH 3 )CH(CH 3 )O-), in which the addition form of R 4 O may be either block or random, and p represents the average number of moles of oxyalkylene groups added, p being a number from 4 to 100.
式(B)及び(b)中のオキシアルキレン基は、好ましくはオキシエチレン基とオキシプロピレン基、オキシエチレン基とオキシブチレン基、オキシプロピレン基とオキシブチレン基、オキシプロピレン基とオキシエチレン基とオキシブチレン基からなる形態を有し、より好ましくはオキシエチレン基とオキシプロピレン基からなる形態を有する。
The oxyalkylene groups in formulae (B) and (b) preferably have a form consisting of an oxyethylene group and an oxypropylene group, an oxyethylene group and an oxybutylene group, an oxypropylene group and an oxybutylene group, or an oxypropylene group, an oxyethylene group and an oxybutylene group, and more preferably have a form consisting of an oxyethylene group and an oxypropylene group.
また、オキシエチレン基、オキシプロピレン基、オキシブチレン基の付加モル数に関しては、全てのオキシアルキレン基の付加モル数に対して、オキシエチレン基の付加モル比率が0~90%であり、好ましくは40~90%であり、より好ましくは60~80%である。また、オキシプロピレン基の付加モル比率は、0~70%であり、より好ましくは10~50%であり、オキシブチレン基の付加モル比率は、0~70%であり、より好ましくは0~30%である。オキシエチレン基の付加モル比率が90%より多い場合、相対的にオキシプロピレン基およびオキシブチレン基の比率が減少し、コンタクトレンズ表面への吸着力が低下する。一方、オキシプロピレン基およびオキシブチレン基は、70%を超えると、共重合体(P)同士の凝集力が過剰となり、得られるコンタクトレンズ用処理液や処理後のコンタクトレンズの透明性が悪化する。
Furthermore, with regard to the number of moles of oxyethylene groups, oxypropylene groups, and oxybutylene groups added, the molar ratio of oxyethylene groups to the number of moles of all oxyalkylene groups added is 0-90%, preferably 40-90%, and more preferably 60-80%. The molar ratio of oxypropylene groups added is 0-70%, more preferably 10-50%, and the molar ratio of oxybutylene groups added is 0-70%, more preferably 0-30%. When the molar ratio of oxyethylene groups added is more than 90%, the ratios of oxypropylene groups and oxybutylene groups are relatively reduced, and the adsorptive force to the contact lens surface is reduced. On the other hand, when the oxypropylene groups and oxybutylene groups exceed 70%, the cohesive force between the copolymers (P) becomes excessive, and the transparency of the resulting contact lens treatment solution and the contact lens after treatment is deteriorated.
式(b)で表される単量体は、示差屈折率計を用いるゲル浸透クロマトグラフィー(GPC)測定により求められるクロマトグラム(縦軸:屈折率強度、横軸:保持時間)から算出されるwbとwfの比率wb/wfが、式(1):
1.10≦wb/wf≦2.50 (1)
(式(1)中、前記クロマトグラムのピークにおいて、最大ピーク高さ(h)における保持時間をthとし、最大ピーク高さの1/10(h1/10)における二つの保持時間をtfおよびtb(ただし、tf<tb)とした場合、wfはthとtfとの差(th-tf)を示し、およびwbはtbとthとの差(tb-th)を示す。)の関係を満たすことが好ましい(図1参照)。 The monomer represented by formula (b) is a monomer having a ratio wb/wf of wb to wf calculated from a chromatogram (vertical axis: refractive index intensity, horizontal axis: retention time) obtained by gel permeation chromatography ( GPC) measurement using a differential refractometer , which satisfies the following formula (1):
1.10≦w b /w f ≦2.50 (1)
(In formula (1), when the retention time at the maximum peak height (h) in the peak of the chromatogram is th and two retention times at 1/10 (h 1/10 ) of the maximum peak height are tf and tb (where tf < tb ), wf represents the difference between th and tf ( th - tf ), and wb represents the difference between tb and th ( tb - th )) is preferably satisfied (see FIG. 1).
1.10≦wb/wf≦2.50 (1)
(式(1)中、前記クロマトグラムのピークにおいて、最大ピーク高さ(h)における保持時間をthとし、最大ピーク高さの1/10(h1/10)における二つの保持時間をtfおよびtb(ただし、tf<tb)とした場合、wfはthとtfとの差(th-tf)を示し、およびwbはtbとthとの差(tb-th)を示す。)の関係を満たすことが好ましい(図1参照)。 The monomer represented by formula (b) is a monomer having a ratio wb/wf of wb to wf calculated from a chromatogram (vertical axis: refractive index intensity, horizontal axis: retention time) obtained by gel permeation chromatography ( GPC) measurement using a differential refractometer , which satisfies the following formula (1):
1.10≦w b /w f ≦2.50 (1)
(In formula (1), when the retention time at the maximum peak height (h) in the peak of the chromatogram is th and two retention times at 1/10 (h 1/10 ) of the maximum peak height are tf and tb (where tf < tb ), wf represents the difference between th and tf ( th - tf ), and wb represents the difference between tb and th ( tb - th )) is preferably satisfied (see FIG. 1).
モノマー(b)のwb/wfが1.10より小さくなると、モノマー(b)の分子量分布における高分子量側の偏りが大きくなり、重合性官能基の濃度が低くなり、モノマー(b)の重合性が低下する可能性がある。モノマー(b)の重合性の観点から、wb/wfが、1.20以上であることが好ましく、1.30以上であることがより好ましい。
If the wb / wf of the monomer (b) is smaller than 1.10, the molecular weight distribution of the monomer (b) may be biased toward the high molecular weight side, the concentration of the polymerizable functional group may be reduced, and the polymerizability of the monomer (b) may be reduced. From the viewpoint of the polymerizability of the monomer (b), the wb / wf is preferably 1.20 or more, and more preferably 1.30 or more.
一方、モノマー(b)のwb/wfが2.50より大きくなると、共重合体(P)のソフトコンタクトレンズ表面への吸着力が低下する可能性がある。好ましくはwb/wfが、2.00以下であり、より好ましくは1.80以下である。
On the other hand, if the wb / wf of the monomer (b) is greater than 2.50, the adsorptivity of the copolymer (P) to the surface of a soft contact lens may decrease. Preferably, wb / wf is 2.00 or less, more preferably 1.80 or less.
wb/wfを算出するためのクロマトグラム(縦軸:屈折率強度、横軸:保持時間)は、ゲル浸透クロマトグラフィー(GPC)のシステムとしてHLC-8320GPC(登録商標)、ガードカラムとしてSHODEXKF-G、カラムとしてSHODEXKF804Lを3本連続装着し、カラム温度40℃ 、展開溶剤としてテトラヒドロフランを1mL/分の流速で流し、ポリアルキレングリコールモノ(メタ)アクリレートの0.1重量%テトラヒドロフラン溶液0.1mLを注入し、EcoSECGPC計算プログラムを用いて得られるものである。
The chromatogram for calculating w b /w f (vertical axis: refractive index intensity, horizontal axis: retention time) was obtained by using an EcoSEC GPC calculation program, with a gel permeation chromatography (GPC) system equipped with an HLC-8320GPC (registered trademark), a guard column equipped with a SHODEXKF-G, and three SHODEXKF804L columns in series, a column temperature of 40° C., tetrahydrofuran as a developing solvent flowing at a flow rate of 1 mL/min, and 0.1 mL of a 0.1 wt % tetrahydrofuran solution of polyalkylene glycol mono(meth)acrylate injected.
共重合体(P)中の式(B)で表される構成単位の含有量(モル比率nB)は、20~90モル%であり、好ましくは25~85モル%であり、より好ましくは35~75モル%であり、さらに好ましくは45~70モル%である。前述の通り、本発明に用いる共重合体(P)は式(B)で表される単量体を構成単位として有するため、共重合体(P)のソフトコンタクトレンズ表面への吸着力を向上させることができ、装用感の持続性が良好となる。
The content (molar ratio n B ) of the structural unit represented by formula (B) in copolymer (P) is 20 to 90 mol %, preferably 25 to 85 mol %, more preferably 35 to 75 mol %, and even more preferably 45 to 70 mol %. As described above, since copolymer (P) used in the present invention has a monomer represented by formula (B) as a structural unit, the adsorptive power of copolymer (P) to the surface of a soft contact lens can be improved, and the durability of the wearing comfort can be improved.
式(B)で表される構成単位の含有量(モル比率nB)は、式(A)で表される構成単位の含有量(モル比率nA)よりも多いことが好ましい。これにより、ソフトコンタクトレンズ表面の親水性および潤滑性を向上させる効果がより高まる。モル比率nAとモル比率nBとの割合(nB/nA)は、0.5~7.0であることが好ましく、1.0~3.0であることがより好ましい。
The content of the structural unit represented by formula (B) (molar ratio nB ) is preferably greater than the content of the structural unit represented by formula (A) (molar ratio nA ). This further enhances the effect of improving the hydrophilicity and lubricity of the soft contact lens surface. The ratio of the molar ratio nA to the molar ratio nB ( nB / nA ) is preferably 0.5 to 7.0, and more preferably 1.0 to 3.0.
前記式(B)中、pは、4~100であり、好ましくは5~70であり、より好ましくは7~40である。pが4未満になると共重合体(P)のソフトコンタクトレンズ表面への吸着力が低下し、100より大きくなると共重合体(P)同士の凝集力が強くなり、得られるコンタクトレンズ用処理液や処理後のコンタクトレンズの透明性が悪化する。
In the formula (B), p is 4 to 100, preferably 5 to 70, and more preferably 7 to 40. If p is less than 4, the adhesive force of the copolymer (P) to the surface of a soft contact lens decreases, and if it is greater than 100, the cohesive force between the copolymers (P) becomes strong, and the transparency of the resulting contact lens treatment solution and the contact lens after treatment deteriorates.
前記式(b)は、複合金属シアン化物錯体触媒(以下「DMC触媒」と記載することがある)の存在下で、出発原料(例えば、2-ヒドロキシプロピルメタクリレート)にエチレンオキシド、プロピレンオキシド、ブチレンオキシド(好ましくはプロピレンオキシド、エチレンオキシド)を付加させることによって製造することができる。具体的には、反応容器内に、出発原料とDMC触媒を加え、不活性ガス雰囲気の撹拌下、エチレンオキシド、プロピレンオキシド、ブチレンオキシド(以下、これらをまとめて「炭素数2~4のアルキレンオキシド」と記載する)のうち少なくとも2種を連続または断続的に添加し付加重合する。炭素数2~4のアルキレンオキシドは加圧して添加してもよく、大気圧下で添加してもよい。
The above formula (b) can be produced by adding ethylene oxide, propylene oxide, or butylene oxide (preferably propylene oxide or ethylene oxide) to a starting material (e.g., 2-hydroxypropyl methacrylate) in the presence of a composite metal cyanide complex catalyst (hereinafter sometimes referred to as "DMC catalyst"). Specifically, the starting material and the DMC catalyst are added to a reaction vessel, and at least two of ethylene oxide, propylene oxide, and butylene oxide (hereinafter collectively referred to as "alkylene oxides having 2 to 4 carbon atoms") are added continuously or intermittently under stirring in an inert gas atmosphere to carry out addition polymerization. The alkylene oxides having 2 to 4 carbon atoms may be added under pressure or at atmospheric pressure.
出発原料に炭素数2~4のアルキレンオキシドを付加させるための反応温度は、50℃~120℃が好ましく、70℃~90℃がより好ましい。この反応温度が50℃より低いと反応速度が非常に小さく、120℃より高いと、出発原料における重合性基の重合や、着色の問題が生じる。
The reaction temperature for adding an alkylene oxide having 2 to 4 carbon atoms to the starting material is preferably 50°C to 120°C, and more preferably 70°C to 90°C. If the reaction temperature is lower than 50°C, the reaction rate is very slow, and if it is higher than 120°C, problems such as polymerization of the polymerizable groups in the starting material and discoloration occur.
本発明におけるDMC触媒は公知のものを用いることができるが、たとえば、特開2022-130139記載のDMC触媒を使用することができる。
A known DMC catalyst can be used in the present invention, for example, the DMC catalyst described in JP-A-2022-130139.
特に好ましいDMC触媒は、Zn(II)3[Co(III)(CN)6]2(H2O)4(tert-ブチルアルコール)2である。
A particularly preferred DMC catalyst is Zn(II) 3 [Co(III)(CN) 6 ] 2 (H 2 O) 4 (tert-butyl alcohol) 2 .
DMC触媒の使用量は、特に制限されるものではないが、式(b)で表される単量体100質量部に対して、0.0001~0.1質量部が好ましく、0.001~0.05質量部がより好ましい。DMC触媒の反応系への投入は初めに一括して行ってもよく、順次分割して行ってもよい。重合反応終了後、DMC触媒の除去を行う。触媒の除去は、ろ別や遠心分離、合成吸着剤による処理など公知の方法により行うことができる。
The amount of the DMC catalyst used is not particularly limited, but is preferably 0.0001 to 0.1 parts by mass, and more preferably 0.001 to 0.05 parts by mass, per 100 parts by mass of the monomer represented by formula (b). The DMC catalyst may be added to the reaction system all at once at the beginning, or may be added in portions one by one. After the polymerization reaction is completed, the DMC catalyst is removed. The catalyst can be removed by known methods such as filtration, centrifugation, or treatment with a synthetic adsorbent.
出発原料に炭素数2~4のアルキレンオキシドを付加させる反応においては、その他の添加剤を使用してもよい。例えば、重合禁止剤としてヒドロキノン(HQ)、ヒドロキノンモノメチルエーテル(MQ)、2,6-ジ-tert-ブチルヒドロキシトルエン(BHT)、ジ-tert-ブチルヒドロキシアニソール(BHA)、α-トコフェロール、β-トコフェロール、γ-トコフェロールなどを反応系に添加することができる。重合禁止剤は、好ましくはMQおよび/またはBHTであり、より好ましくはBHTである。重合禁止剤の添加量としては、出発原料(例えば、2-ヒドロキシプロピルメタクリレート)と炭素数2~4のアルキレンオキシドとの合計100質量部に対し、0.001~0.3質量部が好ましい。この添加量が0.001質量部より少ないと、重合禁止剤の機能が不十分となり、炭素数2~4のアルキレンオキシドの付加中にゲル化が生じる可能性がある。この添加量が0.3質量部より多いと、得られる式(1b′)の純度が低くなる場合がある。
In the reaction of adding an alkylene oxide having 2 to 4 carbon atoms to the starting material, other additives may be used. For example, hydroquinone (HQ), hydroquinone monomethyl ether (MQ), 2,6-di-tert-butylhydroxytoluene (BHT), di-tert-butylhydroxyanisole (BHA), α-tocopherol, β-tocopherol, γ-tocopherol, etc., may be added to the reaction system as a polymerization inhibitor. The polymerization inhibitor is preferably MQ and/or BHT, more preferably BHT. The amount of polymerization inhibitor added is preferably 0.001 to 0.3 parts by mass per 100 parts by mass of the total of the starting material (e.g., 2-hydroxypropyl methacrylate) and the alkylene oxide having 2 to 4 carbon atoms. If the amount added is less than 0.001 part by mass, the function of the polymerization inhibitor becomes insufficient, and gelation may occur during the addition of the alkylene oxide having 2 to 4 carbon atoms. If the amount added is more than 0.3 parts by mass, the purity of the resulting compound of formula (1b') may be low.
[式(C)及び(D)で表される構成単位]
本発明で用いられる共重合体(P)は、下記式(C)または(D)で表される構成単位を含めることができる。該構成単位は、それぞれ下記一般式(c)及び(d)で表される単量体を重合して得られる。共重合体(P)が(c)または(d)を含むことで、コンタクトレンズの種類によっては共重合体(P)のソフトコンタクトレンズへの吸着力が維持されやすくなり、良好な装用感の持続が可能となる。 [Constituent units represented by formulas (C) and (D)]
The copolymer (P) used in the present invention may contain a structural unit represented by the following formula (C) or (D). The structural unit is obtained by polymerizing a monomer represented by the following general formula (c) or (d), respectively. When the copolymer (P) contains (c) or (d), the adhesive force of the copolymer (P) to a soft contact lens is easily maintained depending on the type of contact lens, and a good wearing comfort can be maintained.
本発明で用いられる共重合体(P)は、下記式(C)または(D)で表される構成単位を含めることができる。該構成単位は、それぞれ下記一般式(c)及び(d)で表される単量体を重合して得られる。共重合体(P)が(c)または(d)を含むことで、コンタクトレンズの種類によっては共重合体(P)のソフトコンタクトレンズへの吸着力が維持されやすくなり、良好な装用感の持続が可能となる。 [Constituent units represented by formulas (C) and (D)]
The copolymer (P) used in the present invention may contain a structural unit represented by the following formula (C) or (D). The structural unit is obtained by polymerizing a monomer represented by the following general formula (c) or (d), respectively. When the copolymer (P) contains (c) or (d), the adhesive force of the copolymer (P) to a soft contact lens is easily maintained depending on the type of contact lens, and a good wearing comfort can be maintained.
前記式(C)及び(c)中、R5はHまたはメチレン基であり、R6は炭素数1~5のアルキル基、またはR5がメチレン基である場合はR5に結合し環状構造を形成している炭素数1~5のアルキレン基である。式(D)及び(d)中、R7は水素原子またはメチル基であり、YはOまたはNR10、ここで、R10はHまたは炭素数1~4のアルキル基であり、YがOの場合は、E1は式(E)で表される構造であり、YがNR10の場合は、E1は水素原子または炭素数1~4のアルキル基または式(E)で表される構造である。式(E)中、R8はHまたは炭素数1~4のアルキル基、R9は水素原子または炭素数1~18のアルキル基を示す。
In the formulas (C) and (c), R 5 is H or a methylene group, R 6 is an alkyl group having 1 to 5 carbon atoms, or when R 5 is a methylene group, R 6 is an alkylene group having 1 to 5 carbon atoms that is bonded to R 5 to form a cyclic structure. In the formulas (D) and (d), R 7 is a hydrogen atom or a methyl group, Y is O or NR 10 , where R 10 is H or an alkyl group having 1 to 4 carbon atoms, when Y is O, E 1 is a structure represented by formula (E), and when Y is NR 10 , E 1 is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, or a structure represented by formula (E). In the formula (E), R 8 is H or an alkyl group having 1 to 4 carbon atoms, and R 9 is a hydrogen atom or an alkyl group having 1 to 18 carbon atoms.
式(c)で表される単量体は、例えば、N-ビニルピロリドン、N-ビニルカプロラクタム、N-ビニルホルムアミド、N-ビニルアセトアミド、N-メチル-N-ビニルアセトアミド等が挙げられる。
式(d)で表される単量体は、例えば、N-メチル(メタ)アクリルアミド、N-エチル(メタ)アクリルアミド、N-プロピル(メタ)アクリルアミド、N-イソプロピル(メタ)アクリルアミド、N-ブチル(メタ)アクリルアミド、N-tert-ブチル(メタ)アクリルアミド、N,N-ジメチル(メタ)アクリルアミド、N,N-ジエチル(メタ)アクリルアミド、2-(アセチルアミノ)エチル(メタ)アクリレート、2-(ステアルアミド)エチル(メタ)アクリレート、2-パルミタアミドエチル(メタ)アクリレート等が挙げられる。 Examples of the monomer represented by formula (c) include N-vinylpyrrolidone, N-vinylcaprolactam, N-vinylformamide, N-vinylacetamide, and N-methyl-N-vinylacetamide.
Examples of the monomer represented by formula (d) include N-methyl(meth)acrylamide, N-ethyl(meth)acrylamide, N-propyl(meth)acrylamide, N-isopropyl(meth)acrylamide, N-butyl(meth)acrylamide, N-tert-butyl(meth)acrylamide, N,N-dimethyl(meth)acrylamide, N,N-diethyl(meth)acrylamide, 2-(acetylamino)ethyl(meth)acrylate, 2-(stearamido)ethyl(meth)acrylate, and 2-palmitamidoethyl(meth)acrylate.
式(d)で表される単量体は、例えば、N-メチル(メタ)アクリルアミド、N-エチル(メタ)アクリルアミド、N-プロピル(メタ)アクリルアミド、N-イソプロピル(メタ)アクリルアミド、N-ブチル(メタ)アクリルアミド、N-tert-ブチル(メタ)アクリルアミド、N,N-ジメチル(メタ)アクリルアミド、N,N-ジエチル(メタ)アクリルアミド、2-(アセチルアミノ)エチル(メタ)アクリレート、2-(ステアルアミド)エチル(メタ)アクリレート、2-パルミタアミドエチル(メタ)アクリレート等が挙げられる。 Examples of the monomer represented by formula (c) include N-vinylpyrrolidone, N-vinylcaprolactam, N-vinylformamide, N-vinylacetamide, and N-methyl-N-vinylacetamide.
Examples of the monomer represented by formula (d) include N-methyl(meth)acrylamide, N-ethyl(meth)acrylamide, N-propyl(meth)acrylamide, N-isopropyl(meth)acrylamide, N-butyl(meth)acrylamide, N-tert-butyl(meth)acrylamide, N,N-dimethyl(meth)acrylamide, N,N-diethyl(meth)acrylamide, 2-(acetylamino)ethyl(meth)acrylate, 2-(stearamido)ethyl(meth)acrylate, and 2-palmitamidoethyl(meth)acrylate.
共重合体(P)が、(C)及び(D)で表される構成単位を含有する場合、共重合体(P)中の、式(C)で表される構成単位の含有量(モル比率nC)および式(D)で表される構成単位の含有量(モル比率nD)の合計は、0モルより多く50モル%以下であることが好ましく、10~50モル%であることがより好ましい。
When copolymer (P) contains structural units represented by formula (C) and formula (D), the total content of the structural unit represented by formula (C) (molar ratio n C ) and the content of the structural unit represented by formula (D) (molar ratio n D ) in copolymer (P) is preferably more than 0 mol and not more than 50 mol%, and more preferably 10 to 50 mol%.
前記式(d)におけるE1が式(E)である単量体は、一例として、特開2017-160380号公報に記載の、末端にアミド構造を有するアルコールと(メタ)アクリル酸又は(メタ)アクリル酸クロリドとのエステル化反応によって合成することができる。
The monomer in which E 1 in the formula (d) is the formula (E) is, for example, as described in JP 2017-160380 A, which can be synthesized by an esterification reaction between an alcohol having an amide structure at its terminal and (meth)acrylic acid or (meth)acrylic acid chloride.
[その他の単量体]
共重合体(P)は、本発明の効果を損なわない範囲において、PC単量体、PAG単量体、(c)または(d)で表される構成単位以外の他の重合性単量体を有することも可能である。その配合割合は、本発明の効果に影響を与えない範囲で適宜選択できるが、前記PC単量体及びPAG単量体のみからなることが好ましい。 [Other monomers]
Copolymer (P) may contain polymerizable monomers other than the PC monomer, PAG monomer, and the structural units represented by (c) or (d) within a range that does not impair the effects of the present invention. The blending ratio of these monomers may be appropriately selected within a range that does not affect the effects of the present invention, but it is preferable that the copolymer (P) is composed only of the PC monomer and PAG monomer.
共重合体(P)は、本発明の効果を損なわない範囲において、PC単量体、PAG単量体、(c)または(d)で表される構成単位以外の他の重合性単量体を有することも可能である。その配合割合は、本発明の効果に影響を与えない範囲で適宜選択できるが、前記PC単量体及びPAG単量体のみからなることが好ましい。 [Other monomers]
Copolymer (P) may contain polymerizable monomers other than the PC monomer, PAG monomer, and the structural units represented by (c) or (d) within a range that does not impair the effects of the present invention. The blending ratio of these monomers may be appropriately selected within a range that does not affect the effects of the present invention, but it is preferable that the copolymer (P) is composed only of the PC monomer and PAG monomer.
その他の単量体は、例えば、直鎖又は分岐鎖のアルキル(メタ)アクリレート、環状アルキル(メタ)アクリレート、芳香族基含有(メタ)アクリレート、スチレン系単量体、ビニルエーテル単量体、ビニルエステル単量体、水酸基含有(メタ)アクリレート、カルボキシ基含有単量体、スルホニル基含有単量体などから選ばれる重合性単量体が挙げられる。
The other monomers may be, for example, polymerizable monomers selected from linear or branched alkyl (meth)acrylates, cyclic alkyl (meth)acrylates, aromatic group-containing (meth)acrylates, styrene-based monomers, vinyl ether monomers, vinyl ester monomers, hydroxyl group-containing (meth)acrylates, carboxyl group-containing monomers, and sulfonyl group-containing monomers.
直鎖又は分岐鎖アルキル(メタ)アクリレートとしては、例えば、メチル(メタ)アクリレート、エチル(メタ)アクリレート、プロピル(メタ)アクリレート、ブチル(メタ)アクリレート、エチルヘキシル(メタ)アクリレート、ラウリル(メタ)アクリレート、ステアリル(メタ)アクリレート、エチレングリコールジ(メタ)アクリレート、ジエチレングリコールジ(メタ)アクリレート、トリエチレングリコールジ(メタ)アクリレート等が挙げられる。
環状アルキル(メタ)アクリレートとしては、例えば、シクロヘキシル(メタ)アクリレート等が挙げられる。
芳香族基含有(メタ)アクリレートとしては、例えば、ベンジル(メタ)アクリレート及びフェノキシエチル(メタ)アクリレート等が挙げられる。
スチレン系単量体としては、例えば、スチレン、メチルスチレン及びクロロスチレン等が挙げられる。
ビニルエーテル単量体としては、例えば、メチルビニルエーテル、プロピルビニルエーテル、ブチルビニルエーテル、トリエチレングリコールジビニルエーテル、エチレングリコールモノビニルエーテル等が挙げられる。
ビニルエステル単量体としては、例えば、酢酸ビニル及びプロピオン酸ビニル等が挙げられる。
親水性の水酸基含有(メタ)アクリレートとしては、例えば、ヒドロキシエチル(メタ)アクリレート、ヒドロキシプロピル(メタ)アクリレート、ヒドロキシブチル(メタ)アクリレート、グリセロール(メタ)アクリレート等が挙げられる。
カルボキシ基含有単量体、スルホニル基含有単量体として、例えば、(メタ)アクリル酸及びスチレンスルホン酸、(メタ)アクリロイルオキシホスホン酸等が挙げられる。 Examples of the linear or branched alkyl (meth)acrylate include methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, butyl (meth)acrylate, ethylhexyl (meth)acrylate, lauryl (meth)acrylate, stearyl (meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, and triethylene glycol di(meth)acrylate.
Examples of cyclic alkyl (meth)acrylates include cyclohexyl (meth)acrylate.
Examples of aromatic group-containing (meth)acrylates include benzyl (meth)acrylate and phenoxyethyl (meth)acrylate.
Examples of the styrene monomer include styrene, methylstyrene, and chlorostyrene.
Examples of the vinyl ether monomer include methyl vinyl ether, propyl vinyl ether, butyl vinyl ether, triethylene glycol divinyl ether, and ethylene glycol monovinyl ether.
Examples of vinyl ester monomers include vinyl acetate and vinyl propionate.
Examples of hydrophilic hydroxyl group-containing (meth)acrylates include hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, hydroxybutyl (meth)acrylate, and glycerol (meth)acrylate.
Examples of the carboxyl group-containing monomer and the sulfonyl group-containing monomer include (meth)acrylic acid, styrenesulfonic acid, and (meth)acryloyloxyphosphonic acid.
環状アルキル(メタ)アクリレートとしては、例えば、シクロヘキシル(メタ)アクリレート等が挙げられる。
芳香族基含有(メタ)アクリレートとしては、例えば、ベンジル(メタ)アクリレート及びフェノキシエチル(メタ)アクリレート等が挙げられる。
スチレン系単量体としては、例えば、スチレン、メチルスチレン及びクロロスチレン等が挙げられる。
ビニルエーテル単量体としては、例えば、メチルビニルエーテル、プロピルビニルエーテル、ブチルビニルエーテル、トリエチレングリコールジビニルエーテル、エチレングリコールモノビニルエーテル等が挙げられる。
ビニルエステル単量体としては、例えば、酢酸ビニル及びプロピオン酸ビニル等が挙げられる。
親水性の水酸基含有(メタ)アクリレートとしては、例えば、ヒドロキシエチル(メタ)アクリレート、ヒドロキシプロピル(メタ)アクリレート、ヒドロキシブチル(メタ)アクリレート、グリセロール(メタ)アクリレート等が挙げられる。
カルボキシ基含有単量体、スルホニル基含有単量体として、例えば、(メタ)アクリル酸及びスチレンスルホン酸、(メタ)アクリロイルオキシホスホン酸等が挙げられる。 Examples of the linear or branched alkyl (meth)acrylate include methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, butyl (meth)acrylate, ethylhexyl (meth)acrylate, lauryl (meth)acrylate, stearyl (meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, and triethylene glycol di(meth)acrylate.
Examples of cyclic alkyl (meth)acrylates include cyclohexyl (meth)acrylate.
Examples of aromatic group-containing (meth)acrylates include benzyl (meth)acrylate and phenoxyethyl (meth)acrylate.
Examples of the styrene monomer include styrene, methylstyrene, and chlorostyrene.
Examples of the vinyl ether monomer include methyl vinyl ether, propyl vinyl ether, butyl vinyl ether, triethylene glycol divinyl ether, and ethylene glycol monovinyl ether.
Examples of vinyl ester monomers include vinyl acetate and vinyl propionate.
Examples of hydrophilic hydroxyl group-containing (meth)acrylates include hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, hydroxybutyl (meth)acrylate, and glycerol (meth)acrylate.
Examples of the carboxyl group-containing monomer and the sulfonyl group-containing monomer include (meth)acrylic acid, styrenesulfonic acid, and (meth)acryloyloxyphosphonic acid.
[共重合体(P)の重量平均分子量]
共重合体(P)の重量平均分子量は10,000~2,000,000であり、好ましくは、20,000以上、より好ましくは30,000以上、更に好ましくは40,000以上、そして、好ましくは1,000,000以下、より好ましくは500,000以下、より更に好ましくは300,000以下である。 [Weight average molecular weight of copolymer (P)]
The weight average molecular weight of the copolymer (P) is 10,000 to 2,000,000, preferably 20,000 or more, more preferably 30,000 or more, even more preferably 40,000 or more, and preferably 1,000,000 or less, more preferably 500,000 or less, and even more preferably 300,000 or less.
共重合体(P)の重量平均分子量は10,000~2,000,000であり、好ましくは、20,000以上、より好ましくは30,000以上、更に好ましくは40,000以上、そして、好ましくは1,000,000以下、より好ましくは500,000以下、より更に好ましくは300,000以下である。 [Weight average molecular weight of copolymer (P)]
The weight average molecular weight of the copolymer (P) is 10,000 to 2,000,000, preferably 20,000 or more, more preferably 30,000 or more, even more preferably 40,000 or more, and preferably 1,000,000 or less, more preferably 500,000 or less, and even more preferably 300,000 or less.
重量平均分子量が、10,000未満であるとソフトコンタクトレンズ表面への吸着力が低下し、ソフトコンタクトレンズ表面での共重合体(P)の効果の持続が見込めないおそれがある。重量平均分子量が2,000,000を超える場合は、粘度が増大して取り扱いが困難となるおそれがある。
If the weight-average molecular weight is less than 10,000, the adhesive force to the soft contact lens surface will decrease, and the effect of the copolymer (P) on the soft contact lens surface may not be sustained. If the weight-average molecular weight is more than 2,000,000, the viscosity may increase, making handling difficult.
共重合体(P)の重量平均分子量は、ゲルパーミエーションクロマトグラフィー(GPC)測定による値をいう。
The weight average molecular weight of the copolymer (P) is the value measured by gel permeation chromatography (GPC).
[共重合体(P)の製造方法]
共重合体(P)は、前記単量体の共重合を行うことにより調製することができ、通常はランダム共重合体であるが、各単量体が規則的に配列された交互共重合体やブロック共重合体であってもよく、一部にグラフト構造を有してもよい。 [Method for producing copolymer (P)]
The copolymer (P) can be prepared by copolymerizing the above-mentioned monomers. It is usually a random copolymer, but may be an alternating copolymer or a block copolymer in which the monomers are regularly arranged, or may have a graft structure in part.
共重合体(P)は、前記単量体の共重合を行うことにより調製することができ、通常はランダム共重合体であるが、各単量体が規則的に配列された交互共重合体やブロック共重合体であってもよく、一部にグラフト構造を有してもよい。 [Method for producing copolymer (P)]
The copolymer (P) can be prepared by copolymerizing the above-mentioned monomers. It is usually a random copolymer, but may be an alternating copolymer or a block copolymer in which the monomers are regularly arranged, or may have a graft structure in part.
具体的には、例えば、前記各単量体の混合物を、ラジカル重合開始剤の存在下、窒素、二酸化炭素、アルゴン、及びヘリウム等の不活性ガス雰囲気下でラジカル重合により共重合体(P)を得ることができる。
Specifically, for example, a mixture of the monomers can be subjected to radical polymerization in the presence of a radical polymerization initiator under an inert gas atmosphere such as nitrogen, carbon dioxide, argon, or helium to obtain a copolymer (P).
ラジカル重合方法は、塊状重合、懸濁重合、乳化重合、溶液重合等の公知の方法により行うことができる。ラジカル重合方法は、精製等の観点から溶液重合が好ましい。共重合体(P)の精製は、再沈殿法、透析法、限外濾過法など一般的な精製方法により行うことができる。
The radical polymerization method can be carried out by known methods such as bulk polymerization, suspension polymerization, emulsion polymerization, and solution polymerization. Of the radical polymerization methods, solution polymerization is preferred from the viewpoint of purification, etc. The copolymer (P) can be purified by general purification methods such as reprecipitation, dialysis, and ultrafiltration.
ラジカル重合開始剤としては、アゾ系ラジカル重合開始剤、有機過酸化物、及び過硫酸化物等を挙げる事ができる。
アゾ系ラジカル重合開始剤としては、例えば、2,2'-アゾビス(2-メチルプロピオンアミジン)二塩酸塩(V-50)、2,2’-アゾビス(2-ジアミノプロピル)二塩酸塩、2,2’-アゾビス(2-(5-メチル-2-イミダゾリン-2-イル)プロパン)二塩酸塩、4,4’-アゾビス(4-シアノ吉草酸)、2,2’-アゾビスイソブチルアミド二水和物、2,2’-アゾビス(2,4-ジメチルバレロニトリル)、及び2,2’-アゾビスイソブチロニトリル(AIBN)等が挙げられる。
有機化酸化物としては、例えば、t-ブチルペルオキシネオデカネート(パーブチル(登録商標)ND)、過酸化ベンゾイル、ジイソプロピルペルオキシジカーボネート、t-ブチルペルオキシ-2-エチルヘキサノエート、t-ブチルペルオキシピバレート、t-ブチルペルオキシイソブチレート、過酸化ラウロイル、t-ブチルペルオキシデカネート、及びコハク酸ペルオキシド(サクシニルペルオキシド)等が挙げられる。
過硫酸化物としては、例えば、過硫酸アンモニウム、過硫酸カリウム、及び過硫酸ナトリウム等が挙げられる。
これらラジカル重合開始剤は、単独でも、2種以上を組み合わせて用いることができる。重合開始剤の使用量は、各単量体の合計100質量部に対して通常0.001~10質量部、好ましくは0.02~5.0質量部、より好ましくは0.03~3.0質量部である。 Examples of the radical polymerization initiator include an azo-based radical polymerization initiator, an organic peroxide, and a persulfate.
Examples of the azo radical polymerization initiator include 2,2'-azobis(2-methylpropionamidine) dihydrochloride (V-50), 2,2'-azobis(2-diaminopropyl) dihydrochloride, 2,2'-azobis(2-(5-methyl-2-imidazolin-2-yl)propane) dihydrochloride, 4,4'-azobis(4-cyanovaleric acid), 2,2'-azobisisobutyronitrile dihydrate, 2,2'-azobis(2,4-dimethylvaleronitrile), and 2,2'-azobisisobutyronitrile (AIBN).
Examples of organic peroxides include t-butyl peroxyneodecanate (Perbutyl (registered trademark) ND), benzoyl peroxide, diisopropyl peroxydicarbonate, t-butyl peroxy-2-ethylhexanoate, t-butyl peroxypivalate, t-butyl peroxyisobutyrate, lauroyl peroxide, t-butyl peroxydecanoate, and succinic acid peroxide (succinyl peroxide).
Examples of persulfate oxides include ammonium persulfate, potassium persulfate, and sodium persulfate.
These radical polymerization initiators can be used alone or in combination of two or more. The amount of the polymerization initiator used is usually 0.001 to 10 parts by mass, preferably 0.02 to 5.0 parts by mass, and more preferably 0.03 to 3.0 parts by mass, based on 100 parts by mass of the total of the monomers.
アゾ系ラジカル重合開始剤としては、例えば、2,2'-アゾビス(2-メチルプロピオンアミジン)二塩酸塩(V-50)、2,2’-アゾビス(2-ジアミノプロピル)二塩酸塩、2,2’-アゾビス(2-(5-メチル-2-イミダゾリン-2-イル)プロパン)二塩酸塩、4,4’-アゾビス(4-シアノ吉草酸)、2,2’-アゾビスイソブチルアミド二水和物、2,2’-アゾビス(2,4-ジメチルバレロニトリル)、及び2,2’-アゾビスイソブチロニトリル(AIBN)等が挙げられる。
有機化酸化物としては、例えば、t-ブチルペルオキシネオデカネート(パーブチル(登録商標)ND)、過酸化ベンゾイル、ジイソプロピルペルオキシジカーボネート、t-ブチルペルオキシ-2-エチルヘキサノエート、t-ブチルペルオキシピバレート、t-ブチルペルオキシイソブチレート、過酸化ラウロイル、t-ブチルペルオキシデカネート、及びコハク酸ペルオキシド(サクシニルペルオキシド)等が挙げられる。
過硫酸化物としては、例えば、過硫酸アンモニウム、過硫酸カリウム、及び過硫酸ナトリウム等が挙げられる。
これらラジカル重合開始剤は、単独でも、2種以上を組み合わせて用いることができる。重合開始剤の使用量は、各単量体の合計100質量部に対して通常0.001~10質量部、好ましくは0.02~5.0質量部、より好ましくは0.03~3.0質量部である。 Examples of the radical polymerization initiator include an azo-based radical polymerization initiator, an organic peroxide, and a persulfate.
Examples of the azo radical polymerization initiator include 2,2'-azobis(2-methylpropionamidine) dihydrochloride (V-50), 2,2'-azobis(2-diaminopropyl) dihydrochloride, 2,2'-azobis(2-(5-methyl-2-imidazolin-2-yl)propane) dihydrochloride, 4,4'-azobis(4-cyanovaleric acid), 2,2'-azobisisobutyronitrile dihydrate, 2,2'-azobis(2,4-dimethylvaleronitrile), and 2,2'-azobisisobutyronitrile (AIBN).
Examples of organic peroxides include t-butyl peroxyneodecanate (Perbutyl (registered trademark) ND), benzoyl peroxide, diisopropyl peroxydicarbonate, t-butyl peroxy-2-ethylhexanoate, t-butyl peroxypivalate, t-butyl peroxyisobutyrate, lauroyl peroxide, t-butyl peroxydecanoate, and succinic acid peroxide (succinyl peroxide).
Examples of persulfate oxides include ammonium persulfate, potassium persulfate, and sodium persulfate.
These radical polymerization initiators can be used alone or in combination of two or more. The amount of the polymerization initiator used is usually 0.001 to 10 parts by mass, preferably 0.02 to 5.0 parts by mass, and more preferably 0.03 to 3.0 parts by mass, based on 100 parts by mass of the total of the monomers.
共重合体(P)の重合反応は、溶媒の存在下で行うことができる。該溶媒としては、各単量体組成物を溶解し、溶媒自体が反応しないものであれば特に制限はなく、例えば、水、アルコール系溶媒、ケトン系溶媒、エステル系溶媒、直鎖又は環状のエーテル系溶媒、及び含窒素系溶媒を挙げることができる。
アルコール系溶媒としては、例えば、メタノール、エタノール、n-プロパノール、及びイソプロパノール等が挙げられる。
ケトン系溶媒としては、例えば、アセトン、メチルエチルケトン、及びジエチルケトン等が挙げられる。
エステル系溶媒としては、例えば、酢酸エチルが挙げられる。
直鎖又は環状のエーテル系溶媒としては、例えば、エチルセルソルブ、及びテトラヒドロフラン等が挙げられる。
含窒素系溶媒としては、例えば、アセトニトリル、ニトロメタン、及びN-メチルピロリドン等が挙げられる。
これら溶媒の中でも、水及びアルコールの混合溶媒が好ましい。 The polymerization reaction of the copolymer (P) can be carried out in the presence of a solvent. The solvent is not particularly limited as long as it dissolves each monomer composition and is not reactive itself, and examples of the solvent include water, alcohol solvents, ketone solvents, ester solvents, linear or cyclic ether solvents, and nitrogen-containing solvents.
Examples of the alcohol solvent include methanol, ethanol, n-propanol, and isopropanol.
Examples of the ketone solvent include acetone, methyl ethyl ketone, and diethyl ketone.
An example of the ester solvent is ethyl acetate.
Examples of linear or cyclic ether solvents include ethyl cellosolve and tetrahydrofuran.
Examples of nitrogen-containing solvents include acetonitrile, nitromethane, and N-methylpyrrolidone.
Among these solvents, a mixed solvent of water and an alcohol is preferred.
アルコール系溶媒としては、例えば、メタノール、エタノール、n-プロパノール、及びイソプロパノール等が挙げられる。
ケトン系溶媒としては、例えば、アセトン、メチルエチルケトン、及びジエチルケトン等が挙げられる。
エステル系溶媒としては、例えば、酢酸エチルが挙げられる。
直鎖又は環状のエーテル系溶媒としては、例えば、エチルセルソルブ、及びテトラヒドロフラン等が挙げられる。
含窒素系溶媒としては、例えば、アセトニトリル、ニトロメタン、及びN-メチルピロリドン等が挙げられる。
これら溶媒の中でも、水及びアルコールの混合溶媒が好ましい。 The polymerization reaction of the copolymer (P) can be carried out in the presence of a solvent. The solvent is not particularly limited as long as it dissolves each monomer composition and is not reactive itself, and examples of the solvent include water, alcohol solvents, ketone solvents, ester solvents, linear or cyclic ether solvents, and nitrogen-containing solvents.
Examples of the alcohol solvent include methanol, ethanol, n-propanol, and isopropanol.
Examples of the ketone solvent include acetone, methyl ethyl ketone, and diethyl ketone.
An example of the ester solvent is ethyl acetate.
Examples of linear or cyclic ether solvents include ethyl cellosolve and tetrahydrofuran.
Examples of nitrogen-containing solvents include acetonitrile, nitromethane, and N-methylpyrrolidone.
Among these solvents, a mixed solvent of water and an alcohol is preferred.
[共重合体(P)の濃度]
本発明のソフトコンタクトレンズ用処理液は、共重合体(P)の濃度が0.001w/v%以上であり、好ましくは0.01w/v%以上、より好ましくは0.05w/v%以上であり、そして、5.0w/v%以下であり、好ましくは2.0w/v%以下、より好ましくは1.0w/v%以下である。
共重合体(P)の濃度が0.001w/v%未満であると、共重合体(P)の添加量が少ないため、十分な親水性と潤滑性及びその持続性の付与効果が得られない。5.0w/v%を超えると、製造する際に行う無菌ろ過が困難となるおそれがある。 [Concentration of copolymer (P)]
The soft contact lens treatment solution of the present invention has a concentration of copolymer (P) of 0.001 w/v % or more, preferably 0.01 w/v % or more, more preferably 0.05 w/v % or more, and 5.0 w/v % or less, preferably 2.0 w/v % or less, more preferably 1.0 w/v % or less.
If the concentration of the copolymer (P) is less than 0.001 w/v%, the amount of the copolymer (P) added is so small that sufficient hydrophilicity and lubricity and their durability cannot be obtained, whereas if the concentration exceeds 5.0 w/v%, the sterile filtration performed during production may become difficult.
本発明のソフトコンタクトレンズ用処理液は、共重合体(P)の濃度が0.001w/v%以上であり、好ましくは0.01w/v%以上、より好ましくは0.05w/v%以上であり、そして、5.0w/v%以下であり、好ましくは2.0w/v%以下、より好ましくは1.0w/v%以下である。
共重合体(P)の濃度が0.001w/v%未満であると、共重合体(P)の添加量が少ないため、十分な親水性と潤滑性及びその持続性の付与効果が得られない。5.0w/v%を超えると、製造する際に行う無菌ろ過が困難となるおそれがある。 [Concentration of copolymer (P)]
The soft contact lens treatment solution of the present invention has a concentration of copolymer (P) of 0.001 w/v % or more, preferably 0.01 w/v % or more, more preferably 0.05 w/v % or more, and 5.0 w/v % or less, preferably 2.0 w/v % or less, more preferably 1.0 w/v % or less.
If the concentration of the copolymer (P) is less than 0.001 w/v%, the amount of the copolymer (P) added is so small that sufficient hydrophilicity and lubricity and their durability cannot be obtained, whereas if the concentration exceeds 5.0 w/v%, the sterile filtration performed during production may become difficult.
なお、本発明において、「w/v%」は、100mLの溶液中のある成分の質量をグラム(g)で表したものである。例えば、「本発明の処理液が1.0w/v%の共重合体(P)を含有する」とは、100mLの溶液が1.0gの共重合体(P)を含有していることを意味する。
In the present invention, "w/v %" refers to the mass of a certain component in 100 mL of solution, expressed in grams (g). For example, "the treatment solution of the present invention contains 1.0 w/v % copolymer (P)" means that 100 mL of solution contains 1.0 g of copolymer (P).
本発明の処理液に使用する溶媒としては、水、エタノール、n-プロパノール、イソプロパノール、グリセロール、プロピレングリコール等のアルコールおよびこれらの混合溶媒を用いることができる。好ましくは、水または水とアルコールの混合溶媒であり、より好ましくは、水である。
The solvent used in the treatment solution of the present invention may be water, ethanol, n-propanol, isopropanol, glycerol, alcohol such as propylene glycol, or a mixture of these. Water or a mixture of water and alcohol is preferred, and water is more preferred.
本発明のコンタクトレンズ用処理液に用いる水は、通常、医薬品や医療機器の製造に用いられる水を用いることができる。具体的には、イオン交換水、精製水、滅菌精製水、蒸留水、及び注射用水を用いることができる。
The water used in the contact lens treatment solution of the present invention can be water that is normally used in the manufacture of pharmaceuticals and medical devices. Specifically, ion-exchanged water, purified water, sterilized purified water, distilled water, and water for injection can be used.
[その他の成分]
本発明のコンタクトレンズ用処理液は、重合体(P)以外にも必要に応じてビタミン類、アミノ酸類、糖類、粘稠化剤、清涼化剤、無機塩類、有機酸の塩、酸、塩基、酸化防止剤、安定化剤、防腐剤等のその他の成分を配合することができる。
ビタミン類としては、例えば、フラビンアデニンジヌクレオチドナトリウム、シアノコバラミン、酢酸レチノール、パルミチン酸レチノール、塩酸ピリドキシン、パンテノール、パントテン酸ナトリウム、パントテン酸カルシウム等を挙げられる。
アミノ酸類としては、例えば、アスパラギン酸又はその塩、アミノエチルスルホン酸などが挙げられる。
糖類としては、例えば、ブドウ糖、マンニトール、ソルビトール、キシリトール、トレハロース等が挙げられる。
粘稠化剤としては、例えば、ヒドロキシプロピルメチルセルロール、ヒドロキシエチルセルロースなどが挙げられる。
清涼化剤としては、例えば、メントール、カンフル等が挙げられる。
無機塩類としては、例えば、塩化ナトリウム、塩化カリウム、リン酸水素二ナトリウム、リン酸二水素ナトリウム、無水リン酸二水素ナトリウム、リン酸二水素カリウム、リン酸水素二カリウム等が挙げられる。
有機酸の塩としては、クエン酸ナトリウム等が挙げられる。
酸としては、例えば、リン酸、クエン酸、硫酸、酢酸、塩酸、ホウ酸などが挙げられる。
塩基としては、例えば、水酸化カリウム、水酸化ナトリウム、ホウ砂、トリスヒドロキシメチルアミノメタン、モノエタノールアミン等が挙げられる。
酸化防止剤としては、例えば、酢酸トコフェロール、ジブチルヒドロキシトルエン等が挙げられる。
安定化剤としては、例えば、エデト酸ナトリウム、グリシン、タウリン等が挙げられる。
防腐剤としては、例えば、塩化ベンザルコニウム、クロルヘキシジングルコン酸塩、ソルビン酸カリウム、メチルパラベン、エチルパラベン、プロピルパラベン、イソプロピルパラベン、ブチルパラベン、イソブチルパラベン、塩酸ポリヘキサニド、スルファメキサゾール等が挙げられる。 [Other ingredients]
In addition to the polymer (P), the contact lens treatment solution of the present invention may contain other ingredients, such as vitamins, amino acids, sugars, thickening agents, cooling agents, inorganic salts, salts of organic acids, acids, bases, antioxidants, stabilizers, preservatives, etc., as necessary.
Examples of vitamins include sodium flavin adenine dinucleotide, cyanocobalamin, retinol acetate, retinol palmitate, pyridoxine hydrochloride, panthenol, sodium pantothenate, calcium pantothenate, and the like.
Examples of the amino acids include aspartic acid or a salt thereof, and aminoethylsulfonic acid.
Examples of sugars include glucose, mannitol, sorbitol, xylitol, and trehalose.
Examples of thickening agents include hydroxypropylmethylcellulose and hydroxyethylcellulose.
Examples of the cooling agent include menthol and camphor.
Examples of inorganic salts include sodium chloride, potassium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, anhydrous sodium dihydrogen phosphate, potassium dihydrogen phosphate, and dipotassium hydrogen phosphate.
The salts of organic acids include sodium citrate and the like.
Examples of the acid include phosphoric acid, citric acid, sulfuric acid, acetic acid, hydrochloric acid, and boric acid.
Examples of the base include potassium hydroxide, sodium hydroxide, borax, trishydroxymethylaminomethane, monoethanolamine, and the like.
Examples of the antioxidant include tocopherol acetate and dibutylhydroxytoluene.
Examples of stabilizers include sodium edetate, glycine, and taurine.
Examples of preservatives include benzalkonium chloride, chlorhexidine gluconate, potassium sorbate, methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, polyhexanide hydrochloride, and sulfamexazole.
本発明のコンタクトレンズ用処理液は、重合体(P)以外にも必要に応じてビタミン類、アミノ酸類、糖類、粘稠化剤、清涼化剤、無機塩類、有機酸の塩、酸、塩基、酸化防止剤、安定化剤、防腐剤等のその他の成分を配合することができる。
ビタミン類としては、例えば、フラビンアデニンジヌクレオチドナトリウム、シアノコバラミン、酢酸レチノール、パルミチン酸レチノール、塩酸ピリドキシン、パンテノール、パントテン酸ナトリウム、パントテン酸カルシウム等を挙げられる。
アミノ酸類としては、例えば、アスパラギン酸又はその塩、アミノエチルスルホン酸などが挙げられる。
糖類としては、例えば、ブドウ糖、マンニトール、ソルビトール、キシリトール、トレハロース等が挙げられる。
粘稠化剤としては、例えば、ヒドロキシプロピルメチルセルロール、ヒドロキシエチルセルロースなどが挙げられる。
清涼化剤としては、例えば、メントール、カンフル等が挙げられる。
無機塩類としては、例えば、塩化ナトリウム、塩化カリウム、リン酸水素二ナトリウム、リン酸二水素ナトリウム、無水リン酸二水素ナトリウム、リン酸二水素カリウム、リン酸水素二カリウム等が挙げられる。
有機酸の塩としては、クエン酸ナトリウム等が挙げられる。
酸としては、例えば、リン酸、クエン酸、硫酸、酢酸、塩酸、ホウ酸などが挙げられる。
塩基としては、例えば、水酸化カリウム、水酸化ナトリウム、ホウ砂、トリスヒドロキシメチルアミノメタン、モノエタノールアミン等が挙げられる。
酸化防止剤としては、例えば、酢酸トコフェロール、ジブチルヒドロキシトルエン等が挙げられる。
安定化剤としては、例えば、エデト酸ナトリウム、グリシン、タウリン等が挙げられる。
防腐剤としては、例えば、塩化ベンザルコニウム、クロルヘキシジングルコン酸塩、ソルビン酸カリウム、メチルパラベン、エチルパラベン、プロピルパラベン、イソプロピルパラベン、ブチルパラベン、イソブチルパラベン、塩酸ポリヘキサニド、スルファメキサゾール等が挙げられる。 [Other ingredients]
In addition to the polymer (P), the contact lens treatment solution of the present invention may contain other ingredients, such as vitamins, amino acids, sugars, thickening agents, cooling agents, inorganic salts, salts of organic acids, acids, bases, antioxidants, stabilizers, preservatives, etc., as necessary.
Examples of vitamins include sodium flavin adenine dinucleotide, cyanocobalamin, retinol acetate, retinol palmitate, pyridoxine hydrochloride, panthenol, sodium pantothenate, calcium pantothenate, and the like.
Examples of the amino acids include aspartic acid or a salt thereof, and aminoethylsulfonic acid.
Examples of sugars include glucose, mannitol, sorbitol, xylitol, and trehalose.
Examples of thickening agents include hydroxypropylmethylcellulose and hydroxyethylcellulose.
Examples of the cooling agent include menthol and camphor.
Examples of inorganic salts include sodium chloride, potassium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate, anhydrous sodium dihydrogen phosphate, potassium dihydrogen phosphate, and dipotassium hydrogen phosphate.
The salts of organic acids include sodium citrate and the like.
Examples of the acid include phosphoric acid, citric acid, sulfuric acid, acetic acid, hydrochloric acid, and boric acid.
Examples of the base include potassium hydroxide, sodium hydroxide, borax, trishydroxymethylaminomethane, monoethanolamine, and the like.
Examples of the antioxidant include tocopherol acetate and dibutylhydroxytoluene.
Examples of stabilizers include sodium edetate, glycine, and taurine.
Examples of preservatives include benzalkonium chloride, chlorhexidine gluconate, potassium sorbate, methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, polyhexanide hydrochloride, and sulfamexazole.
[コンタクトレンズ用処理液のpH]
本発明のコンタクトレンズ用処理液のpHは、装用感を向上させる観点から、好ましくは3.0~8.0、より好ましくは3.5~7.8、更に好ましくは4.0~7.6、より更に好ましくは4.5~7.5である。
なお、本明細書におけるコンタクトレンズ用処理液のpHは、第18改正日本薬局方 一般試験法 2.54 pH測定法に従って測定した値をいう。 [pH of contact lens treatment solution]
From the viewpoint of improving the wearing comfort, the pH of the contact lens treatment solution of the present invention is preferably 3.0 to 8.0, more preferably 3.5 to 7.8, even more preferably 4.0 to 7.6, and still more preferably 4.5 to 7.5.
In this specification, the pH of the contact lens treatment solution refers to a value measured in accordance with the 18th Edition of the Japanese Pharmacopoeia, General Test Method 2.54 pH Measurement Method.
本発明のコンタクトレンズ用処理液のpHは、装用感を向上させる観点から、好ましくは3.0~8.0、より好ましくは3.5~7.8、更に好ましくは4.0~7.6、より更に好ましくは4.5~7.5である。
なお、本明細書におけるコンタクトレンズ用処理液のpHは、第18改正日本薬局方 一般試験法 2.54 pH測定法に従って測定した値をいう。 [pH of contact lens treatment solution]
From the viewpoint of improving the wearing comfort, the pH of the contact lens treatment solution of the present invention is preferably 3.0 to 8.0, more preferably 3.5 to 7.8, even more preferably 4.0 to 7.6, and still more preferably 4.5 to 7.5.
In this specification, the pH of the contact lens treatment solution refers to a value measured in accordance with the 18th Edition of the Japanese Pharmacopoeia, General Test Method 2.54 pH Measurement Method.
[コンタクトレンズ用処理液の浸透圧及び浸透圧比]
本発明のコンタクトレンズ用処理液の浸透圧は、装用感を向上させる観点から、好ましくは200~400mOsm、より好ましくは225~375mOsm、更に好ましくは230~350mOsm、より更に好ましくは240~340mOsmである。浸透圧比は好ましくは0.7~1.4、より好ましくは0.7~1.3、更に好ましくは0.8~1.2である。
なお、本明細書におけるコンタクトレンズ用処理液の浸透圧は、第18改正日本薬局方 一般試験法 2.47 浸透圧測定法(オスモル濃度測定法)に従って測定した値をいい、浸透圧比は得られた浸透圧の値を0.9質量%生理食塩液の浸透圧の値(286mOsm)で除した値を指す。 [Osmotic pressure and osmotic pressure ratio of contact lens treatment solution]
From the viewpoint of improving the wearing comfort, the osmotic pressure of the contact lens treatment solution of the present invention is preferably 200 to 400 mOsm, more preferably 225 to 375 mOsm, even more preferably 230 to 350 mOsm, and even more preferably 240 to 340 mOsm. The osmotic pressure ratio is preferably 0.7 to 1.4, more preferably 0.7 to 1.3, and even more preferably 0.8 to 1.2.
In this specification, the osmotic pressure of the contact lens treatment solution refers to a value measured in accordance with the 18th Edition of the Japanese Pharmacopoeia, General Test Method 2.47 Osmotic Pressure Measurement Method (Osmolarity Measurement Method), and the osmotic pressure ratio refers to a value obtained by dividing the obtained osmotic pressure value by the osmotic pressure value (286 mOsm) of 0.9 mass % physiological saline solution.
本発明のコンタクトレンズ用処理液の浸透圧は、装用感を向上させる観点から、好ましくは200~400mOsm、より好ましくは225~375mOsm、更に好ましくは230~350mOsm、より更に好ましくは240~340mOsmである。浸透圧比は好ましくは0.7~1.4、より好ましくは0.7~1.3、更に好ましくは0.8~1.2である。
なお、本明細書におけるコンタクトレンズ用処理液の浸透圧は、第18改正日本薬局方 一般試験法 2.47 浸透圧測定法(オスモル濃度測定法)に従って測定した値をいい、浸透圧比は得られた浸透圧の値を0.9質量%生理食塩液の浸透圧の値(286mOsm)で除した値を指す。 [Osmotic pressure and osmotic pressure ratio of contact lens treatment solution]
From the viewpoint of improving the wearing comfort, the osmotic pressure of the contact lens treatment solution of the present invention is preferably 200 to 400 mOsm, more preferably 225 to 375 mOsm, even more preferably 230 to 350 mOsm, and even more preferably 240 to 340 mOsm. The osmotic pressure ratio is preferably 0.7 to 1.4, more preferably 0.7 to 1.3, and even more preferably 0.8 to 1.2.
In this specification, the osmotic pressure of the contact lens treatment solution refers to a value measured in accordance with the 18th Edition of the Japanese Pharmacopoeia, General Test Method 2.47 Osmotic Pressure Measurement Method (Osmolarity Measurement Method), and the osmotic pressure ratio refers to a value obtained by dividing the obtained osmotic pressure value by the osmotic pressure value (286 mOsm) of 0.9 mass % physiological saline solution.
[ソフトコンタクトレンズ用処理液の製造方法]
本発明のソフトコンタクトレンズ用処理液は、一般的なコンタクトレンズ用溶液の製造方法により製造することができる。例えば、重合体(P)、必要に応じて溶媒及びその他の成分を混合して攪拌することにより製造できる。なお、得られたソフトコンタクトレンズ用処理液は、必要に応じて無菌ろ過等の操作を行ってもよい。 [Method of manufacturing a treatment solution for soft contact lenses]
The soft contact lens treatment solution of the present invention can be produced by a general method for producing a contact lens solution. For example, it can be produced by mixing and stirring the polymer (P), a solvent and other components as necessary. The obtained soft contact lens treatment solution may be subjected to a procedure such as sterilization filtration as necessary.
本発明のソフトコンタクトレンズ用処理液は、一般的なコンタクトレンズ用溶液の製造方法により製造することができる。例えば、重合体(P)、必要に応じて溶媒及びその他の成分を混合して攪拌することにより製造できる。なお、得られたソフトコンタクトレンズ用処理液は、必要に応じて無菌ろ過等の操作を行ってもよい。 [Method of manufacturing a treatment solution for soft contact lenses]
The soft contact lens treatment solution of the present invention can be produced by a general method for producing a contact lens solution. For example, it can be produced by mixing and stirring the polymer (P), a solvent and other components as necessary. The obtained soft contact lens treatment solution may be subjected to a procedure such as sterilization filtration as necessary.
以下、実施例及び比較例により本発明をより詳細に説明するが、本発明はそれらに限定されるものではない。実施例及び比較例において用いた共重合体は、以下の通りである。
The present invention will be described in more detail below with reference to examples and comparative examples, but the present invention is not limited thereto. The copolymers used in the examples and comparative examples are as follows.
<式(b)で表される化合物Iの合成>[合成例1-1]
温度計、圧力計、安全弁、窒素ガス吹き込み管、撹拌機、真空排気管、冷却コイル、蒸気ジャケットを装備した5Lオートクレーブに、2-ヒドロキシプロピルメタクリレート(HPMA)500gとDMC触媒0.07g、および2,6-ジ-tert-ブチルヒドロキシトルエン(BHT)1.0gを仕込んだ。窒素置換後、80℃へと昇温し、0.3MPa以下の条件で、窒素ガス吹き込み管より、プロピレンオキシド(PO)403gを滴下し、反応槽内の圧力と温度の経時的変化を測定したところ、5時間後、反応槽内の圧力が急激に減少した。その後、反応槽内を80℃に保ちながら、0.5MPa以下の条件で、窒素ガス吹き込み管より、徐々にPO262gとエチレンオキシド(EO)870gの混合物を滴下した。添加終了後、80℃で1時間反応させ、反応層から反応混合物を抜き取り、反応混合物の濾過操作を行って、固体を除去することで、HPMAにPOが2モル付加し、その後PO1.3モルとEO5.7モルがランダムに付加した式(b)の単量体の液状物を得ることができた。GPCにより分子量分布を確認したところ、wb/wfは1.59であった。構造は1H NMRで確認した。
なお、DMC触媒は特開2022-130139号公報記載の手順で合成したものを使用した。 <Synthesis of Compound I represented by formula (b)> [Synthesis Example 1-1]
A 5L autoclave equipped with a thermometer, pressure gauge, safety valve, nitrogen gas inlet tube, stirrer, vacuum exhaust tube, cooling coil, and steam jacket was charged with 500g of 2-hydroxypropyl methacrylate (HPMA), 0.07g of DMC catalyst, and 1.0g of 2,6-di-tert-butylhydroxytoluene (BHT). After nitrogen replacement, the temperature was raised to 80°C, and 403g of propylene oxide (PO) was dropped from the nitrogen gas inlet tube under conditions of 0.3MPa or less, and the changes in pressure and temperature over time in the reaction vessel were measured. After that, the pressure in the reaction vessel suddenly decreased after 5 hours. Thereafter, while maintaining the reaction vessel at 80°C, a mixture of 262g of PO and 870g of ethylene oxide (EO) was gradually dropped from the nitrogen gas inlet tube under conditions of 0.5MPa or less. After the addition was completed, the mixture was reacted at 80° C. for 1 hour, the reaction mixture was extracted from the reaction layer, and the reaction mixture was filtered to remove solids, thereby obtaining a liquid product of the monomer of formula (b) in which 2 moles of PO were added to HPMA, and then 1.3 moles of PO and 5.7 moles of EO were randomly added. The molecular weight distribution was confirmed by GPC, and w b /w f was 1.59. The structure was confirmed by 1 H NMR.
The DMC catalyst used was synthesized according to the procedure described in JP-A-2022-130139.
温度計、圧力計、安全弁、窒素ガス吹き込み管、撹拌機、真空排気管、冷却コイル、蒸気ジャケットを装備した5Lオートクレーブに、2-ヒドロキシプロピルメタクリレート(HPMA)500gとDMC触媒0.07g、および2,6-ジ-tert-ブチルヒドロキシトルエン(BHT)1.0gを仕込んだ。窒素置換後、80℃へと昇温し、0.3MPa以下の条件で、窒素ガス吹き込み管より、プロピレンオキシド(PO)403gを滴下し、反応槽内の圧力と温度の経時的変化を測定したところ、5時間後、反応槽内の圧力が急激に減少した。その後、反応槽内を80℃に保ちながら、0.5MPa以下の条件で、窒素ガス吹き込み管より、徐々にPO262gとエチレンオキシド(EO)870gの混合物を滴下した。添加終了後、80℃で1時間反応させ、反応層から反応混合物を抜き取り、反応混合物の濾過操作を行って、固体を除去することで、HPMAにPOが2モル付加し、その後PO1.3モルとEO5.7モルがランダムに付加した式(b)の単量体の液状物を得ることができた。GPCにより分子量分布を確認したところ、wb/wfは1.59であった。構造は1H NMRで確認した。
なお、DMC触媒は特開2022-130139号公報記載の手順で合成したものを使用した。 <Synthesis of Compound I represented by formula (b)> [Synthesis Example 1-1]
A 5L autoclave equipped with a thermometer, pressure gauge, safety valve, nitrogen gas inlet tube, stirrer, vacuum exhaust tube, cooling coil, and steam jacket was charged with 500g of 2-hydroxypropyl methacrylate (HPMA), 0.07g of DMC catalyst, and 1.0g of 2,6-di-tert-butylhydroxytoluene (BHT). After nitrogen replacement, the temperature was raised to 80°C, and 403g of propylene oxide (PO) was dropped from the nitrogen gas inlet tube under conditions of 0.3MPa or less, and the changes in pressure and temperature over time in the reaction vessel were measured. After that, the pressure in the reaction vessel suddenly decreased after 5 hours. Thereafter, while maintaining the reaction vessel at 80°C, a mixture of 262g of PO and 870g of ethylene oxide (EO) was gradually dropped from the nitrogen gas inlet tube under conditions of 0.5MPa or less. After the addition was completed, the mixture was reacted at 80° C. for 1 hour, the reaction mixture was extracted from the reaction layer, and the reaction mixture was filtered to remove solids, thereby obtaining a liquid product of the monomer of formula (b) in which 2 moles of PO were added to HPMA, and then 1.3 moles of PO and 5.7 moles of EO were randomly added. The molecular weight distribution was confirmed by GPC, and w b /w f was 1.59. The structure was confirmed by 1 H NMR.
The DMC catalyst used was synthesized according to the procedure described in JP-A-2022-130139.
<式(b)で表される化合物IIの合成>[合成例1-2]
温度計、圧力計、安全弁、窒素ガス吹き込み管、撹拌機、真空排気管、冷却コイル、蒸気ジャケットを装備した5Lオートクレーブに、HPMA520gとDMC触媒0.08g、およびBHT1.0gを仕込んだ。窒素置換後、80℃へと昇温し、0.3MPa以下の条件で、窒素ガス吹き込み管より、PO419gを滴下し、反応槽内の圧力と温度の経時的変化を測定したところ、5時間後、反応槽内の圧力が急激に減少した。その後、反応槽内を80℃に保ちながら、0.5MPa以下の条件で、窒素ガス吹き込み管より、徐々にEO1111gの混合物を滴下した。添加終了後、80℃で1時間反応させ、反応層から反応混合物を抜き取り、反応混合物の濾過操作を行って、固体を除去することで、HPMAにPOが2モル付加し、その後EO7モルが付加した式(b)の単量体の液状物を得ることができた。GPCにより分子量分布を確認したところ、wb/wfは1.75であった。構造は1H NMRで確認した。 <Synthesis of Compound II represented by Formula (b)> [Synthesis Example 1-2]
In a 5L autoclave equipped with a thermometer, a pressure gauge, a safety valve, a nitrogen gas inlet tube, a stirrer, a vacuum exhaust tube, a cooling coil, and a steam jacket, 520g of HPMA, 0.08g of DMC catalyst, and 1.0g of BHT were charged. After nitrogen replacement, the temperature was raised to 80°C, and 419g of PO was dropped from the nitrogen gas inlet tube under conditions of 0.3MPa or less, and the changes in pressure and temperature in the reaction vessel over time were measured. After 5 hours, the pressure in the reaction vessel suddenly decreased. Then, while maintaining the reaction vessel at 80°C, a mixture of 1111g of EO was gradually dropped from the nitrogen gas inlet tube under conditions of 0.5MPa or less. After the addition was completed, the reaction was carried out at 80°C for 1 hour, the reaction mixture was extracted from the reaction layer, and the reaction mixture was filtered to remove the solid, and a liquid product of the monomer of formula (b) in which 2 moles of PO were added to HPMA and then 7 moles of EO were added was obtained. The molecular weight distribution was confirmed by GPC, and w b /w f was found to be 1.75. The structure was confirmed by 1 H NMR.
温度計、圧力計、安全弁、窒素ガス吹き込み管、撹拌機、真空排気管、冷却コイル、蒸気ジャケットを装備した5Lオートクレーブに、HPMA520gとDMC触媒0.08g、およびBHT1.0gを仕込んだ。窒素置換後、80℃へと昇温し、0.3MPa以下の条件で、窒素ガス吹き込み管より、PO419gを滴下し、反応槽内の圧力と温度の経時的変化を測定したところ、5時間後、反応槽内の圧力が急激に減少した。その後、反応槽内を80℃に保ちながら、0.5MPa以下の条件で、窒素ガス吹き込み管より、徐々にEO1111gの混合物を滴下した。添加終了後、80℃で1時間反応させ、反応層から反応混合物を抜き取り、反応混合物の濾過操作を行って、固体を除去することで、HPMAにPOが2モル付加し、その後EO7モルが付加した式(b)の単量体の液状物を得ることができた。GPCにより分子量分布を確認したところ、wb/wfは1.75であった。構造は1H NMRで確認した。 <Synthesis of Compound II represented by Formula (b)> [Synthesis Example 1-2]
In a 5L autoclave equipped with a thermometer, a pressure gauge, a safety valve, a nitrogen gas inlet tube, a stirrer, a vacuum exhaust tube, a cooling coil, and a steam jacket, 520g of HPMA, 0.08g of DMC catalyst, and 1.0g of BHT were charged. After nitrogen replacement, the temperature was raised to 80°C, and 419g of PO was dropped from the nitrogen gas inlet tube under conditions of 0.3MPa or less, and the changes in pressure and temperature in the reaction vessel over time were measured. After 5 hours, the pressure in the reaction vessel suddenly decreased. Then, while maintaining the reaction vessel at 80°C, a mixture of 1111g of EO was gradually dropped from the nitrogen gas inlet tube under conditions of 0.5MPa or less. After the addition was completed, the reaction was carried out at 80°C for 1 hour, the reaction mixture was extracted from the reaction layer, and the reaction mixture was filtered to remove the solid, and a liquid product of the monomer of formula (b) in which 2 moles of PO were added to HPMA and then 7 moles of EO were added was obtained. The molecular weight distribution was confirmed by GPC, and w b /w f was found to be 1.75. The structure was confirmed by 1 H NMR.
<(d)で表されるMAEMの合成>[合成例1-3]
温度計、ガス吹き込み管、撹拌機、滴下漏斗を取り付けた250mLフラスコに、2-アセトアミドエタノール9.28g、脱水ジクロロメタン100mLを加え、アルゴンガスでフラスコ内を十分に置換した後、トリエチルアミン13.15gを加えた。その後、-15℃まで系中を冷却し、メタクリル酸クロリド11.29gを、温度計を見ながら、温度が約-9℃を維持するようにゆっくりと滴下漏斗から滴下し、滴下終了後、室温で3時間攪拌した。反応混合物の濾過操作を行い、析出物を除去し、濾液を水、飽和炭酸水素ナトリウム水溶液、飽和塩化ナトリウム水溶液で順に洗浄後、硫酸ナトリウムで水分を乾燥させた後、ロータリーエバポレーターで減圧濃縮して油状物を得た。更にヘキサンと酢酸エチルを溶出液として、シリカゲルクロマトグラフィーにより精製し、実施例化合物2-(アセチルアミノ)エチルメタクリレートを得ることができた。構造は1H NMRで確認した。
なお、2-(アセチルアミノ)エチルメタクリレート(MAEM)は特開2017-160380号公報記載の手順に従い合成した。 <Synthesis of MAEM represented by (d)> [Synthesis Example 1-3]
9.28 g of 2-acetamidoethanol and 100 mL of dehydrated dichloromethane were added to a 250 mL flask equipped with a thermometer, a gas inlet tube, a stirrer, and a dropping funnel. The flask was thoroughly replaced with argon gas, and then 13.15 g of triethylamine was added. The system was then cooled to -15°C, and 11.29 g of methacrylic acid chloride was slowly dropped from the dropping funnel while watching the thermometer so that the temperature was maintained at about -9°C. After the dropwise addition was completed, the mixture was stirred at room temperature for 3 hours. The reaction mixture was filtered to remove the precipitate, and the filtrate was washed with water, a saturated aqueous solution of sodium bicarbonate, and a saturated aqueous solution of sodium chloride in that order, and then dried with sodium sulfate. The mixture was concentrated under reduced pressure with a rotary evaporator to obtain an oily product. The mixture was further purified by silica gel chromatography using hexane and ethyl acetate as eluents, and the example compound 2-(acetylamino)ethyl methacrylate was obtained. The structure was confirmed by 1 H NMR.
2-(acetylamino)ethyl methacrylate (MAEM) was synthesized according to the procedure described in JP-A-2017-160380.
温度計、ガス吹き込み管、撹拌機、滴下漏斗を取り付けた250mLフラスコに、2-アセトアミドエタノール9.28g、脱水ジクロロメタン100mLを加え、アルゴンガスでフラスコ内を十分に置換した後、トリエチルアミン13.15gを加えた。その後、-15℃まで系中を冷却し、メタクリル酸クロリド11.29gを、温度計を見ながら、温度が約-9℃を維持するようにゆっくりと滴下漏斗から滴下し、滴下終了後、室温で3時間攪拌した。反応混合物の濾過操作を行い、析出物を除去し、濾液を水、飽和炭酸水素ナトリウム水溶液、飽和塩化ナトリウム水溶液で順に洗浄後、硫酸ナトリウムで水分を乾燥させた後、ロータリーエバポレーターで減圧濃縮して油状物を得た。更にヘキサンと酢酸エチルを溶出液として、シリカゲルクロマトグラフィーにより精製し、実施例化合物2-(アセチルアミノ)エチルメタクリレートを得ることができた。構造は1H NMRで確認した。
なお、2-(アセチルアミノ)エチルメタクリレート(MAEM)は特開2017-160380号公報記載の手順に従い合成した。 <Synthesis of MAEM represented by (d)> [Synthesis Example 1-3]
9.28 g of 2-acetamidoethanol and 100 mL of dehydrated dichloromethane were added to a 250 mL flask equipped with a thermometer, a gas inlet tube, a stirrer, and a dropping funnel. The flask was thoroughly replaced with argon gas, and then 13.15 g of triethylamine was added. The system was then cooled to -15°C, and 11.29 g of methacrylic acid chloride was slowly dropped from the dropping funnel while watching the thermometer so that the temperature was maintained at about -9°C. After the dropwise addition was completed, the mixture was stirred at room temperature for 3 hours. The reaction mixture was filtered to remove the precipitate, and the filtrate was washed with water, a saturated aqueous solution of sodium bicarbonate, and a saturated aqueous solution of sodium chloride in that order, and then dried with sodium sulfate. The mixture was concentrated under reduced pressure with a rotary evaporator to obtain an oily product. The mixture was further purified by silica gel chromatography using hexane and ethyl acetate as eluents, and the example compound 2-(acetylamino)ethyl methacrylate was obtained. The structure was confirmed by 1 H NMR.
2-(acetylamino)ethyl methacrylate (MAEM) was synthesized according to the procedure described in JP-A-2017-160380.
<共重合体(P)>
実施例において、実施用重合体として下記に示す共重合体1~6を用いた。 <Copolymer (P)>
In the examples, the following copolymers 1 to 6 were used as working polymers.
実施例において、実施用重合体として下記に示す共重合体1~6を用いた。 <Copolymer (P)>
In the examples, the following copolymers 1 to 6 were used as working polymers.
MPC:2-メタクリロイルオキシエチルホスホリルコリン(日油株式会社の製品)
化合物I:ポリエチレングリコール-ポリプロピレングリコールモノメタクリレート(POとEOのランダム付加体(PO/EO=3.3/5.7モル)、p≒10、wb/wf=1.59、合成例1-1で合成したもの)
化合物II:ポリエチレングリコール-ポリプロピレングリコールモノメタクリレート(POとEOのブロック付加体(PO/EO=2.0/7.0モル)、p≒10、wb/wf=1.75、合成例1-2で合成したもの)
MAEM:2-(アセチルアミノ)エチルメタクリレート(合成例1-3で合成したもの)
NVP:N-ビニルピロリドン(富士フィルム和光純薬株式会社の製品)
表1に使用した化合物の該当式をまとめた。
MPC: 2-methacryloyloxyethyl phosphorylcholine (product of NOF Corporation)
Compound I: polyethylene glycol-polypropylene glycol monomethacrylate (random adduct of PO and EO (PO/EO=3.3/5.7 mol), p≈10, w b /w f =1.59, synthesized in Synthesis Example 1-1)
Compound II: polyethylene glycol-polypropylene glycol monomethacrylate (block adduct of PO and EO (PO/EO=2.0/7.0 mol), p≈10, w b /w f =1.75, synthesized in Synthesis Example 1-2)
MAEM: 2-(acetylamino)ethyl methacrylate (synthesized in Synthesis Example 1-3)
NVP: N-vinylpyrrolidone (product of Fujifilm Wako Pure Chemical Industries, Ltd.)
Table 1 summarizes the corresponding formulas of the compounds used.
化合物I:ポリエチレングリコール-ポリプロピレングリコールモノメタクリレート(POとEOのランダム付加体(PO/EO=3.3/5.7モル)、p≒10、wb/wf=1.59、合成例1-1で合成したもの)
化合物II:ポリエチレングリコール-ポリプロピレングリコールモノメタクリレート(POとEOのブロック付加体(PO/EO=2.0/7.0モル)、p≒10、wb/wf=1.75、合成例1-2で合成したもの)
MAEM:2-(アセチルアミノ)エチルメタクリレート(合成例1-3で合成したもの)
NVP:N-ビニルピロリドン(富士フィルム和光純薬株式会社の製品)
表1に使用した化合物の該当式をまとめた。
Compound I: polyethylene glycol-polypropylene glycol monomethacrylate (random adduct of PO and EO (PO/EO=3.3/5.7 mol), p≈10, w b /w f =1.59, synthesized in Synthesis Example 1-1)
Compound II: polyethylene glycol-polypropylene glycol monomethacrylate (block adduct of PO and EO (PO/EO=2.0/7.0 mol), p≈10, w b /w f =1.75, synthesized in Synthesis Example 1-2)
MAEM: 2-(acetylamino)ethyl methacrylate (synthesized in Synthesis Example 1-3)
NVP: N-vinylpyrrolidone (product of Fujifilm Wako Pure Chemical Industries, Ltd.)
Table 1 summarizes the corresponding formulas of the compounds used.
<重量平均分子量の測定>
得られた共重合体1mgを移動相1gへ溶解し、測定した。その他の測定条件は下記の通りである。
カラム:SB-802.5 HQ+SB-806MN HQ+SB-G
移動相:20mMリン酸緩衝液(pH7.0)
標準物質:ポリエチレングリコール/オキシド
計測機器:HLC-8320GPC(東ソー(株)製)
重量平均分子量の算出法:分子量計算プログラム(EcoSEC Date Analysis)
流量:毎分0.5mL
注入量:100μL
カラムオーブン:45℃
測定時間:90分間 <Measurement of weight average molecular weight>
1 mg of the copolymer obtained was dissolved in 1 g of mobile phase and measured. Other measurement conditions were as follows.
Column: SB-802.5 HQ + SB-806MN HQ + SB-G
Mobile phase: 20 mM phosphate buffer (pH 7.0)
Standard substance: polyethylene glycol/oxide Measuring instrument: HLC-8320GPC (manufactured by Tosoh Corporation)
Calculation method of weight average molecular weight: Molecular weight calculation program (EcoSEC Date Analysis)
Flow rate: 0.5 mL per minute
Injection volume: 100 μL
Column oven: 45°C
Measurement time: 90 minutes
得られた共重合体1mgを移動相1gへ溶解し、測定した。その他の測定条件は下記の通りである。
カラム:SB-802.5 HQ+SB-806MN HQ+SB-G
移動相:20mMリン酸緩衝液(pH7.0)
標準物質:ポリエチレングリコール/オキシド
計測機器:HLC-8320GPC(東ソー(株)製)
重量平均分子量の算出法:分子量計算プログラム(EcoSEC Date Analysis)
流量:毎分0.5mL
注入量:100μL
カラムオーブン:45℃
測定時間:90分間 <Measurement of weight average molecular weight>
1 mg of the copolymer obtained was dissolved in 1 g of mobile phase and measured. Other measurement conditions were as follows.
Column: SB-802.5 HQ + SB-806MN HQ + SB-G
Mobile phase: 20 mM phosphate buffer (pH 7.0)
Standard substance: polyethylene glycol/oxide Measuring instrument: HLC-8320GPC (manufactured by Tosoh Corporation)
Calculation method of weight average molecular weight: Molecular weight calculation program (EcoSEC Date Analysis)
Flow rate: 0.5 mL per minute
Injection volume: 100 μL
Column oven: 45°C
Measurement time: 90 minutes
<実施例用共重合体の重合>
[実施例1-1]
MPC 0.90g、化合物I(合成例1-1で合成したもの) 4.18gを水14.4g、エタノール14.4gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:化合物I=30:70(モル比))。55℃でパーブチル(登録商標)ND(PB-ND、日油株式会社製)を0.51g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.4gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体1)を得た。重量平均分子量はGPCにより確認し、32,100であった。 <Polymerization of Copolymers for Examples>
[Example 1-1]
0.90 g of MPC and 4.18 g of compound I (synthesized in Synthesis Example 1-1) were dissolved in 14.4 g of water and 14.4 g of ethanol, and the solution was placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes (MPC: compound I = 30: 70 (molar ratio)). 0.51 g of Perbutyl (registered trademark) ND (PB-ND, manufactured by NOF Corporation) was added at 55 ° C. and stirred for 3 hours, and then the temperature was raised to 75 ° C. and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.4 g of water was added, distillation was carried out for 1 hour, and the resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 1). The weight average molecular weight was confirmed by GPC and was 32,100.
[実施例1-1]
MPC 0.90g、化合物I(合成例1-1で合成したもの) 4.18gを水14.4g、エタノール14.4gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:化合物I=30:70(モル比))。55℃でパーブチル(登録商標)ND(PB-ND、日油株式会社製)を0.51g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.4gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体1)を得た。重量平均分子量はGPCにより確認し、32,100であった。 <Polymerization of Copolymers for Examples>
[Example 1-1]
0.90 g of MPC and 4.18 g of compound I (synthesized in Synthesis Example 1-1) were dissolved in 14.4 g of water and 14.4 g of ethanol, and the solution was placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes (MPC: compound I = 30: 70 (molar ratio)). 0.51 g of Perbutyl (registered trademark) ND (PB-ND, manufactured by NOF Corporation) was added at 55 ° C. and stirred for 3 hours, and then the temperature was raised to 75 ° C. and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.4 g of water was added, distillation was carried out for 1 hour, and the resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 1). The weight average molecular weight was confirmed by GPC and was 32,100.
[実施例1-2]
MPC 2.20g、化合物I 2.92gを水14.5g、エタノール14.5gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:化合物I=60:40(モル比))。55℃でPB-NDを0.51g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.5gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体2)を得た。重量平均分子量はGPCにより確認し、150,500であった。 [Example 1-2]
2.20g of MPC and 2.92g of compound I were dissolved in 14.5g of water and 14.5g of ethanol, and the solution was placed in a 100mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2L/min for 30 minutes (MPC: compound I = 60:40 (molar ratio)). 0.51g of PB-ND was added at 55°C and stirred for 3 hours, and then the temperature was raised to 75°C and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.5g of water was added, distillation was carried out for 1 hour, and the resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 2). The weight average molecular weight was confirmed by GPC and was 150,500.
MPC 2.20g、化合物I 2.92gを水14.5g、エタノール14.5gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:化合物I=60:40(モル比))。55℃でPB-NDを0.51g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.5gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体2)を得た。重量平均分子量はGPCにより確認し、150,500であった。 [Example 1-2]
2.20g of MPC and 2.92g of compound I were dissolved in 14.5g of water and 14.5g of ethanol, and the solution was placed in a 100mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2L/min for 30 minutes (MPC: compound I = 60:40 (molar ratio)). 0.51g of PB-ND was added at 55°C and stirred for 3 hours, and then the temperature was raised to 75°C and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.5g of water was added, distillation was carried out for 1 hour, and the resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 2). The weight average molecular weight was confirmed by GPC and was 150,500.
[実施例1-3]
MPC 1.70g、化合物I 5.64g、MAEM(合成例1-3で合成したもの)0.66gを水16.0g、エタノール16.0gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:化合物I:MAEM=30:50:20(モル比))。55℃でPB-NDを0.40g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水16.0gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体3)を得た。重量平均分子量はGPCにより確認し、190,500であった。 [Examples 1-3]
1.70 g of MPC, 5.64 g of compound I, and 0.66 g of MAEM (synthesized in Synthesis Example 1-3) were dissolved in 16.0 g of water and 16.0 g of ethanol, and placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes (MPC: compound I: MAEM = 30: 50: 20 (molar ratio)). 0.40 g of PB-ND was added at 55 ° C. and stirred for 3 hours, and then the temperature was raised to 75 ° C. and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 16.0 g of water was added, distillation was carried out for 1 hour, and the resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 3). The weight average molecular weight was confirmed by GPC and was 190,500.
MPC 1.70g、化合物I 5.64g、MAEM(合成例1-3で合成したもの)0.66gを水16.0g、エタノール16.0gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:化合物I:MAEM=30:50:20(モル比))。55℃でPB-NDを0.40g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水16.0gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体3)を得た。重量平均分子量はGPCにより確認し、190,500であった。 [Examples 1-3]
1.70 g of MPC, 5.64 g of compound I, and 0.66 g of MAEM (synthesized in Synthesis Example 1-3) were dissolved in 16.0 g of water and 16.0 g of ethanol, and placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes (MPC: compound I: MAEM = 30: 50: 20 (molar ratio)). 0.40 g of PB-ND was added at 55 ° C. and stirred for 3 hours, and then the temperature was raised to 75 ° C. and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 16.0 g of water was added, distillation was carried out for 1 hour, and the resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 3). The weight average molecular weight was confirmed by GPC and was 190,500.
[実施例1-4]
MPC 2.20g、化合物I 2.63g、NVP 0.33gを水14.6g、エタノール14.6gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:化合物I:NVP=50:30:20(モル比))。55℃でPB-NDを0.52g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.6gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体4)を得た。重量平均分子量はGPCにより確認し、100,500であった。 [Examples 1 to 4]
2.20g of MPC, 2.63g of compound I, and 0.33g of NVP were dissolved in 14.6g of water and 14.6g of ethanol, and placed in a 100mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2L/min for 30 minutes (MPC: compound I: NVP = 50: 30: 20 (molar ratio)). 0.52g of PB-ND was added at 55°C and stirred for 3 hours, and then the temperature was raised to 75°C and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.6g of water was added, distillation was carried out for 1 hour, and the resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 4). The weight average molecular weight was confirmed by GPC and was 100,500.
MPC 2.20g、化合物I 2.63g、NVP 0.33gを水14.6g、エタノール14.6gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:化合物I:NVP=50:30:20(モル比))。55℃でPB-NDを0.52g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.6gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体4)を得た。重量平均分子量はGPCにより確認し、100,500であった。 [Examples 1 to 4]
2.20g of MPC, 2.63g of compound I, and 0.33g of NVP were dissolved in 14.6g of water and 14.6g of ethanol, and placed in a 100mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2L/min for 30 minutes (MPC: compound I: NVP = 50: 30: 20 (molar ratio)). 0.52g of PB-ND was added at 55°C and stirred for 3 hours, and then the temperature was raised to 75°C and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.6g of water was added, distillation was carried out for 1 hour, and the resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 4). The weight average molecular weight was confirmed by GPC and was 100,500.
[実施例1-5]
MPC 0.50g、化合物I 4.31g、MAEM 0.39gを水14.7g、エタノール14.7gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:化合物I:MAEM=15:65:20(モル比))。55℃でPB-NDを0.52g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.7gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体5)を得た。重量平均分子量はGPCにより確認し、29,500であった。 [Examples 1 to 5]
0.50g of MPC, 4.31g of compound I, and 0.39g of MAEM were dissolved in 14.7g of water and 14.7g of ethanol, and placed in a 100mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2L/min for 30 minutes (MPC: compound I: MAEM = 15:65:20 (molar ratio)). 0.52g of PB-ND was added at 55°C and stirred for 3 hours, and then the temperature was raised to 75°C and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.7g of water was added, distillation was carried out for 1 hour, and the resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 5). The weight average molecular weight was confirmed by GPC and was 29,500.
MPC 0.50g、化合物I 4.31g、MAEM 0.39gを水14.7g、エタノール14.7gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:化合物I:MAEM=15:65:20(モル比))。55℃でPB-NDを0.52g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.7gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体5)を得た。重量平均分子量はGPCにより確認し、29,500であった。 [Examples 1 to 5]
0.50g of MPC, 4.31g of compound I, and 0.39g of MAEM were dissolved in 14.7g of water and 14.7g of ethanol, and placed in a 100mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2L/min for 30 minutes (MPC: compound I: MAEM = 15:65:20 (molar ratio)). 0.52g of PB-ND was added at 55°C and stirred for 3 hours, and then the temperature was raised to 75°C and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.7g of water was added, distillation was carried out for 1 hour, and the resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 5). The weight average molecular weight was confirmed by GPC and was 29,500.
[実施例1-6]
MPC 0.90g、化合物II(合成例1-2で合成したもの) 4.22gを水14.5g、エタノール14.5gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:化合物II=30:70(モル比))。55℃でPB-NDを0.51g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.5gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体6)を得た。重量平均分子量はGPCにより確認し、98,500であった。 [Examples 1 to 6]
0.90 g of MPC and 4.22 g of compound II (synthesized in Synthesis Example 1-2) were dissolved in 14.5 g of water and 14.5 g of ethanol, and the solution was placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes (MPC: compound II = 30: 70 (molar ratio)). 0.51 g of PB-ND was added at 55 ° C. and stirred for 3 hours, and then the temperature was raised to 75 ° C. and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.5 g of water was added, distillation was carried out for 1 hour, and the resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 6). The weight average molecular weight was confirmed by GPC and was 98,500.
MPC 0.90g、化合物II(合成例1-2で合成したもの) 4.22gを水14.5g、エタノール14.5gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:化合物II=30:70(モル比))。55℃でPB-NDを0.51g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.5gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体6)を得た。重量平均分子量はGPCにより確認し、98,500であった。 [Examples 1 to 6]
0.90 g of MPC and 4.22 g of compound II (synthesized in Synthesis Example 1-2) were dissolved in 14.5 g of water and 14.5 g of ethanol, and the solution was placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes (MPC: compound II = 30: 70 (molar ratio)). 0.51 g of PB-ND was added at 55 ° C. and stirred for 3 hours, and then the temperature was raised to 75 ° C. and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.5 g of water was added, distillation was carried out for 1 hour, and the resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 6). The weight average molecular weight was confirmed by GPC and was 98,500.
<比較例用共重合体>
比較例において、比較用重合体として下記に示す単独重合体1、2及び共重合体7、8、PVP K30(ポリビニルピロリドン K30)を用いた。 <Copolymer for comparative example>
In the comparative examples, the following homopolymers 1 and 2, copolymers 7 and 8, and PVP K30 (polyvinylpyrrolidone K30) were used as comparative polymers.
比較例において、比較用重合体として下記に示す単独重合体1、2及び共重合体7、8、PVP K30(ポリビニルピロリドン K30)を用いた。 <Copolymer for comparative example>
In the comparative examples, the following homopolymers 1 and 2, copolymers 7 and 8, and PVP K30 (polyvinylpyrrolidone K30) were used as comparative polymers.
<比較例用共重合体の重合>
[比較例1-1]
MPC 5.00gを水14.2g、エタノール14.2gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ。55℃でPB-NDを0.50g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.2gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(単独共重合体1)を得た。重量平均分子量はGPCにより確認し、300,000であった。 <Polymerization of Comparative Copolymer>
[Comparative Example 1-1]
5.00 g of MPC was dissolved in 14.2 g of water and 14.2 g of ethanol, and the solution was placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes. 0.50 g of PB-ND was added at 55°C and stirred for 3 hours, and then the temperature was raised to 75°C and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.2 g of water was added, and distillation was carried out for 1 hour. The resulting reaction solution was purified by dialysis to obtain a polymer solution (homocopolymer 1). The weight average molecular weight was confirmed by GPC and was 300,000.
[比較例1-1]
MPC 5.00gを水14.2g、エタノール14.2gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ。55℃でPB-NDを0.50g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.2gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(単独共重合体1)を得た。重量平均分子量はGPCにより確認し、300,000であった。 <Polymerization of Comparative Copolymer>
[Comparative Example 1-1]
5.00 g of MPC was dissolved in 14.2 g of water and 14.2 g of ethanol, and the solution was placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes. 0.50 g of PB-ND was added at 55°C and stirred for 3 hours, and then the temperature was raised to 75°C and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.2 g of water was added, and distillation was carried out for 1 hour. The resulting reaction solution was purified by dialysis to obtain a polymer solution (homocopolymer 1). The weight average molecular weight was confirmed by GPC and was 300,000.
[比較例1-2]
化合物I 5.10gを水14.5g、エタノール14.5gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ。55℃でPB-NDを0.51g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.5gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(単独共重合体2)を得た。重量平均分子量はGPCにより確認し、20,000であった。 [Comparative Example 1-2]
5.10 g of compound I was dissolved in 14.5 g of water and 14.5 g of ethanol, and the solution was placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes. 0.51 g of PB-ND was added at 55°C and stirred for 3 hours, and then the temperature was raised to 75°C and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.5 g of water was added, and distillation was carried out for 1 hour. The resulting reaction solution was purified by dialysis to obtain a polymer solution (homocopolymer 2). The weight average molecular weight was confirmed by GPC and was 20,000.
化合物I 5.10gを水14.5g、エタノール14.5gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ。55℃でPB-NDを0.51g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.5gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(単独共重合体2)を得た。重量平均分子量はGPCにより確認し、20,000であった。 [Comparative Example 1-2]
5.10 g of compound I was dissolved in 14.5 g of water and 14.5 g of ethanol, and the solution was placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes. 0.51 g of PB-ND was added at 55°C and stirred for 3 hours, and then the temperature was raised to 75°C and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.5 g of water was added, and distillation was carried out for 1 hour. The resulting reaction solution was purified by dialysis to obtain a polymer solution (homocopolymer 2). The weight average molecular weight was confirmed by GPC and was 20,000.
[比較例1-3]
MPC 3.30g、MAEM1.91gを水14.8g、エタノール14.8gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:MAEM=50:50(モル比))。55℃でPB-NDを0.52g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.8gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体7)を得た。重量平均分子量はGPCにより確認し、53,600であった。 [Comparative Example 1-3]
3.30 g of MPC and 1.91 g of MAEM were dissolved in 14.8 g of water and 14.8 g of ethanol, and the solution was placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes (MPC:MAEM=50:50 (molar ratio)). 0.52 g of PB-ND was added at 55° C. and stirred for 3 hours, and then the temperature was raised to 75° C. and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.8 g of water was added, and distillation was carried out for 1 hour. The resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 7). The weight average molecular weight was confirmed by GPC and was 53,600.
MPC 3.30g、MAEM1.91gを水14.8g、エタノール14.8gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:MAEM=50:50(モル比))。55℃でPB-NDを0.52g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.8gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体7)を得た。重量平均分子量はGPCにより確認し、53,600であった。 [Comparative Example 1-3]
3.30 g of MPC and 1.91 g of MAEM were dissolved in 14.8 g of water and 14.8 g of ethanol, and the solution was placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes (MPC:MAEM=50:50 (molar ratio)). 0.52 g of PB-ND was added at 55° C. and stirred for 3 hours, and then the temperature was raised to 75° C. and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.8 g of water was added, and distillation was carried out for 1 hour. The resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 7). The weight average molecular weight was confirmed by GPC and was 53,600.
[比較例1-4]
MPC 3.50g、2-ヒドロキシエチルメタクリレート(HEMA) 1.54gを水14.3g、エタノール14.3gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:HEMA=50:50(モル比))。55℃でPB-NDを0.50g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.3gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体8)を得た。重量平均分子量はGPCにより確認し、356,000であった。 [Comparative Examples 1 to 4]
3.50 g of MPC and 1.54 g of 2-hydroxyethyl methacrylate (HEMA) were dissolved in 14.3 g of water and 14.3 g of ethanol, and the solution was placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes (MPC:HEMA=50:50 (molar ratio)). 0.50 g of PB-ND was added at 55°C and stirred for 3 hours, and then the temperature was raised to 75°C and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.3 g of water was added, and distillation was carried out for 1 hour. The resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 8). The weight average molecular weight was confirmed by GPC and was 356,000.
MPC 3.50g、2-ヒドロキシエチルメタクリレート(HEMA) 1.54gを水14.3g、エタノール14.3gに溶解し、100mLの4つ口フラスコに入れて、0.2L/分の流量で30分間窒素を吹き込んだ(MPC:HEMA=50:50(モル比))。55℃でPB-NDを0.50g加えて3時間攪拌し、その後、75℃まで昇温してさらに2時間重合反応させた。反応終了後、水14.3gを加え、1時間蒸留を行い、得られた反応液を透析精製し、ポリマー溶液(共重合体8)を得た。重量平均分子量はGPCにより確認し、356,000であった。 [Comparative Examples 1 to 4]
3.50 g of MPC and 1.54 g of 2-hydroxyethyl methacrylate (HEMA) were dissolved in 14.3 g of water and 14.3 g of ethanol, and the solution was placed in a 100 mL four-neck flask, and nitrogen was blown in at a flow rate of 0.2 L/min for 30 minutes (MPC:HEMA=50:50 (molar ratio)). 0.50 g of PB-ND was added at 55°C and stirred for 3 hours, and then the temperature was raised to 75°C and polymerization reaction was carried out for another 2 hours. After the reaction was completed, 14.3 g of water was added, and distillation was carried out for 1 hour. The resulting reaction solution was purified by dialysis to obtain a polymer solution (copolymer 8). The weight average molecular weight was confirmed by GPC and was 356,000.
<評価に使用した試験コンタクトレンズ>
レンズA:ソフトコンタクトレンズであるワンデーファインUVプラス(株式会社シードの製品)
レンズB:ソフトコンタクトレンズであるAQUAFORCE UV(アイミー株式会社の製品) <Test contact lenses used in evaluation>
Lens A: One Day Fine UV Plus, a soft contact lens (a product of Seed Co., Ltd.)
Lens B: AQUAFORCE UV, a soft contact lens (a product of Aimi Co., Ltd.)
レンズA:ソフトコンタクトレンズであるワンデーファインUVプラス(株式会社シードの製品)
レンズB:ソフトコンタクトレンズであるAQUAFORCE UV(アイミー株式会社の製品) <Test contact lenses used in evaluation>
Lens A: One Day Fine UV Plus, a soft contact lens (a product of Seed Co., Ltd.)
Lens B: AQUAFORCE UV, a soft contact lens (a product of Aimi Co., Ltd.)
<生理食塩液の調製>
文献(ISO 18369-3:2017,Ophthalmic Optics-Contact Lenses Part3:Measurement Methods.)を参考に、生理食塩液を調製した。
塩化ナトリウム8.3g、リン酸水素ナトリウム十二水和物 5.993g、リン酸二水素ナトリウム二水和物 0.528gを量り、水に溶かして1000mLとして、ろ過して生理食塩液とした。 <Preparation of physiological saline solution>
A physiological saline solution was prepared with reference to the literature (ISO 18369-3:2017, Ophthalmic Optics-Contact Lenses Part 3: Measurement Methods.).
8.3 g of sodium chloride, 5.993 g of sodium hydrogen phosphate dodecahydrate, and 0.528 g of sodium dihydrogen phosphate dihydrate were weighed out, dissolved in water to make 1000 mL, and filtered to make physiological saline solution.
文献(ISO 18369-3:2017,Ophthalmic Optics-Contact Lenses Part3:Measurement Methods.)を参考に、生理食塩液を調製した。
塩化ナトリウム8.3g、リン酸水素ナトリウム十二水和物 5.993g、リン酸二水素ナトリウム二水和物 0.528gを量り、水に溶かして1000mLとして、ろ過して生理食塩液とした。 <Preparation of physiological saline solution>
A physiological saline solution was prepared with reference to the literature (ISO 18369-3:2017, Ophthalmic Optics-Contact Lenses Part 3: Measurement Methods.).
8.3 g of sodium chloride, 5.993 g of sodium hydrogen phosphate dodecahydrate, and 0.528 g of sodium dihydrogen phosphate dihydrate were weighed out, dissolved in water to make 1000 mL, and filtered to make physiological saline solution.
<ソフトコンタクトレンズ用処理液の調製>
<実施例2-1>
共重合体1の溶液を所定量の生理食塩液に溶解させて、下記表2に示す5wt%の重合体溶液を調整した。さらに、重合体溶液2gと生理食塩液98gを混合することで、下記表2に示すコンタクトレンズ用処理液を調製した。このコンタクトレンズ用処理液で処理した試験コンタクトレンズの親水性、潤滑性及び持続性の評価を実施した。評価結果を下記表2に示す。 <Preparation of treatment solution for soft contact lenses>
<Example 2-1>
The solution of copolymer 1 was dissolved in a predetermined amount of physiological saline to prepare a 5 wt % polymer solution as shown in Table 2 below. Furthermore, 2 g of the polymer solution was mixed with 98 g of physiological saline to prepare a contact lens treatment solution as shown in Table 2 below. Test contact lenses treated with this contact lens treatment solution were evaluated for hydrophilicity, lubricity and durability. The evaluation results are shown in Table 2 below.
<実施例2-1>
共重合体1の溶液を所定量の生理食塩液に溶解させて、下記表2に示す5wt%の重合体溶液を調整した。さらに、重合体溶液2gと生理食塩液98gを混合することで、下記表2に示すコンタクトレンズ用処理液を調製した。このコンタクトレンズ用処理液で処理した試験コンタクトレンズの親水性、潤滑性及び持続性の評価を実施した。評価結果を下記表2に示す。 <Preparation of treatment solution for soft contact lenses>
<Example 2-1>
The solution of copolymer 1 was dissolved in a predetermined amount of physiological saline to prepare a 5 wt % polymer solution as shown in Table 2 below. Furthermore, 2 g of the polymer solution was mixed with 98 g of physiological saline to prepare a contact lens treatment solution as shown in Table 2 below. Test contact lenses treated with this contact lens treatment solution were evaluated for hydrophilicity, lubricity and durability. The evaluation results are shown in Table 2 below.
<実施例2-2~2-9>
下記表2及び表3に示す重合体を使用した以外は、実施例1と同様の手順に従って調製したコンタクトレンズ用処理液で処理した試験コンタクトレンズの親水性、潤滑性及び持続性の評価を実施した。評価結果を下記表2及び表3に示す。 <Examples 2-2 to 2-9>
The hydrophilicity, lubricity and durability of test contact lenses treated with contact lens treatment solutions prepared according to the same procedure as in Example 1 were evaluated, except that the polymers shown in Tables 2 and 3 were used. The evaluation results are shown in Tables 2 and 3.
下記表2及び表3に示す重合体を使用した以外は、実施例1と同様の手順に従って調製したコンタクトレンズ用処理液で処理した試験コンタクトレンズの親水性、潤滑性及び持続性の評価を実施した。評価結果を下記表2及び表3に示す。 <Examples 2-2 to 2-9>
The hydrophilicity, lubricity and durability of test contact lenses treated with contact lens treatment solutions prepared according to the same procedure as in Example 1 were evaluated, except that the polymers shown in Tables 2 and 3 were used. The evaluation results are shown in Tables 2 and 3.
<比較例2-1~2-5>
下記表4に示す重合体及びPVP K30を使用した以外は、実施例1と同様の手順に従って調製したコンタクトレンズ用処理液で処理した試験コンタクトレンズの親水性、潤滑性及び持続性の評価を実施した。評価結果を下記表4に示す。 <Comparative Examples 2-1 to 2-5>
Except for using the polymer and PVP K30 shown in Table 4 below, the contact lenses were treated with the contact lens treatment solutions prepared in the same manner as in Example 1, and the hydrophilicity, lubricity and durability of the treated contact lenses were evaluated. The evaluation results are shown in Table 4 below.
下記表4に示す重合体及びPVP K30を使用した以外は、実施例1と同様の手順に従って調製したコンタクトレンズ用処理液で処理した試験コンタクトレンズの親水性、潤滑性及び持続性の評価を実施した。評価結果を下記表4に示す。 <Comparative Examples 2-1 to 2-5>
Except for using the polymer and PVP K30 shown in Table 4 below, the contact lenses were treated with the contact lens treatment solutions prepared in the same manner as in Example 1, and the hydrophilicity, lubricity and durability of the treated contact lenses were evaluated. The evaluation results are shown in Table 4 below.
<親水性評価>
実施例及び比較例において、ソフトコンタクトレンズの表面親水性評価は下記の手順に従って行った。〇ソフトコンタクトレンズの装用開始時を想定した表面親水性評価
(1)15mLコニカルチューブに生理食塩液10mLを加え、ブリスターパックから取り出した試験コンタクトレンズ5枚を浸漬させ、ローラーミキサーを使用し、50rpmの回転速度で、6時間室温で振盪した。
(2)試験コンタクトレンズを取り出し、1枚ずつ調製したソフトコンタクトレンズ用処理液5mLを加えた10mLガラスバイアルに封入した。
(3)121℃、20分の条件で滅菌処理した。
(4)ガラスバイアルから試験コンタクトレンズを取り出し、レンズ表面の水膜が切れるまでの時間(BUT)をストップウォッチで計測し、下記の基準で評価した。 <Evaluation of hydrophilicity>
In the Examples and Comparative Examples, the surface hydrophilicity of the soft contact lenses was evaluated according to the following procedure: Surface hydrophilicity evaluation assuming the start of wearing the soft contact lenses (1) 10 mL of physiological saline was added to a 15 mL conical tube, and five test contact lenses removed from the blister pack were immersed in the solution, and the lenses were shaken at room temperature for 6 hours at a rotation speed of 50 rpm using a roller mixer.
(2) The test contact lenses were taken out and each was placed in a 10 mL glass vial containing 5 mL of the prepared soft contact lens treatment solution.
(3) The container was sterilized at 121°C for 20 minutes.
(4) The test contact lens was removed from the glass vial, and the time (BUT) until the water film on the lens surface disappeared was measured with a stopwatch and evaluated according to the following criteria.
実施例及び比較例において、ソフトコンタクトレンズの表面親水性評価は下記の手順に従って行った。〇ソフトコンタクトレンズの装用開始時を想定した表面親水性評価
(1)15mLコニカルチューブに生理食塩液10mLを加え、ブリスターパックから取り出した試験コンタクトレンズ5枚を浸漬させ、ローラーミキサーを使用し、50rpmの回転速度で、6時間室温で振盪した。
(2)試験コンタクトレンズを取り出し、1枚ずつ調製したソフトコンタクトレンズ用処理液5mLを加えた10mLガラスバイアルに封入した。
(3)121℃、20分の条件で滅菌処理した。
(4)ガラスバイアルから試験コンタクトレンズを取り出し、レンズ表面の水膜が切れるまでの時間(BUT)をストップウォッチで計測し、下記の基準で評価した。 <Evaluation of hydrophilicity>
In the Examples and Comparative Examples, the surface hydrophilicity of the soft contact lenses was evaluated according to the following procedure: Surface hydrophilicity evaluation assuming the start of wearing the soft contact lenses (1) 10 mL of physiological saline was added to a 15 mL conical tube, and five test contact lenses removed from the blister pack were immersed in the solution, and the lenses were shaken at room temperature for 6 hours at a rotation speed of 50 rpm using a roller mixer.
(2) The test contact lenses were taken out and each was placed in a 10 mL glass vial containing 5 mL of the prepared soft contact lens treatment solution.
(3) The container was sterilized at 121°C for 20 minutes.
(4) The test contact lens was removed from the glass vial, and the time (BUT) until the water film on the lens surface disappeared was measured with a stopwatch and evaluated according to the following criteria.
〇ソフトコンタクトレンズの装用終了時を想定した表面親水性評価
(1)15mLコニカルチューブに生理食塩液10mLを加え、ブリスターパックから取り出した試験コンタクトレンズ5枚を浸漬させ、ローラーミキサーを使用し、50rpmの回転速度で、6時間室温で振盪した。
(2)試験コンタクトレンズを取り出し、1枚ずつ調製したソフトコンタクトレンズ用処理液5mLを加えた10mLガラスバイアルに封入した。
(3)121℃、20分の条件で滅菌処理した。
(4)12ウェルプレートの1ウェルに生理食塩液2mLを加えて、ガラスバイアルから取り出した試験コンタクトレンズ1枚を浸漬させ、振盪機を使用し、80rpmにて、4時間37℃で振盪した。
(5)12ウェルプレートから試験コンタクトレンズを取り出し、レンズ表面の水膜が切れるまでの時間(BUT)をストップウォッチで計測し、下記の基準で評価した。 ○ Evaluation of surface hydrophilicity of soft contact lenses at the end of wearing period (1) 10 mL of physiological saline was added to a 15 mL conical tube, and five test contact lenses removed from their blister packs were immersed in the solution and shaken at room temperature for 6 hours at a rotation speed of 50 rpm using a roller mixer.
(2) The test contact lenses were taken out and each was placed in a 10 mL glass vial containing 5 mL of the prepared soft contact lens treatment solution.
(3) The container was sterilized at 121°C for 20 minutes.
(4) 2 mL of physiological saline was added to one well of a 12-well plate, and one test contact lens taken out of the glass vial was immersed in the saline solution, followed by shaking at 80 rpm at 37° C. for 4 hours using a shaker.
(5) The test contact lenses were removed from the 12-well plate, and the time (BUT) until the water film on the lens surface disappeared was measured with a stopwatch and evaluated according to the following criteria.
(1)15mLコニカルチューブに生理食塩液10mLを加え、ブリスターパックから取り出した試験コンタクトレンズ5枚を浸漬させ、ローラーミキサーを使用し、50rpmの回転速度で、6時間室温で振盪した。
(2)試験コンタクトレンズを取り出し、1枚ずつ調製したソフトコンタクトレンズ用処理液5mLを加えた10mLガラスバイアルに封入した。
(3)121℃、20分の条件で滅菌処理した。
(4)12ウェルプレートの1ウェルに生理食塩液2mLを加えて、ガラスバイアルから取り出した試験コンタクトレンズ1枚を浸漬させ、振盪機を使用し、80rpmにて、4時間37℃で振盪した。
(5)12ウェルプレートから試験コンタクトレンズを取り出し、レンズ表面の水膜が切れるまでの時間(BUT)をストップウォッチで計測し、下記の基準で評価した。 ○ Evaluation of surface hydrophilicity of soft contact lenses at the end of wearing period (1) 10 mL of physiological saline was added to a 15 mL conical tube, and five test contact lenses removed from their blister packs were immersed in the solution and shaken at room temperature for 6 hours at a rotation speed of 50 rpm using a roller mixer.
(2) The test contact lenses were taken out and each was placed in a 10 mL glass vial containing 5 mL of the prepared soft contact lens treatment solution.
(3) The container was sterilized at 121°C for 20 minutes.
(4) 2 mL of physiological saline was added to one well of a 12-well plate, and one test contact lens taken out of the glass vial was immersed in the saline solution, followed by shaking at 80 rpm at 37° C. for 4 hours using a shaker.
(5) The test contact lenses were removed from the 12-well plate, and the time (BUT) until the water film on the lens surface disappeared was measured with a stopwatch and evaluated according to the following criteria.
装用終了時を想定した評価では、実際の終日における涙液量や瞬き回数を考慮し、終日装用(連続装着12時間)した後のコンタクトレンズの状態を想定している。
The evaluation assuming the end of wearing takes into account the actual tear volume and blink rate throughout the day, and estimates the condition of the contact lenses after wearing them all day (12 hours of continuous wear).
評価基準は下記の通りである。
4点:20秒以上
3点:15秒以上
2点:10秒以上、15秒未満
1点:5秒以上、10秒未満
0点:5秒未満 The evaluation criteria are as follows:
4 points: 20 seconds or more 3 points: 15 seconds or more 2 points: 10 seconds or more but less than 15 seconds 1 point: 5 seconds or more but less than 10 seconds 0 point: Less than 5 seconds
4点:20秒以上
3点:15秒以上
2点:10秒以上、15秒未満
1点:5秒以上、10秒未満
0点:5秒未満 The evaluation criteria are as follows:
4 points: 20 seconds or more 3 points: 15 seconds or more 2 points: 10 seconds or more but less than 15 seconds 1 point: 5 seconds or more but less than 10 seconds 0 point: Less than 5 seconds
<潤滑性評価>
実施例及び比較例において、コンタクトレンズの潤滑性評価は下記の手順に従って行った。〇ソフトコンタクトレンズの装用開始時を想定した潤滑性評価
(1)15mLコニカルチューブに生理食塩液10mLを加え、ブリスターパックから取り出した試験コンタクトレンズ5枚を浸漬させ、ローラーミキサーを使用し、50rpmの回転速度で、6時間室温で振盪した。
(2)試験コンタクトレンズを取り出し、1枚ずつ調製したソフトコンタクトレンズ用処理液5mLを加えた10mLガラスバイアルに封入した。
(3)121℃、20分の条件で滅菌処理した。
(4)ガラスバイアルから試験コンタクトレンズを取り出し、ナノトライボメーターNTR3で生理食塩液中での摩擦係数を測定し(プローブ材質:ポリプロピレン、荷重:2mN、移動距離:1.00mm、速度:0.1mm/s)、下記の基準で評価した。 <Lubricity evaluation>
In the Examples and Comparative Examples, the lubricity evaluation of the contact lenses was carried out according to the following procedure: Lubricity evaluation assuming the start of wearing soft contact lenses (1) 10 mL of physiological saline was added to a 15 mL conical tube, and five test contact lenses removed from a blister pack were immersed in the solution, and the solution was shaken at room temperature for 6 hours at a rotation speed of 50 rpm using a roller mixer.
(2) The test contact lenses were taken out and each was placed in a 10 mL glass vial containing 5 mL of the prepared soft contact lens treatment solution.
(3) The container was sterilized at 121°C for 20 minutes.
(4) The test contact lens was removed from the glass vial, and the friction coefficient in physiological saline was measured using a nanotribometer NTR3 (probe material: polypropylene, load: 2 mN, movement distance: 1.00 mm, speed: 0.1 mm/s), and the results were evaluated according to the following criteria.
実施例及び比較例において、コンタクトレンズの潤滑性評価は下記の手順に従って行った。〇ソフトコンタクトレンズの装用開始時を想定した潤滑性評価
(1)15mLコニカルチューブに生理食塩液10mLを加え、ブリスターパックから取り出した試験コンタクトレンズ5枚を浸漬させ、ローラーミキサーを使用し、50rpmの回転速度で、6時間室温で振盪した。
(2)試験コンタクトレンズを取り出し、1枚ずつ調製したソフトコンタクトレンズ用処理液5mLを加えた10mLガラスバイアルに封入した。
(3)121℃、20分の条件で滅菌処理した。
(4)ガラスバイアルから試験コンタクトレンズを取り出し、ナノトライボメーターNTR3で生理食塩液中での摩擦係数を測定し(プローブ材質:ポリプロピレン、荷重:2mN、移動距離:1.00mm、速度:0.1mm/s)、下記の基準で評価した。 <Lubricity evaluation>
In the Examples and Comparative Examples, the lubricity evaluation of the contact lenses was carried out according to the following procedure: Lubricity evaluation assuming the start of wearing soft contact lenses (1) 10 mL of physiological saline was added to a 15 mL conical tube, and five test contact lenses removed from a blister pack were immersed in the solution, and the solution was shaken at room temperature for 6 hours at a rotation speed of 50 rpm using a roller mixer.
(2) The test contact lenses were taken out and each was placed in a 10 mL glass vial containing 5 mL of the prepared soft contact lens treatment solution.
(3) The container was sterilized at 121°C for 20 minutes.
(4) The test contact lens was removed from the glass vial, and the friction coefficient in physiological saline was measured using a nanotribometer NTR3 (probe material: polypropylene, load: 2 mN, movement distance: 1.00 mm, speed: 0.1 mm/s), and the results were evaluated according to the following criteria.
〇ソフトコンタクトレンズの装用終了時を想定した潤滑性評価
(1)15mLコニカルチューブに生理食塩液10mLを加え、ブリスターパックから取り出した試験コンタクトレンズ5枚を浸漬させ、ローラーミキサーを使用し、50rpmの回転速度で、6時間室温で振盪した。
(2)試験コンタクトレンズを取り出し、1枚ずつ調製したソフトコンタクトレンズ用処理液5mLを加えた10mLガラスバイアルに封入した。
(3)121℃、20分の条件で滅菌処理した。
(4)12ウェルプレートの1ウェルに生理食塩液2mLを加えて、ガラスバイアルから取り出した試験コンタクトレンズ1枚を浸漬させ、振盪機を使用し、80rpmにて、4時間37℃で振盪した。
(5)12ウェルプレートから試験コンタクトレンズを取り出し、ナノトライボメーターNTR3で摩擦係数を測定し(プローブ材質:ポリプロピレン、荷重:2mN、移動距離:1.00mm、速度:0.1mm/s)、下記の基準で評価した。 Lubricity evaluation assuming the end of wearing soft contact lenses (1) 10 mL of physiological saline was added to a 15 mL conical tube, and five test contact lenses removed from their blister packs were immersed in the solution, followed by shaking at room temperature for 6 hours at a rotation speed of 50 rpm using a roller mixer.
(2) The test contact lenses were taken out and each was placed in a 10 mL glass vial containing 5 mL of the prepared soft contact lens treatment solution.
(3) The container was sterilized at 121°C for 20 minutes.
(4) 2 mL of physiological saline was added to one well of a 12-well plate, and one test contact lens taken out of the glass vial was immersed in the saline solution, followed by shaking at 80 rpm at 37° C. for 4 hours using a shaker.
(5) The test contact lenses were removed from the 12-well plate, and the friction coefficient was measured using a nanotribometer NTR3 (probe material: polypropylene, load: 2 mN, movement distance: 1.00 mm, speed: 0.1 mm/s) and evaluated according to the following criteria.
(1)15mLコニカルチューブに生理食塩液10mLを加え、ブリスターパックから取り出した試験コンタクトレンズ5枚を浸漬させ、ローラーミキサーを使用し、50rpmの回転速度で、6時間室温で振盪した。
(2)試験コンタクトレンズを取り出し、1枚ずつ調製したソフトコンタクトレンズ用処理液5mLを加えた10mLガラスバイアルに封入した。
(3)121℃、20分の条件で滅菌処理した。
(4)12ウェルプレートの1ウェルに生理食塩液2mLを加えて、ガラスバイアルから取り出した試験コンタクトレンズ1枚を浸漬させ、振盪機を使用し、80rpmにて、4時間37℃で振盪した。
(5)12ウェルプレートから試験コンタクトレンズを取り出し、ナノトライボメーターNTR3で摩擦係数を測定し(プローブ材質:ポリプロピレン、荷重:2mN、移動距離:1.00mm、速度:0.1mm/s)、下記の基準で評価した。 Lubricity evaluation assuming the end of wearing soft contact lenses (1) 10 mL of physiological saline was added to a 15 mL conical tube, and five test contact lenses removed from their blister packs were immersed in the solution, followed by shaking at room temperature for 6 hours at a rotation speed of 50 rpm using a roller mixer.
(2) The test contact lenses were taken out and each was placed in a 10 mL glass vial containing 5 mL of the prepared soft contact lens treatment solution.
(3) The container was sterilized at 121°C for 20 minutes.
(4) 2 mL of physiological saline was added to one well of a 12-well plate, and one test contact lens taken out of the glass vial was immersed in the saline solution, followed by shaking at 80 rpm at 37° C. for 4 hours using a shaker.
(5) The test contact lenses were removed from the 12-well plate, and the friction coefficient was measured using a nanotribometer NTR3 (probe material: polypropylene, load: 2 mN, movement distance: 1.00 mm, speed: 0.1 mm/s) and evaluated according to the following criteria.
装用終了時を想定した評価では、実際の終日における涙液量や瞬き回数を考慮し、終日装用(連続装着12時間)した後のコンタクトレンズの状態を想定している。
The evaluation assuming the end of wearing takes into account the actual tear volume and blink rate throughout the day, and estimates the condition of the contact lenses after wearing them all day (12 hours of continuous wear).
評価基準は下記の通りである。
4点:0.30未満
3点:0.30以上、0.5未満
2点:0.50以上、1.0未満
1点:1.0以上、1.5未満
0点:1.5以上 The evaluation criteria are as follows:
4 points: less than 0.30 3 points: 0.30 or more, less than 0.5 2 points: 0.50 or more, less than 1.0 1 point: 1.0 or more, less than 1.5 0 point: 1.5 or more
4点:0.30未満
3点:0.30以上、0.5未満
2点:0.50以上、1.0未満
1点:1.0以上、1.5未満
0点:1.5以上 The evaluation criteria are as follows:
4 points: less than 0.30 3 points: 0.30 or more, less than 0.5 2 points: 0.50 or more, less than 1.0 1 point: 1.0 or more, less than 1.5 0 point: 1.5 or more
<持続性評価>
実施例及び比較例において、持続性評価は親水性と潤滑性の評価結果を基に、下記の基準で評価した。
◎:両評価とも装用開始時想定と装用終了時想定のスコアが同一
〇:いずれかの評価で装用開始時想定と装用終了時想定のスコアが1点減少した、または両評価とも装用開始時想定と装用終了時想定のスコアが1点減少した
△:いずれかの評価で装用開始時想定と装用終了時想定のスコアが2点減少した
×:両評価とも装用開始時想定と装用終了時想定のスコアが2点減少した、またはいずれかの評価で装用開始時想定が装用終了時想定のスコアが3点以上減少した <Sustainability evaluation>
In the examples and comparative examples, the durability was evaluated based on the evaluation results of hydrophilicity and lubricity and was evaluated according to the following criteria.
◎: The scores for the assumed time at the start and end of wearing were the same in both evaluations. 〇: The scores for the assumed time at the start and end of wearing were reduced by 1 point in either evaluation, or the scores for the assumed time at the start and end of wearing were reduced by 1 point in both evaluations. △: The scores for the assumed time at the start and end of wearing were reduced by 2 points in either evaluation. ×: The scores for the assumed time at the start and end of wearing were reduced by 2 points in both evaluations, or the scores for the assumed time at the start and end of wearing were reduced by 3 points or more in either evaluation.
実施例及び比較例において、持続性評価は親水性と潤滑性の評価結果を基に、下記の基準で評価した。
◎:両評価とも装用開始時想定と装用終了時想定のスコアが同一
〇:いずれかの評価で装用開始時想定と装用終了時想定のスコアが1点減少した、または両評価とも装用開始時想定と装用終了時想定のスコアが1点減少した
△:いずれかの評価で装用開始時想定と装用終了時想定のスコアが2点減少した
×:両評価とも装用開始時想定と装用終了時想定のスコアが2点減少した、またはいずれかの評価で装用開始時想定が装用終了時想定のスコアが3点以上減少した <Sustainability evaluation>
In the examples and comparative examples, the durability was evaluated based on the evaluation results of hydrophilicity and lubricity and was evaluated according to the following criteria.
◎: The scores for the assumed time at the start and end of wearing were the same in both evaluations. 〇: The scores for the assumed time at the start and end of wearing were reduced by 1 point in either evaluation, or the scores for the assumed time at the start and end of wearing were reduced by 1 point in both evaluations. △: The scores for the assumed time at the start and end of wearing were reduced by 2 points in either evaluation. ×: The scores for the assumed time at the start and end of wearing were reduced by 2 points in both evaluations, or the scores for the assumed time at the start and end of wearing were reduced by 3 points or more in either evaluation.
<装用感評価>
実施例及び比較例に関し、装用感評価は、装用終了時想定の親水性と潤滑性の評価結果を基に、下記の基準で評価した。
装用感に優れている:親水性:4、潤滑性:4
親水性:4、潤滑性:3
親水性:3、潤滑性:4
装用感が良好 :親水性:3、潤滑性:3
:親水性:2、潤滑性:3
:親水性:3、潤滑性:2
:親水性:2、潤滑性:2
装用感が不十分 :上記以外 <Wearing comfort evaluation>
Regarding the Examples and Comparative Examples, the wearing comfort was evaluated according to the following criteria based on the evaluation results of hydrophilicity and lubricity assumed at the end of wearing.
Excellent wearing comfort: Hydrophilicity: 4, Lubricity: 4
Hydrophilicity: 4, Lubricity: 3
Hydrophilicity: 3, Lubricity: 4
Comfortable to wear: Hydrophilicity: 3, Lubricity: 3
: Hydrophilicity: 2, Lubricity: 3
: Hydrophilicity: 3, Lubricity: 2
: Hydrophilicity: 2, Lubricity: 2
Insufficient wearing comfort: Other than the above
実施例及び比較例に関し、装用感評価は、装用終了時想定の親水性と潤滑性の評価結果を基に、下記の基準で評価した。
装用感に優れている:親水性:4、潤滑性:4
親水性:4、潤滑性:3
親水性:3、潤滑性:4
装用感が良好 :親水性:3、潤滑性:3
:親水性:2、潤滑性:3
:親水性:3、潤滑性:2
:親水性:2、潤滑性:2
装用感が不十分 :上記以外 <Wearing comfort evaluation>
Regarding the Examples and Comparative Examples, the wearing comfort was evaluated according to the following criteria based on the evaluation results of hydrophilicity and lubricity assumed at the end of wearing.
Excellent wearing comfort: Hydrophilicity: 4, Lubricity: 4
Hydrophilicity: 4, Lubricity: 3
Hydrophilicity: 3, Lubricity: 4
Comfortable to wear: Hydrophilicity: 3, Lubricity: 3
: Hydrophilicity: 2, Lubricity: 3
: Hydrophilicity: 3, Lubricity: 2
: Hydrophilicity: 2, Lubricity: 2
Insufficient wearing comfort: Other than the above
<評価>
実施例2-2、2-4、2-5、2-9のコンタクトレンズ用処理液は、装用開始時想定及び装用終了時想定においてソフトコンタクトレンズ表面へ優れた親水性及び優れた潤滑性を付与でき、それらの持続性も非常に良好だった。すなわち、実施例2-2、2-4、2-5、2-9のコンタクトレンズ用処理液は、優れた親水性及び潤滑性とそれらの持続性により、長時間の優れた装用感をソフトコンタクトレンズに付与できる。
実施例2-7、2-8のコンタクトレンズ用処理液は、装用開始時想定及び装用終了時想定においてソフトコンタクトレンズ表面へ良好な親水性及び良好な潤滑性を付与でき、それらの持続性も非常に良好だった。すなわち、実施例2-7、2-8のコンタクトレンズ用処理液は、良好な親水性及び良好な潤滑性とそれらの持続性により、長時間の良好な装用感をソフトコンタクトレンズに付与できる。
実施例2-1、2-3、2-6のコンタクトレンズ用処理液は、装用開始時想定及び装用終了時想定においてソフトコンタクトレンズ表面へ良好な親水性及び良好な潤滑性を付与でき、それらの持続性も良好だった。すなわち、実施例2-1、2-3、2-6のコンタクトレンズ用処理液は、良好な親水性及び潤滑性とそれらの持続性により、長時間の良好な装用感をソフトコンタクトレンズに付与できる。
比較例1-1のコンタクトレンズ用処理液は、各実施例と比較して装用開始時想定の親水性は良好だったものの、持続性が著しく劣っていた。
比較例1-2のコンタクトレンズ用処理液は、装用開始時想定の親水性は良好であったものの、潤滑性は十分ではなく、装用感は十分ではなかった。
比較例1-3のコンタクトレンズ用処理液は、装用開始時想定の親水性は良好であったものの、潤滑性が十分ではなく、また持続性、装用感は十分ではなかった。
比較例1-4のコンタクトレンズ用処理液は、装用開始時想定の親水性は良好であったものの、潤滑性が十分ではなく、持続性が著しく劣っていた。
比較例1-5のコンタクトレンズ用処理液は、装用開始時想定の装用感は良好であったものの、持続性が著しく劣っていた。 <Evaluation>
The contact lens treatment solutions of Examples 2-2, 2-4, 2-5, and 2-9 were able to impart excellent hydrophilicity and excellent lubricity to the surface of soft contact lenses at the start and end of wear, and the persistence of these properties was also very good. That is, the contact lens treatment solutions of Examples 2-2, 2-4, 2-5, and 2-9 were able to impart an excellent wearing sensation to soft contact lenses for a long period of time due to their excellent hydrophilicity and lubricity and the persistence of these properties.
The contact lens treatment solutions of Examples 2-7 and 2-8 were able to impart good hydrophilicity and good lubricity to the surface of soft contact lenses at the start and end of wear, and the persistence of these properties was also very good. That is, the contact lens treatment solutions of Examples 2-7 and 2-8 were able to impart good wearing comfort to soft contact lenses for long periods of time due to their good hydrophilicity and good lubricity and the persistence of these properties.
The contact lens treatment solutions of Examples 2-1, 2-3, and 2-6 were able to impart good hydrophilicity and good lubricity to the surface of soft contact lenses at the start and end of wear, and the persistence of these properties was also good. That is, the contact lens treatment solutions of Examples 2-1, 2-3, and 2-6 were able to impart good wearing comfort to soft contact lenses for long periods of time due to their good hydrophilicity and lubricity and the persistence of these properties.
The contact lens treatment solution of Comparative Example 1-1 had good hydrophilicity at the start of use compared to the other Examples, but was significantly inferior in durability.
The contact lens treatment solution of Comparative Example 1-2 had good hydrophilicity as expected at the start of wearing, but did not have sufficient lubricity and was not comfortable to wear.
The contact lens treatment solution of Comparative Example 1-3 had good hydrophilicity as expected at the start of use, but did not have sufficient lubricity, and the durability and wearing comfort were also insufficient.
The contact lens treatment solution of Comparative Example 1-4 had good hydrophilicity as expected at the start of wearing, but did not have sufficient lubricity and was extremely poor in durability.
The contact lens treatment solution of Comparative Example 1-5 provided a good wearing sensation as expected at the beginning of use, but was significantly inferior in durability.
実施例2-2、2-4、2-5、2-9のコンタクトレンズ用処理液は、装用開始時想定及び装用終了時想定においてソフトコンタクトレンズ表面へ優れた親水性及び優れた潤滑性を付与でき、それらの持続性も非常に良好だった。すなわち、実施例2-2、2-4、2-5、2-9のコンタクトレンズ用処理液は、優れた親水性及び潤滑性とそれらの持続性により、長時間の優れた装用感をソフトコンタクトレンズに付与できる。
実施例2-7、2-8のコンタクトレンズ用処理液は、装用開始時想定及び装用終了時想定においてソフトコンタクトレンズ表面へ良好な親水性及び良好な潤滑性を付与でき、それらの持続性も非常に良好だった。すなわち、実施例2-7、2-8のコンタクトレンズ用処理液は、良好な親水性及び良好な潤滑性とそれらの持続性により、長時間の良好な装用感をソフトコンタクトレンズに付与できる。
実施例2-1、2-3、2-6のコンタクトレンズ用処理液は、装用開始時想定及び装用終了時想定においてソフトコンタクトレンズ表面へ良好な親水性及び良好な潤滑性を付与でき、それらの持続性も良好だった。すなわち、実施例2-1、2-3、2-6のコンタクトレンズ用処理液は、良好な親水性及び潤滑性とそれらの持続性により、長時間の良好な装用感をソフトコンタクトレンズに付与できる。
比較例1-1のコンタクトレンズ用処理液は、各実施例と比較して装用開始時想定の親水性は良好だったものの、持続性が著しく劣っていた。
比較例1-2のコンタクトレンズ用処理液は、装用開始時想定の親水性は良好であったものの、潤滑性は十分ではなく、装用感は十分ではなかった。
比較例1-3のコンタクトレンズ用処理液は、装用開始時想定の親水性は良好であったものの、潤滑性が十分ではなく、また持続性、装用感は十分ではなかった。
比較例1-4のコンタクトレンズ用処理液は、装用開始時想定の親水性は良好であったものの、潤滑性が十分ではなく、持続性が著しく劣っていた。
比較例1-5のコンタクトレンズ用処理液は、装用開始時想定の装用感は良好であったものの、持続性が著しく劣っていた。 <Evaluation>
The contact lens treatment solutions of Examples 2-2, 2-4, 2-5, and 2-9 were able to impart excellent hydrophilicity and excellent lubricity to the surface of soft contact lenses at the start and end of wear, and the persistence of these properties was also very good. That is, the contact lens treatment solutions of Examples 2-2, 2-4, 2-5, and 2-9 were able to impart an excellent wearing sensation to soft contact lenses for a long period of time due to their excellent hydrophilicity and lubricity and the persistence of these properties.
The contact lens treatment solutions of Examples 2-7 and 2-8 were able to impart good hydrophilicity and good lubricity to the surface of soft contact lenses at the start and end of wear, and the persistence of these properties was also very good. That is, the contact lens treatment solutions of Examples 2-7 and 2-8 were able to impart good wearing comfort to soft contact lenses for long periods of time due to their good hydrophilicity and good lubricity and the persistence of these properties.
The contact lens treatment solutions of Examples 2-1, 2-3, and 2-6 were able to impart good hydrophilicity and good lubricity to the surface of soft contact lenses at the start and end of wear, and the persistence of these properties was also good. That is, the contact lens treatment solutions of Examples 2-1, 2-3, and 2-6 were able to impart good wearing comfort to soft contact lenses for long periods of time due to their good hydrophilicity and lubricity and the persistence of these properties.
The contact lens treatment solution of Comparative Example 1-1 had good hydrophilicity at the start of use compared to the other Examples, but was significantly inferior in durability.
The contact lens treatment solution of Comparative Example 1-2 had good hydrophilicity as expected at the start of wearing, but did not have sufficient lubricity and was not comfortable to wear.
The contact lens treatment solution of Comparative Example 1-3 had good hydrophilicity as expected at the start of use, but did not have sufficient lubricity, and the durability and wearing comfort were also insufficient.
The contact lens treatment solution of Comparative Example 1-4 had good hydrophilicity as expected at the start of wearing, but did not have sufficient lubricity and was extremely poor in durability.
The contact lens treatment solution of Comparative Example 1-5 provided a good wearing sensation as expected at the beginning of use, but was significantly inferior in durability.
本出願は、2023年3月29日出願の日本国出願第2023-053617号に基づく優先権を主張する出願であり、当該出願の明細書、特許請求の範囲および図面に記載された内容は本出願に援用される。
This application claims priority to Japanese Application No. 2023-053617, filed March 29, 2023, and the contents of the specification, claims and drawings of that application are incorporated by reference into this application.
本発明のソフトコンタクトレンズ用処理液をソフトコンタクトレンズに使用することで、終日(長時間)優れた装用感をソフトコンタクトレンズに付与できる。
By using the soft contact lens treatment solution of the present invention on soft contact lenses, it is possible to impart excellent wearing comfort to the soft contact lenses all day (for a long period of time).
By using the soft contact lens treatment solution of the present invention on soft contact lenses, it is possible to impart excellent wearing comfort to the soft contact lenses all day (for a long period of time).
Claims (4)
- 下記式(A)及び(B)で表される構成単位を有し、共重合体(P)全体に対する下記式(A)で表される構成単位のモル比率nAが10~80モル%であり、共重合体(P)全体に対する下記式(B)で表される構成単位のモル比率nBが20~90モル%であり、重量平均分子量が10,000~2,000,000である共重合体。
- 前記共重合体(P)が、下記式(C)または(D)で表される構成単位を有し、共重合体(P)全体に対する下記式(C)または(D)で表される構成単位のモル比率nCおよびnDの合計が0モル%より多く50モル%以下である、請求項1に記載の共重合体。
- 前記構成単位(A)が2-(メタクリロイルオキシ)エチル2-(トリメチルアンモニオ)エチルホスフェートに由来する構成単位である、請求項1または2に記載の共重合体。 The copolymer according to claim 1 or 2, wherein the structural unit (A) is a structural unit derived from 2-(methacryloyloxy)ethyl 2-(trimethylammonio)ethyl phosphate.
- 請求項1から3のいずれか一項に記載の共重合体(P)を0.001w/v%以上、5.0w/v%以下含有する、コンタクトレンズ用処理液。 A contact lens treatment solution containing 0.001 w/v % or more and 5.0 w/v % or less of the copolymer (P) according to any one of claims 1 to 3.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023-053617 | 2023-03-29 | ||
JP2023053617 | 2023-03-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024203572A1 true WO2024203572A1 (en) | 2024-10-03 |
Family
ID=92904776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2024/010658 WO2024203572A1 (en) | 2023-03-29 | 2024-03-19 | Copolymer and contact lens treatment solution |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024203572A1 (en) |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005008607A (en) * | 2003-06-23 | 2005-01-13 | National Institute Of Advanced Industrial & Technology | Insulin secretomotor and endothelin-1 production-suppressing substance |
CN102796224A (en) * | 2012-08-01 | 2012-11-28 | 刘丽平 | Multifunctional bionic polymer, its preparation method and application |
CN103193927A (en) * | 2013-04-27 | 2013-07-10 | 南京构友生物材料有限公司 | Bondable blood-friendly polymer as well as production method and application thereof |
JP2013228383A (en) * | 2012-03-27 | 2013-11-07 | Sumitomo Bakelite Co Ltd | Detection kit and examination method |
WO2014192731A1 (en) * | 2013-05-27 | 2014-12-04 | Jsr株式会社 | Surface treatment agent for surface configured from inorganic material, tool and device having modified surface, and method for manufacturing tool and device |
WO2017018425A1 (en) * | 2015-07-27 | 2017-02-02 | Jsr株式会社 | Method for producing medical device and medical device |
WO2017022815A1 (en) * | 2015-08-04 | 2017-02-09 | Jsr株式会社 | Polymer composition, article, medical device, article production method, and cell cluster production method |
JP2018070716A (en) * | 2016-10-27 | 2018-05-10 | 住友ベークライト株式会社 | Copolymer, bioactive material immobilization polymer for catching biomolecules, coating composition, and article |
JP2018178072A (en) * | 2017-04-13 | 2018-11-15 | 株式会社日本触媒 | Biocompatible medical material |
JP2019026825A (en) * | 2017-08-03 | 2019-02-21 | 住友ベークライト株式会社 | Copolymer, coating composition, and article |
JP2021509738A (en) * | 2018-01-30 | 2021-04-01 | アルコン インク. | Contact lenses with a lubricating coating on it |
JP2022535605A (en) * | 2019-06-28 | 2022-08-09 | アルコン インク. | Ophthalmic composition |
-
2024
- 2024-03-19 WO PCT/JP2024/010658 patent/WO2024203572A1/en unknown
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005008607A (en) * | 2003-06-23 | 2005-01-13 | National Institute Of Advanced Industrial & Technology | Insulin secretomotor and endothelin-1 production-suppressing substance |
JP2013228383A (en) * | 2012-03-27 | 2013-11-07 | Sumitomo Bakelite Co Ltd | Detection kit and examination method |
CN102796224A (en) * | 2012-08-01 | 2012-11-28 | 刘丽平 | Multifunctional bionic polymer, its preparation method and application |
CN103193927A (en) * | 2013-04-27 | 2013-07-10 | 南京构友生物材料有限公司 | Bondable blood-friendly polymer as well as production method and application thereof |
WO2014173299A1 (en) * | 2013-04-27 | 2014-10-30 | 南京构友生物材料有限公司 | Bondable blood-friendly polymer and preparing method and usage thereof |
WO2014192731A1 (en) * | 2013-05-27 | 2014-12-04 | Jsr株式会社 | Surface treatment agent for surface configured from inorganic material, tool and device having modified surface, and method for manufacturing tool and device |
WO2017018425A1 (en) * | 2015-07-27 | 2017-02-02 | Jsr株式会社 | Method for producing medical device and medical device |
WO2017022815A1 (en) * | 2015-08-04 | 2017-02-09 | Jsr株式会社 | Polymer composition, article, medical device, article production method, and cell cluster production method |
JP2018070716A (en) * | 2016-10-27 | 2018-05-10 | 住友ベークライト株式会社 | Copolymer, bioactive material immobilization polymer for catching biomolecules, coating composition, and article |
JP2018178072A (en) * | 2017-04-13 | 2018-11-15 | 株式会社日本触媒 | Biocompatible medical material |
JP2019026825A (en) * | 2017-08-03 | 2019-02-21 | 住友ベークライト株式会社 | Copolymer, coating composition, and article |
JP2021509738A (en) * | 2018-01-30 | 2021-04-01 | アルコン インク. | Contact lenses with a lubricating coating on it |
JP2022535605A (en) * | 2019-06-28 | 2022-08-09 | アルコン インク. | Ophthalmic composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5707843B2 (en) | Contact lens care formulation and packaging solution | |
EP2821841B1 (en) | Contact lens care preparation and packaging solution | |
US20030186825A1 (en) | Contact lens wetting solution | |
JP5609525B2 (en) | Contact lens care formulation and packaging solution | |
EP0580435B1 (en) | Diester monomer, its polymer, water-containing soft contact lens, and processing solution for contact lens | |
US9295747B2 (en) | Contact lens care preparation and packaging solution | |
WO2024203572A1 (en) | Copolymer and contact lens treatment solution | |
JP7228119B2 (en) | Treatment liquid for soft contact lenses | |
JP6944124B2 (en) | Ophthalmic agent | |
TW202438545A (en) | Copolymer and contact lens treatment solution | |
JP7415306B2 (en) | Ophthalmic lens composition | |
JP2019060917A (en) | Solution for storing soft contact lenses | |
WO2023074596A1 (en) | Treatment fluid for soft contact lens | |
JP7567803B2 (en) | Method for treating soft contact lens surfaces | |
JP2022151117A (en) | Contact lens conditioning solution | |
WO2023190365A1 (en) | Copolymer and contact lens treatment solution | |
WO2023276858A1 (en) | Soft contact lens solution | |
JP7099077B2 (en) | Contact lens solution | |
WO2024135647A1 (en) | Copolymer, and composition for eyes | |
JP2019219620A (en) | Contact lens solution | |
JP2019101278A (en) | Treatment solution for contact lenses | |
JP2019060916A (en) | Solution for storing soft contact lenses |